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The group 1 metabotropic glutamate receptors (mGluR1/5) are of key interest in the 
synaptic plasticity that underlies learning and memory and have been implicated as a 
cause or target in many disease models such as Parkinson’s, Huntington’s, Alzheimer’s, 
depression, schizophrenia and fragile X syndrome. Alongside this, group 1 mGluRs are 
linked, via the production endocannabinoid 2-archidonyl glycerol (2-AG), to 
cannabinoid receptor 1 (CB1). CB1 is one of the most highly expressed G-protein 
coupled receptors (GPCRs) in the central nervous system (CNS) and its function has not 
been confirmed in Xenopus laevis tadpoles. Debate and research are still ongoing as to 
how CB1 can be targeted to improve disease outcomes and the extent of its effect in 
vivo.  
The pattern of neuronal signalling in the X. laevis central pattern generator (CPG) has 
been well categorised using electrophysiological recording in the immobilised tadpole 
at stages 37-42. We sought to build on these previous experiments to assess the 
swimming behaviour of the X. laevis tadpole in vivo using slow-motion high frame rate 
video (400 frames per second) to determine the frequency of tail swim cycles and the 
angle of tail flexion achieved during these swim cycles. Using this well-characterised 
model the effects of the two GPCRs can be determined in the unadulterated swimming 
behaviour. X. laevis tadpoles are also advantageous because of low cost in 
maintenance, a simple primary culture that can be set up at room temperature and an 
ectothermic development meaning large batches can be staggered in age.  
We looked to assess well-known plasticity inducing modulatory receptors mGluR1/5 and 
corroborate electrophysiological recordings previously showing mGluR1/5 activation via 
Dihydroxyphenylglycine (DHPG) increased motoneuron output frequency. We tested if, 
as in other models such as lamprey, this increase is partly mediated by retrograde 
cannabinoid signalling. 
Our results show group 1 metabotropic glutamate receptors cause increases in the 
frequency of X. laevis swim-cycles at stage 40-42 evidenced through the application of 
DHPG, a group 1 mGluR agonist. This increase appears to be mainly through mGluR1 as 
inhibition of this receptor via LY367385 caused significant decreases in swim cycle 
frequency whereas inhibition of mGluR5 with 2-Methyl-6-(phenylethynyl)pyridine 
(MPEP) caused no significant decreases, indicating an intrinsic role for mGluR1 over 
mGluR5 in the maintenance of normal swim cycle frequency. Antagonism of CB1 with 
AM-251 caused significant decreases at 50µM and 10μM. However, a significant 
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increase was observed at 2μM indicating a biphasic effect dependent on concentration. 
Inhibition of CB1 with AM-251 (10μM) followed by application of DHPG (50μM) had no 
significant effect on the frequency of swim cycles when compared with vehicle control, 
indicating that the increase seen with DHPG application may be blocked by CB1 
inhibition. Application of endogenous CB1 agonist N-arachidonoylethanolamide (AEA) 
decreased frequency of swim cycles at lower concentrations (0.1-10μM), but no 
significant change was observed at the highest concentration (50μM). This may be 
some form of partial antagonism due to a higher affinity of AEA than other endogenous 
ligand 2-AG, but lower efficacy, effectively occupying the CB1 receptor without 
activation. Our data suggest that mGluR5 and CB1 may be involved in the normal 
muscle flexion during swimming with the application of MPEP alone or with AM-251 
causing significant decreases in the angle of tail flexion. 
We wanted to see if these changes in behaviour reflect in the morphology of neurons, 
particularly the dendritic spines dimension and membrane viscoelasticity. To do this, a 
primary X. laevis neuron-muscle co-culture was developed from the literature. The 
cultures were treated with the same pharmacological treatments and fixed in 
glutaraldehyde 5%. The dendritic spines of the neurons were scanned with an Atomic 
Force Microscope (AFM). From these scans the dendritic spine dimensions measured 
were; radius, volume, cross-sectional area, and membrane roughness. Using the phase 
contrast images, the loss tangent was calculated to give a unitless ratio of membrane 
stiffness. This  measure of the stiffness/viscosity of the sample was used to determine if 
the dendritic spine head changed significantly in stiffness after group 1 mGluR or CB1 
targeted drug treatment. 
With AFM analysis of dendritic spine morphology and membrane stiffness, we found 
that group 1 mGluR activation elongated dendritic spines corroborating previous 
evidence in immature developing spines and in mature hippocampal cultures. 
Interestingly inhibition of mGluR5 also elongated the spines alongside increasing the 
volume of the spines. Both mGluR5 inhibition with MPEP and group 1 mGluR activation 
with DHPG caused significant increases in dendritic spine membrane stiffness 
compared with vehicle controls.  
We aimed to investigate if the 20-minute application of treatments induced changes in 
protein expression, particularly postsynaptic density protein-95 (PSD-95) a postsynaptic 
structural protein present in glutamate synapses linked to NMDAR function, a key 
receptor in the glutamate excitation of descending interneurons (dINs).  
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After the behavioural assessment, the tadpoles were fixed and embedded in paraffin 
wax for microtome sections, which enabled observation of the spinal cord, which was 
investigated for changes in PSD-95 density using immunohistochemical means.  
After scanning with AFM, the cultures were stained with anti-PSD-95 antibodies and 
changes in fluorescence were measured. The results of this investigation were 
inconclusive due to large autofluorescence meaning a clear positive signal could not be 
identified. 
The in vivo swimming analysis gives almost completely unadulterated tadpoles for 
analysis of swim-cycle output with a very well understood neuronal network that 
serves as an excellent model for the interplay between excitatory and inhibitory 
signalling of CPG networks. 
In future AFM scanning can be used alongside fluorescent confocal microscopy to build 
a detailed picture of morphology and changes in membrane dynamics that may aid our 
understanding of synapse formation in normal development and in genetic disease 
such as fragile X.  
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Neurons are the main signalling cells in the central and peripheral nervous system that enable 
the co-ordination of our various biological functions. The higher brain regions are a complex 
array of over 3 billion neurons that store our memories, control our emotional response to 
events and allow cognitional processing that gives us decision making abilities and control over 
our lives. As we move towards the centre of the brain more primitive structures in the pons, 
medulla and hypothalamus regulate everything that keeps us alive such as heart rate, 
breathing and temperature. As we move down through the brainstem, neurons of the spinal 
cord and periphery initiate actions such as movement in muscle and stimulate or inhibit organs 
in the production of hormones. They do all this and more by communicating with each other 
and their target tissues via the release of neurotransmitters across the synaptic cleft. Although 
the outcome of neural signalling can be drastically different, whether they are creating and 
storing memories in the hippocampus or regulating the antagonistic contractions of muscle 
groups, the primary principles with which they operate is universal from humans to tadpoles.   
Neuron structure varies dependent on location in the central nervous system (CNS) 
and peripheral nervous system (PNS) but all neurons have some form of dendritic projections 
which receive inputs, a soma containing the nucleus and an axon. Neurons enable function 
through tight regulation of ion channels and receptor systems, meaning that through rapid 
changes in the net charge of the membrane potential, summation of these inputs generate an 
action potential once the threshold for that neuron is reached. Figure 1.1.1 demonstrates the 
classic structure of a neuron, the dendritic tree of most neurons has dendritic spines, tiny 
protrusions that receive the signals across the small gap termed the synapse, from another 
neuron’s axon terminal. However, the axon does not have to synapse onto dendritic spines 
and can synapse with the soma or dendritic tree. Dendritic spines are currently thought to only 
receive excitatory signals although some emerging evidence of dendritic spines receiving 
inhibitory neurotransmission has been provided (Chen et al., 2012; van Versendaal et al., 
2012).  
The internal charge of a neuron at rest usually exist at -70mV in comparison to the 
extracellular space. When the dendrite receives an input in the form of a neurotransmitter or a 
physical phenomenon such as pressure change or light, sodium (Na+) channels open allowing 
Na+ to diffuse into the cell along the electrochemical gradient in a localised area close to that 
input. This increases the net charge of the neuron. If the signal is large enough or enough 
signals summate together Na+ channels will open in a wave like fashion along the membrane 
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and the internal charge of the neuron will eventually reach the threshold potential. Once this 
occurs an action potential will fire. This involves sodium channels opening in a wave down the 
axon rapidly propagating the signal to the axon terminal. At the axon terminal the final step is 
the opening of calcium (Ca2+) channels which initiate the release (exocytosis) of 
neurotransmitters. These neurotransmitters will diffuse across the synapse and either cause 
the excitation or inhibition of the receiving neuron. If the excitation is a strong enough signal it 
will repeat the process and fire another action potential, continuing the process, or inhibition 
will stop it from firing an action potential.  Once the action potential has fired membrane 
bound sodium/potassium ATPase pumps return the internal net charge of the neuron to 
resting -70mV after a brief hyperpolarisation (Figure 1.1.1). 
Although there is a wide variety of neurotransmitters and their corresponding 
receptors the principle of all of them is the same: they either depolarise the neuron in events 
of excitatory postsynaptic currents (EPSC), which summate to excitatory postsynaptic 
potentials (EPSP), or hyperpolarise the neuron inhibiting or reducing the likelihood of action 
potential generation with inhibitory postsynaptic currents (IPSC), which summate to inhibitory 
postsynaptic potentials (IPSP). 
In this thesis I will predominantly focus on glutamate and glycine neurotransmitter releasing 
neurons of the Xenopus laevis tadpole, stages 37-42, in the central pattern generator (CPG) of 
Figure 1.1.1- Neuron structure and action potential generation. Left schematic of a neuron its dendritic tree 
with many dendritic spines, soma and axon. Right- classic representation of the net charge change of the 
intracellular space of the neuron during an action potential. 1 Stimulus and summation -if the inputs 
received at the dendritic spines, dendritic tree and soma summate to a large enough change in charge the 
threshold potential is reached, 2. Depolarisation- once passed threshold ion channels (mainly sodium) 
rapidly open causing massive influx of positively charged ions until action potential is reached. 3 
repolarisation- potassium channels open and sodium channels inactivated leads to efflux of K+ alongside 
K+/Na+ pumps reducing internal charge of neuron. 4 hyperpolarisation – the efflux of K+ overshoots 
inhibiting neuron from firing action potential in this time. 5 return to resting potential ready to fire another 





the hindbrain and spinal cord. We have focussed on these two neurotransmitter systems 
because they are the main neurotransmitters that regulate the speed of left-right alternating 
contractions of the tadpole tail during swimming. However, they are also ubiquitous systems 
that are implicated in diseased systems such as neurodegeneration, excitotoxity, anxiety, 
depression, loss of memory function and motor control. 
We will investigate if the group 1 metabotropic glutamate receptors (mGluRs) and 
cannabinoid receptor 1 (CB1) affect the frequency of swim-cycles and the flexion of the tail 
during swimming in vivo. These are two receptor systems that modulate glutamate signalling 
and CB1 can also reduce glycine release. We will ask whether the manipulation of these 
receptor systems affect changes in behaviour, and if this is transient through short term ion 
channel changes or by changing the morphology of dendritic spines in culture, assessed using 
atomic force microscopy. We will then investigate if these changes are reflected in the 
expression of a key post-synaptic density protein PSD-95 assessed using 
immunohistochemistry. Morphology of dendritic spines is a key marker to function (discussed 
in section 1.7) and has implications for neuron recovery from injury and abnormal systems, 
such as fragile X and autism. PSD-95 is a key structural protein in excitatory synapses and 
increases in expression may be an indicator of enhanced excitatory post synaptic density 
efficiency. 
1.1 Central Pattern Generators  
CPGs are neural networks that control rhythmic motor patterns such as breathing, walking, 
flying and swimming (Marder and Bucher, 2001; Ijspeert, 2008). When maintaining a rhythmic 
motion antagonistic muscle groups are excited near simultaneously, and the regulation of 
alternation between them is controlled by inhibitory interneurons. While one side contracts 
the other side is inhibited. In walking, once the thought to stimulate walking has occurred the 
process of alternating legs is controlled by a CPG meaning the signal from the brain can be 
thought of as always on, while inhibitory interneurons regulate the timing of when and which 
legs move. This process of maintaining a complex motor pattern with low-level input from 
higher brain regions means CPGs are an excellent model for investigation into the fundamental 
interplay between interneurons that regulate motor output. Their ubiquitous nature from 
drosophila to humans means that more accessible models such as Drosophila, X. laevis and 
Petromyzontiformes can be useful studies for disease models such as spinal cord injury, fragile 
X and autism. The ease of genetic manipulation and pharmacological intervention makes these 
models, which have predictable and well-characterised patterns of CPG output, essential if we 
want to improve disease outcomes in humans. Further to this, as we enter the realm of 
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robotics (Ijspeert, 2008), understanding the CPG networks’ regulation of motor patterns such 
as walking will be key to producing functional robots that can perform the complex function of 
walking upright, something many of us take for granted. CPG networks offer a reliable output 
measurable by electrophysiological recording and, as we will show, high-speed video, that 
means fundamental question can be answered. Questions relating to the structure and 
function of neuron groups, the effect of receptor signalling and elucidating the integral role of 
excitation-inhibition balance present throughout the CNS, dysregulation of which is implicated 
in many neurological disorders such as schizophrenia, depression and autism.  
1.2 The synapse and plasticity 
Synaptic plasticity is a term used to define the activity-dependent change in synapse 
configuration. This involves changes in receptor expression, changes in the probability of 
neurotransmitter released and changes in protein expression that can result in structural 
changes, which either enhance receptor position and enable more efficient signalling or 
decrease receptor expression, change dendritic spine morphology and depress/reduce 
efficiency in signalling. The change in synapse organisation requires structural changes which 
enable efficiency and stability. These changes are separated into short-term and long-term 
changes (Bosch and Hayashi, 2012; Hunt and Castillo, 2012; Huganir and Nicoll, 2013; Sala and 
Segal, 2014).   
1.3 Group 1 metabotropic glutamate receptors in health and disease 
Group 1 mGluRs have been implicated in neurological disease. Most prominently in the study 
of fragile X syndrome (FXS) a form of autism (Dölen and Bear, 2008). FXS is caused by a 
mutation that leads to transcriptional silencing of the FMR1 gene which transcribes FMRP, a 
key downstream protein initiated by group 1 mGluR activation that is thought to suppress 
gene transcription. It was shown in FMR1 knockout mice that mGluR-LTD was increased. When 
mice were generated that either lacked the FMR1 gene or the mGluR5 receptor it was found 
that a 50% reduction in mGluR5 expression in FMR1 knockout mice almost corrected the FXS 
phenotype, providing more evidence that mGluR5 increases protein synthesis and FMRP 
negatively regulates this protein synthesis (Dölen and Bear, 2008). The current theory suggests 
that lacking FMRP produces an LTD phenotype similar to DHPG-LTD (100µM) because 
unregulated/massive increases in mGluR induced protein synthesis, produce an LTD phenotype 
without regulation of these genes or high-frequency stimulation. This is somewhat 
corroborated by in vitro evidence of the geometric changes in dendritic spine shape observed 
with DHPG-LTD (Vanderklish and Edelman, 2002). Antagonism of mGluR5 inhibited elongation 
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of developing dendritic spines in a similar way to FMR1 knockout mice, in contrast to the 
healthy mouse brain, where DHPG or glutamate-induced elongation and stabilisation of 
developing dendritic spines (Cruz-Martín, Crespo and Portera-Cailliau, 2012). This also 
highlights the possibility of different roles for group 1 mGluRs during development compared 
with the maintenance of dendritic spines in mature organisms. 
Group 1 mGluRs are also of keen interest to the treatment of epilepsy (Ure, Baudry and 
Perassolo, 2006), Alzheimer’s disease (Kumar, Dhull and Mishra, 2015), Parkinson’s (Amalric, 
2015) and prion toxicity (Goniotaki et al., 2017). 
1.4 Glutamate and excitatory signalling 
Glutamate is the main excitatory neurotransmitter in the CNS. It was first acknowledged to be 
an excitatory neurotransmitter in the 1980s (Fonnum, 1984). L-glutamate, the amino acid, is 
the starting block for the two most abundant signalling systems in the CNS: the excitatory 
glutamate releasing neurons, and the inhibitory γ-aminobutyric acid (GABA) releasing neurons. 
This is achieved through the enzyme L-glutamic acid decarboxylase. L-glutamate is modified to 
GABA, which when released produces inhibitory effects in the postsynaptic neuron through 
activation of GABARs and subsequent influx of chlorine ions. Glutamate signalling is of key 
interest in synaptic plasticity involved in learning and memory, and genetic disorders, such as 
anxiety, depression, fragile X and excitotoxicity induced by stroke or neuron death. 
Being such a ubiquitous neurotransmitter in the CNS it stands to reason there are several 
receptors activated by glutamate (Jahr and Stevens, 1987). These are typically split into two 
categories: ionotropic and metabotropic. The ionotropic receptors encompass the N-Methyl-D-
aspartic acid (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and 
kainite receptors, which differ in their synthetic agonist specificities and ions they allow into 
the cell. Each receptor has multiple subunits which combine differently dependent on cell 
type, and the combination of these subunits changes their ionic conductance properties. The 
similarity is their function as gated ion channels, enabling depolarisation after activation by 
glutamate (Glutamate receptors summarised in table 1.4.1). 
AMPARs have four subunits GluA1-4 that form heteromeric tetrameric complexes. When 
activated by glutamate AMPARs allow conductance of Na+ through its ion channel and a small 
efflux of K+ (termed the leak current). AMPARs are the main excitatory glutamate receptor, 
they are the first receptor activated in a glutamate postsynaptic density (PSD) and initiate the 
depolarisation of the membrane. The position and density of AMPARs are linked to the state of 
the synapse (Matsuzaki et al., 2004). A key area for research is how AMPARs are cycled in and 
out of the PSD. Current evidence suggests that large rafts of AMPARs are tethered to the PSD 
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in a potentiated synapse (Matsuzaki et al., 2001, 2004; Huganir and Nicoll, 2013). The GluA1-4 
subunits are phosphorylated on serine, threonine, and tyrosine residues by several protein 
kinases including calcium/calmodulin-dependent protein kinase II (CaMKII), protein kinase A 
(PKA), protein kinase C (PKC), cyclic GMP-dependent protein kinase (PKG), proto-oncogene 
tyrosine-protein kinase (FYN), and c-Jun N-terminal kinases (JNK) on over 20 different 
phosphorylation sites (Shepherd and Huganir, 2007; Lu and Roche, 2012). The differences in 
phosphorylation of AMPARs are numerous, but they can be thought of in two categories: 
either enhancing synaptic transmission or decreasing synaptic transmission. 
The NMDAR has subunits GluN1-3, with each subunit having several splice variants. At 
resting potential NMDAR is blocked by Mg2+ in the channel pore of the receptor. NMDARs are 
only activated when the Mg2+ block is removed by AMPAR-mediated depolarisation or voltage-
clamp experiments where the potential of the membrane is increased. Then, the binding of 
glutamate and glycine to the active site in the extracellular N-terminus (Mayer, Westbrook and 
Guthrie, 1984) opens the channel and allows Ca2+ and Na+ into the cell. NMDARs are thought 
to be the key to the enhancement or reduction in the size of the PSD, structural changes which 
are thought to underlie learning and memory (Li and Tsien, 2009). Their activation allows Ca2+ 
influx through which CAMKII is activated stimulating a series of phosphorylation events which 
are linked to synapse growth (Herring and Nicoll, 2016). CAMKII was originally thought to be 
the sole molecule responsible for potentiation. However, evidence showed that calcium spikes 
only caused transient increases in CAMKII activity and it was the downstream effectors that 
are phosphorylated by CAMKII that cause potentiation (Lee et al., 2009). PSD-95 (postsynaptic 
density protein-95) binds directly to the carboxy-terminal tails of GluN2 subunits of NMDARs 
(Kornau et al., 1995; Niethammer, Kim and Sheng, 1996). In this way, PSD-95 appears to 
stabilize NMDARs at the cell surface. Phosphorylation of GluN2 subunits affects their 
interaction with PSD-95 and regulates GluN2 subunit composition at synapses (Sanz-Clemente 
et al., 2010). 
  NMDAR dysfunction is linked to many psychiatric disorders such as schizophrenia. It 
was discovered that the illicit drug ‘angel dust’ is an antagonist of NMDAR and causes severe 
hallucinations similar to psychosis (Luby et al., 1959; Bowers and Hoffman, 1984; Freeman and 
Bunney, 1984; Moghaddam and Krystal, 2012). Although the Na+ flow across the cell 
membrane is essential, it is the regulation of Ca2+ that is linked to many biological processes. In 
the post-synaptic density concentration of Ca2+ is essential. Dysregulation of Ca2+ can cause cell 
death, which can be initiated by excessive glutamate stimulation of neurons, termed 
excitotoxicity (Kornau et al., 1995). 
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Modulating the activity of excitatory glutamate releasing neurons are the inhibitory neurons, 
which produce neurotransmitters GABA or glycine. Unlike excitatory synapses, inhibitory 
neurons usually release their inhibitory neurotransmitters onto the neuron soma, although 
emerging evidence suggests they may also synapse with dendritic spines (Chen et al., 2012). 
When inhibitory neurotransmitters (GABA or glycine) are released across the synapse they 
activate their respective ionic receptors (GABAR or GlyR) allowing Cl- into the cell, 
hyperpolarising the membrane potential. The Cl- influx counteracts the future influx of positive 
ions (Na+ and Ca2+) and disables the ability of the cell to depolarise and fire an action potential 
(Mody and Pearce, 2004). The interplay between excitatory glutamate and inhibitory 
GABA/Glycine signalling regulates the firing frequency of the majority of the CNS and are the 
two most studied systems involved in synaptic plasticity.  
Table 1.4.1- The Glutamate receptors 




release and firing 
rate 





Increase in Na+ entry 




will increase the rate 
of fire of neuron 






required to remove 
Mg2+ block once 
open Ca2+ and Na+ 
entry enhances final 
push to 
depolarisation and 
action potential. On 
its own constitutive 
activity would not 






Metabotropic GPCR Predominantly post-
synaptic, also presynaptic 
discoveries. Often exist 
extra-synaptically 
Increased release of 
internal calcium will 





signalling via 2-AG 















release (when on 
presynaptic 
terminal) via 
inhibition of calcium 
channels. Activation 
of K+ channels, 








Metabotropic GPCR Predominantly 




release (when on 
presynaptic 
terminal) via 
inhibition of calcium 
channels. Activation 
of K+ channels, 















1.4.1 Metabotropic glutamate receptors 
The metabotropic glutamate receptors (mGluRs) have 8 subtypes (mGluR1-8) that are split into 
three groups depending on their structure and function. They are all GPCRs with seven 
transmembrane loops and different second messenger signalling pathways regulated by the g-
proteins they couple to. Group 2 and 3 mGluRs are predominantly coupled to Gi/o proteins. Gi/o 
linked receptors are classically coupled to the inhibition of adenylyl cyclase. Through the action 
of Gβγ subunits they also directly regulate ion channels, such as g protein-coupled inwardly 
rectifying potassium channels (GIRKs). They have also been shown to affect many other 
downstream signalling pathways, such as activation of MAPK and phosphatidyl Inositol 
trisphosphate (IP3) and Phosphoinositide 3-kinase (PI3K) pathways (Iacovelli et al., 2002; 
Niswender and Conn, 2010). They are predominantly presynaptic, although many instances of 
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postsynaptic group 2 and 3 mGluRs have been documented, their activation is generally linked 
to inhibition of neurotransmitter release, although this can vary depending on cell type. 
 
1.4.2 Group 1 metabotropic glutamate receptors 
There are two group 1 mGluR sub-types, mGluR1 and mGluR5 (summarised in Table 1.4.2), 
predominantly found in the extra-synaptic location of dendritic spines, although they are also 
commonly found on glia and presynaptically on axon terminals (Watabe, Carlisle and O’Dell, 
2002). Many splice variants  have been categorised (mGluR1a,b,c,d,e,f; mGluR5a,b, (Niswender 
and Conn, 2010). mGluRs contain a large N-terminal domain named the Venus Fly Trap domain 
(VDF). The VDF is the active site of glutamate binding (Kunishima et al., 2000; Bessis et al., 
2002). As shown in Figure 1.4.1, when glutamate binds to mGluR1/5 the signal propagates 
through the cysteine-rich domain causing a conformational change, which liberates the g-
proteins coupled intra-cellularly. They couple to Gq /G11 and activate phospholipase Cβ (PLCβ), 
resulting in the hydrolysis of phosphoinositides and generation of inositol 1,4,5-trisphosphate 
(IP3) and diacylglycerol (DAG) (Hermans and Challiss, 2001). IP3 releases Ca2+ from intracellular 
stores of the endoplasmic reticulum, that enhances depolarisation and activates protein kinase 
C (PKC). Depending on the cell type or neuronal population, group I mGluRs can activate a 
range of downstream effectors, including phospholipase D (PLD), protein kinase pathways such 
as casein kinase 1, Jun kinase, cyclin-dependent protein kinase, the mitogen-activated protein 
kinase extracellular receptor kinase (MAPK/ERK) pathway, and the mammalian target of 
rapamycin (MTOR)/p70 S6 kinase pathway (Page et al., 2006; Li et al., 2007). Their main 
function is to enhance the signal, whether it be depression or potentiation of the dendritic 
spine. Through interaction with the main ionic glutamate receptors (AMPAR and NMDAR), 
they can enhance depolarisation or ensure depression. It is also thought that through 





Table 1.4.2- The group 1 metabotropic glutamate receptors agonist and antagonist and signalling 
cascades 
   





Signalling cascades and ion channel 
activation 
mGluR1 DHPG LY367385 Phospholipase C-IP3-Ca2+ release 
from endoplasmic reticulum, 
adenylyl cyclase activation, DAG 
lipase activation 
GIRK channel opening 
mGluR5 DHPG MPEP 
Figure 1.4.1- Schematic of the glutamate receptors AMPAR, NMDAR and group 1 mGluRs. Once glutamate 
(blue circles large) bind to the AMPAR the channel opens and allow influx of Na+ (blue dots). This 
depolarisation in the membrane removes the magnesium block from the NMDAR channel. Glutamate and 
glycine (purple) bind to the receptor opening the channel and allowing Ca2+ (red dots) to enter increasing 
the postivie internal charge of the neuron enhancing the likelyhood of action potential generation. Group 1 
mGluR’s are a GPCR activated by glutamate. The g-proteins release PLCβ from the membrane which 
activates DAG and IP3. IP3 releases Ca2+ from internal stores in the endoplasmic reticulum. 
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1.5 The endocannabinoid system: Background and basics 
The cannabinoid system has been shown to affect many processes in the body, some of which 
are: hunger and metabolism (DiPatrizio and Piomelli, 2012); sleep (Vaughn et al., 2010); 
learning and plasticity (Marsicano and Lafenêtre, 2009; Yang and Calakos, 2013); and motor 
control (El Manira and Kyriakatos, 2010; Chaouloff et al., 2011; Polissidis et al., 2013). It may 
also be a new therapeutic target for obesity, inflammation and neurodegeneration, 
schizophrenia and autism (Younts and Castillo, 2014). 
The endocannabinoid system has been of keen interest to research since the discovery of the 
cannabinoid receptors (Devane et al., 1988) and the subsequent discovery of endogenous 
ligand N-arachidonoylethanolamide (AEA) from the porcine brain (Devane et al., 1992). 
Successive ligands have been discovered the most studied of which is 2-archidonyl glycerol (2-
AG) (Mechoulam et al., 1995). The cannabinoid receptors are G-protein coupled receptors 
(GPCRs) and their ligands are eicosanoids, lipid-based, that are cleaved from membrane 
precursors and the metabolised products of both ligands feed into the arachidonic acid 
prostaglandin signalling system. The cannabinoid system is best known in society for the 
recreational plant marijuana, which contains Tetrahydrocannabinol (THC). THC produces a 
“high” when smoked or consumed orally in large quantities and is linked to psychosis and 
schizophrenia in vulnerable/at-risk users, most likely through a process of NMDAR 
hypofunction (Sánchez-Blázquez, Rodríguez-Muñoz and Garzón, 2014). Its use is also linked to 
short term memory loss (Mallet and Beninger, 1998; Robinson et al., 2007). However, there 
are many studies that show that cannabinoids may help with insomnia, anorexia (Støving et 
al., 2009), depression and anxiety(Huang, Chen and Zhang, 2016). And cannabidiol (CBD) 
(another component of the marijuana plant) may even combat psychosis (Schubart et al., 
2014), due to an inverse agonist/ functional selectivity effect (essentially having the opposite 
effect at the CB1 receptor, it recruits the stimulatory alpha subunit stimulating adenylyl cyclase 
conversion of ATP to cAMP).  
There are two known cannabinoid receptors named CB1 and CB2, though other orphan 
receptors have been suggested, such as GPR55 and GPR119 (Brown, 2007; Ryberg et al., 2007; 
Godlewski et al., 2009). CB1 has been identified mainly in the CNS and periphery (Tsou et al., 
1998) with CB2 found in tissues and immune cells. However, recent evidence suggests their 
presence in neurons (Morgan, Stanford and Woodhall, 2009). CB1 is a presynaptic receptor 
and its ligands are produced from postsynaptic membrane based on its activity. The short term 
function of CB1 was first determined in Purkinje cells (Vincent, Armstrong and Marty, 1992) 
and confirmed in hippocampal slices (Pitler and Alger, 1992). The process is termed 
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depolarisation induced suppression of inhibition/excitation (DSI/E), due to its ability to inhibit 
the future release of neurotransmitter from the inhibitory/excitatory presynaptic terminals on 
which it resides. As summarised in Figure 1.5.1, the CB1 receptor achieves DSI/E  primarily by 
inhibiting the N, P/Q and L-type Ca2+ channels (Howlett, Blume and Dalton, 2010), reducing 
calcium influx at axon terminals and stopping neurotransmitter release. CB1 also activates 
inwardly rectifying K+ Channels (Diana and Marty, 2003)(Augustine, 2001). This function means 
that CB1 can alter the glutamate excitation of postsynaptic cells and thus affect the 
development of LTP and LTD at synapses (Cui et al., 2015). As a GPCRαi/o the CB1 receptor also 
decreases cyclic AMP (cAMP) response element binding protein (CREB) transcription through 
the inhibition of adenylyl cyclase by its alpha subunit. It also activates MAPK signalling and 
modulates the phosphoinositide-3-kinase (PI3K)-mediated signalling cascade (Castillo et al., 
2012; Huang, Chen and Zhang, 2016). 
The synthesis of the endocannabinoids is dependent on postsynaptic conditions with 
production linked to calcium influx, group 1 mGluR activation and NMDAR activation (Kettunen 
et al., 2005; Liu et al., 2006; Sánchez-Blázquez, Rodríguez-Muñoz and Garzón, 2014). AEA 
synthesis has multiple pathways from the membrane precursor N-Arachidonoyl-
phosphatidylethanolamine (NAPE). Its synthesis from NAPE is normally mediated by NAPE –
Phospholipase D (NAPE-PLD), although AEA levels in most tissues were found unchanged in 
NAPE-PLD knockout mice (Leung et al., 2006), which has led to the proposal of other pathways. 
The catabolism of AEA is carried out by fatty acid amide hydrolase (FAAH) to give arachidonic 
acid and ethanolamine. 2-AG has a much simpler synthetic pathway cleaved from the 
membrane precursor Phosphatidylinositol 4,5-bisphosphate (PIP2) via the phospholipase C- β 
(PLC-β) pathway to diacylglycerol (DAG). This is converted to 2-AG mediated by DAG lipase and 
is catabolised by monoacylglycerol lipase (MAGL) to arachidonic acid and glycerol (figure 1.5.1) 
(Bisogno et al., 2003; Gao et al., 2010) Interestingly FAAH is located primarily in postsynaptic 
regions of dendrites and somata with MAGL localised in axon terminals (Gulyas et al., 2004). 
There is some controversy over the transport of AEA. It has been reported that inhibition of 
the FAAH-like anandamide transporter (FLAT) increases levels of AEA, indicating this protein 
was involved in carrying AEA back across the synapse to FAAH in the postsynaptic neuron. This 
has recently been disputed (Leung et al., 2013) as it was found that FLAT does not leave the 
postsynaptic cell and is mainly located in intracellular membranes and cytoplasm, suggesting 
that its effects to speed up the catabolism are enzymatic signalling from within the cell. 
There have been other endocannabinoids discovered and characterized which are: 
virodhamine (Porter et al., 2002), N-arachidonoyl-dopamine (NADA)(Huang et al., 2002), 2-
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arachidonyl glycerol ether (Hanus et al., 2001), N-palmitoylethanolamine (PEA) and N-
oleoylethanolamide (OEA). Virodhamine is the same atomic make-up as AEA with the amide 
bond changed to an ester bond and this change makes it an antagonist at CB1, but a full 
agonist at CB2 (Porter et al., 2002). The experiment quantifying virodhamine in the rat and 
human hippocampus found it to be similar in concentration to that of anandamide. This 
suggests a complex control mechanism of AEA activation and virodhamine inhibition of CB1 in 
the brain. N-arachidonoyl-dopamine is an agonist of CB1 and not an agonist of the dopamine 
receptors. It acts like capsaicin (the active component of chilli peppers) and activates the 
receptor transient receptor potential vanilloid 1 (TRPV1) causing the production of substance P 
involved in nociception (Huang et al., 2002). Anandamide has been investigated as an 
analgesic, even suggested to be an endovanniloid (Tóth, Blumberg and Boczán, 2009) due to its 
endogenous agonist activity at TRVP1. This receptor is an unspecific cation channel that is 
linked to pain perception, and often referred to as the capsaicin receptor or vanilloid receptor 
1. NADAs discovery suggests further roles for the cannabinoids in pain regulation. 2-
arachidonyl glycerol ether has been shown to be an endogenous ligand of CB1 causing 
hypothermia and mild anti-nociception (Hanus et al., 2001). N-palmitoylethanolamine (PEA) 
and N-oleoylethanolamide (OEA) although classed as endocannabinoids do not activate either 
receptor. Their effects are classed as “entourage effects” and are thought to be synthesised 
alongside AEA, enhancing or regulating the outcome of AEA induced CB1 activation (Okamoto 
et al., 2004). They have been shown to activate peroxisome proliferator-activated receptor 
alpha (PPARα), although this receptor did not account for all of their physiological effects. 
Recently, they have been shown to have an affinity to the orphan GPCRs GPR55 and GPR119, 
whose function is still being explored. Although deletion displays no clear disease phenotypes 
they appear to have some role in development (Godlewski et al., 2009). PPARα is nuclear 
receptor transcription factor, the activation of which upregulates genes that co-ordinate the 
transport, uptake and utilisation of fatty acids. The endocannabinoid system has effects on 
energy metabolism and this receptor may contribute to this through the entourage effects of 





Figure 1.5.1-Retrograde endocannabinoid signalling and signal transduction of CB1. Endocannabinoids 2-AG and 
AEA are synthesised in response to post-synaptic density stimulation. For AEA, calcium increases activate NAPE-
PLD to cleave membrane precursor NAPE to AEA. From here it can activate TRVP1, travel to presynaptic terminal 
to activate CB1, be degraded immediately by FAAH to arachidonic acid (AA) and ethanolamine (EA) or activate 
internal CB1 possibly mitochondrial CB1 (not shown). TRVP1 has been identified as a receptor responsible for the 
production of substance P (SP) involved in the perception of pain particularly with regards to heat, high pH or 
capsicum. 2-AG is synthesised by the cleavage of membrane precursor PIP2 to DAG by PLCβ (which can be 
activated by group 1 mGluR activation). DAG is converted to 2-AG by DAG lipase. 2-AG can travel retrogradely to 
presynaptic CB1. 2-AG is broken down in the presynaptic terminal by MAGL to AA and glycerol. CB1 activation 
inhibits adenylyl cyclase via its α subunit. This stops the conversion of ATP to cAMP. This reduction in cAMP 
activates protein kinase A (PKA) which activates inwardly rectifying potassium channels (GIRKs) aiding 
hyperpolarisation. The βγ subunits inhibit calcium channels further hyperpolarising the axon terminal and 
inhibiting neurotransmitter release. The reduction in cAMP also effects the transcription factor CREB. Other 
downstream effects of CB1 activation are activation of MAPK and PI3K signal cascade. 
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Table 1.5.1-Table of the endocannabinoid ligands, receptors they can activate and their effects in 
neurons with those receptors 
Endocannabinoids Effects the 
Receptor(s)  
Effects in neurons 
N-
arachidonoylethanolamine 
(AEA or anandamide) 
CB1 (agonist) 
CB2 (partial agonist) 
TRPV1 (agonist) 
-Inhibits release of neurotransmitters 
-anti-inflammatory 
-increase in post-synaptic ion flow into cell 






-Inhibits the release of neurotransmitters 
- anti-inflammatory 
O-arachidonoyl 






-G13 GPCR leads to stimulation of rhoA, 
cdc42 and rac1. 






-inhibits neurotransmitter release 
- increase in post-synaptic ion flow into 







- inhibits neurotransmitter release 
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- increase in post-synaptic ion flow into 










-nuclear receptor gating expression of 
genes involved in energy homeostasis 
- G13 GPCR leads to stimulation of rhoA, 
cdc42 and rac1 
-possibly regulates E-cadherin and 
involved in metastasis. Highly expressed in 










-nuclear receptor gating expression of 
genes involved in energy homeostasis 
- G13 GPCR leads to stimulation of rhoA, 
cdc42 and rac1 
-possibly regulates E-cadherin and 
involved in metastasis. Highly expressed in 




1.5.1 Cannabinoids in Motor studies affect outcomes in a biphasic manner  
In motor output studies cannabinoid agonists and antagonists have opposing effects between 
high and low concentrations. Many studies have reported the decreased activity with 
cannabinoid agonist application usually at very high exogenous concentrations, which one 
would expect considering the primary function of CB1 is to inhibit neurotransmitter release 
and this is especially the case when looking at voluntary movement. However, the picture 
becomes far more complicated when the concentration range is expanded and can depend on 
the neural network assessed (i.e. motor cortex vs spinal cord). Studies in mice  (Sulcova 1998) 
analysed AEA effects on catalepsy on a ring, horizontal ambulation, vertical rearing, 
defecation, analgesia on a hotplate, the aggressiveness of interaction with other mice and 
chemiluminescence of leukocytes. All areas were tested with a range of concentrations from 
0.001mg/kg to 100mg/kg increasing in factors of 10 and all areas except analgesia on the 
hotplate gave a biphasic result. In ambulation and rearing, lowest dose increased activity with 
high doses decreasing activity. Catalepsy on the ring was decreased in low dose and increased 
in high dose. Similarly, leukocyte phagocytic activity was increased at low does and decreased 
at high dose. These interesting results are made more so by the knowledge that all these 
behaviours and cellular events are controlled by different pathways, yet the overall pattern is 
the same. The consistency of results throughout various analysis methods points to an intrinsic 
function of the cannabinoid receptors that enable dual-action dependent on dose and 
environmental physiology. Following this study a similar analysis in rats was performed using 
∆9-THC, which also recorded a biphasic interaction in voluntary movement recorded by light 
beams broken, catalepsy on ring and faecal boluses produced (Sañudo-Peña et al., 2000). In 
this study low doses (0.2-0.5mg/kg) decreased activity, middle doses (1.5-2mg/kg) increased 
activity and high doses (2.5-5mg/kg) decreased movement and increased catalepsy with no 
concentrations affecting autonomic activity of faecal boluses. The synthetic agonist WIN 
55,212-2 also induced a biphasic result in rats with low dose 0.1M increasing voluntary 
ambulation and 1M decreasing ambulation. This was the same in vertical counts and all 
significant changes were negated with the application of 0.3M of synthetic antagonist SR-
121716A (Polissidis et al., 2013). This group went further than previous studies and performed 
micro dialysis of dopamine and glutamate release in the striatum, nucleus accumbens and 
prefrontal cortex. The dopamine release in the striatum was increased by both doses of WIN 
with 1M increasing more than 0.1M. Interestingly, glutamate was decreased by 1M WIN with 
no change in 0.1M. This result could go some way in explaining the biphasic effect of dose as 
glutamate release in the brain region is likely the driving force behind voluntary movement. 
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To explain this, we first must look at the distribution of CB1 which is found primarily on 
inhibitory GABAergic/Glycinergic or excitatory glutamatergic terminals. Studies in rat medial 
prefrontal cortex (mPFC) estimate the ratio of glutamate neurons to GABA producing neurons 
as 80:20% however the ratio of excitation: inhibition% (E: I%) release is reversed at 18:82 due 
to the nature of feed forward and feedback regulation. One study showed that exogenous 
cannabinoid (WIN 55) application super infused into the mPFC shifted the E:I% in favour of 
excitation as far as 30:70% (den Boon et al., 2014). It was noted in this study that the overall 
production of both IPSC and EPSCs were decreased, although the inhibitory currents decreased 
more. This is evidence that CB1 activation reduces all neurotransmission, but, due to higher 
expression at inhibitory neuron terminals reduces inhibitory signalling to a greater extent, thus 




1.6 Long-term synaptic plasticity 
The famous theory of Donald Hebb has dominated neuroscience since 1949- “Neurons that fire 
together wire together” (Hebb, 1949). Behind the simplicity of this statement is a truth that 
neuroscientists have been trying to fully understand since. From this theory and through 
extensive experimentation, synaptic plasticity is now often thought of in short-term changes 
(0-30 minutes) and long-term changes (30 minutes-10 hours). Short-term changes may be 
increased fire rate of a motoneuron due to increased glutamate at the synapse. How these 
immediate changes then reflect into long-term changes have been well characterised. Long 
term changes are divided into two categories: long-term potentiation (LTP) and long-term 
depression (LTD). If 2 neurons forming a synapse are stimulated repeatedly (general protocol 
states that 100 paired- pulses at 100Hz induces LTP (Dudek and Bear, 1993)) the synapse 
between the neurons will become potentiated. To do this involves synaptic plasticity changes, 
in receptor expression (AMPAR) and glutamate expression, but, most crucially of all, NMDAR 
activation. This will mean for the long-term future (30 mins -10 hours in vitro, 1 month or 
longer in vivo) this synapse will signal more efficiently, it will grow larger, and the rate of action 
potential generation will be increased. The key tenets of LTP are association and convergence, 
input specificity and cooperativity. Specifically, to induce LTP both the pre and post synapse 
must be stimulated by high-frequency stimulation (HFS). Mechanistically the AMPARs initiate 
depolarisation, relieving the magnesium block of the NMDAR allowing conductance and the 
subsequent secondary signalling that follows. If this is experienced repetitively in a short time 
period (HFS) LTP will occur, this is defined as NMDAR-dependent-LTP. Previously, it was 
thought NMDAR-independent-LTP was only regulated by increased Ca2+ channel conductance. 
However, recent evidence provided a role for group 1 metabotropic glutamate receptors in 
this process (Wang et al., 2016). 
Long-term depression of synaptic transmission is defined by a long-lasting decrease in 
efficacy and strength of signalling. LTD has a number of forms, it was first observed in 
heterosynaptic transmission where stimulating potentiation between two neurons induced 
depression of a nearby non-stimulated pathway (Lynch, Dunwiddie and Gribkoff, 1977). 
Depotentiation or homosynaptic depression is another form of LTD that is induced by low-
frequency stimulation (LFS-5-10Hz to the presynaptic neuron) (Staubli and Lynch, 1990). After 
this discovery in the hippocampus, LTD was confirmed in many other brain regions in vivo and 
it is now considered a key function of regulating neuronal systems.  
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1.6.1 Group 1 mGluR-dependent-LTD 
LTD can also be induced chemically through group 1 mGluRs (mGluR-LTD) (Ito, Sakurai and 
Tongroach, 1982). The key requisites for this induction are calcium increase and mGluR 
activation. Since then the complexity has increased and it is now well accepted that low-
frequency stimulation (LFS) induces LTD through low NMDAR activity and group 1 mGluRs. 
mGluR-LTD requires mGLuR activation without NMDAR, although in some brain regions, such 
as the amygdala and perirhinal cortex (Wang and Gean, 1999; Cho et al., 2000), it requires 
NMDAR activation.  
Two of the key signalling mechanisms that underlie mGluR-LTD are p38 MAPK activation 
alongside tyrosine dephosphorylation (Moult et al., 2008), the inhibition of these two events 
was found to occlude mGluR-LTD. Gene transcription events lead to activated proteins, such as 
eEF2, Arc/Arg3.1, which are involved in AMPAR endocytosis. Other proteins synthesized during 
mGluR-LTD include; Striatal-Enriched protein tyrosine Phosphatase (STEP), fragile X mental 
retardation protein (FMRP), and microtubule-associated protein 1B (MAP1B), which may also 
regulate AMPAR synaptic trafficking (Beattie et al., 2000; Lee, Simonetta and Sheng, 2004). The 
key difference in LTP or LTD induction usually lies with the rate of activation. As shown LTD can 
be chemically induced with 100μM DHPG. However, this is in neurons with a low or negligible 
fire rate, combined with the high level of activation of proteins, that negatively regulate the 




1.7 Dendritic spines in plasticity 
Dendritic spines are tiny protrusions from the dendritic tree that receive excitatory inputs. 
They were first proposed by Ramon y Cajal over 100 years ago, who recognised them as a 
structure in cultured hippocampal neurons stained with the Golgi method (García-López, 
García-Marín and Freire, 2007). Dendritic spines are generally split into four categories based 
on morphology; mushroom, filopodia, thin and stubby (Matsuzaki et al., 2004; Basu et al., 
2018).  Evidence has shown that the structure of a dendritic spine may be a determinant for 
the state of the spine (potentiated or depressed) (Matsuzaki et al., 2001, 2004; Bosch et al., 
2014; On et al., 2017; Basu et al., 2018). Dendritic spines consist of a thin neck protruding from 
the dendrite with a head containing the post-synaptic density (PSD). The PSD is located directly 
behind the synapse membrane and consists of a dense and complex array of structural 
proteins to which the receptors are tethered (figure 1.7.1). The PSD proteins are linked to actin 
filaments (primarily f-actin) which define the structure of the spine and are key targets for 
structural plasticity. 
When quantifying the structure of dendritic spines under different conditions it has 
been shown that mushroom spines with a larger surface area and volume represent 
potentiated spines and that under conditions that induce LTD in hippocampal neurons, the 
spines elongate in length but do not change in volume (Vanderklish and Edelman, 2002). This is 
evidence that the shape of the spine and the volume are critical determinants of potentiated 
vs depressed spines (Matsuzaki et al., 2004). In a mushroom spine, the surface area is primed 
to receive neurotransmitters, presenting AMPA receptor rafts on the surface for fast synaptic 
transmission of glutamate. In an elongated spine, the surface area at the head of the spine is 
decreased allowing less space for AMPA receptor expression. This is supported by other work 
which shows the location of AMPA receptors to be a predictor of the state of the dendritic 
spine (Matsuzaki et al., 2001, 2004) When a spine becomes depressed the AMPARs are located 
extrasynaptically trafficked away from the head surface.  
Depolarisation events have been shown to provoke gene transcription through double 
strand DNA break inducing transcription of growth causing actors such as c-fos almost 
immediately (Madabhushi et al., 2015). Recent high-speed atomic force microscope scans 
show dendrites forming within 20 minutes (Shibata et al., 2015). Investigations into the 
remodelling of spines undergoing potentiation defined the key events of potentiation into 3 
phases. In the first phase, reorganisation of the actin cytoskeleton occurs. This happens in the 
first 1-7 minutes after LTP induction, where it was observed that actin fills the spine and it is 
quickly polymerised to F-actin. During this period there is a transient decrease in G3 proteins 
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(CAMKIIβ, α-actinin and drebrin), that are responsible for the stabilisation of F-actin through 
binding it to the PSD. At the same time, there is an increase in G1 and G2 proteins, such as 
cofilin and Arp2/3, proteins responsible for severing and branching F-actin. The increased 
cofilin in the spine is triggered by NMDAR activation. The second phase is defined by the 
stabilisation of the newly remodelled cytoskeleton. This occurs over the next 7-60 minutes, 
during which time cofilin continues to rise. G2 and G3 proteins return to their normal levels 
and increase in proportion with spine volume. The G3 proteins such as CAMKIIβ are thought to 
stabilise the increasing F-actin which is the key driver of growth. The third phase was defined 
as delayed PSD protein synthesis. It was found that during phase 1 and 2 the PSD structure and 
protein density remained unchanged. It was after 1 hour that increases in G4 proteins, such as 
Homer and Shank, were observed (Bosch et al., 2014; Bosch et al., 2015).  
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1.7.1 Summary of plasticity in dendritic spines 
LTP induction- Glutamate released from the presynaptic terminal activates the glutamate 
receptors NMDAR, AMPAR and mGluR. AMPAR and NMDAR are connected to PSD-95, Homer 
and SHANK (as shown in figure 1.7.1). Increased Ca2+ influx via NMDARs activates CAMKII 
which translocates to the PSD where it phosphorylates synapse proteins including receptors, 
MAGUKS and other synapse proteins. Calcium released from intracellular stores in the 
endoplasmic reticulum induced by mGluR g-protein-mediated activation of IP3 enhances the 
depolarisation event and trigger second messenger systems. Repetitive increases in signalling 
(100 pulse pairs LTP) and persistent Ca2+ increases, lead to local gene transcription events, 
which over the first 1-7 minutes after LTP induction, increase the concentration of cofilin and 
ARP2/3, which cleave and branch actin respectively. In the second phase of growth CAMKIIβ, 
drebrin and α-actinin return to normal levels and stabilize the F-actin cytoskeleton. After this 
process, structural MAGUKs (PSD-95, Homer and SHANK) begin to increase in density, enabling 
more receptor expression. 
LTD induction- During low-frequency stimulation all the same receptor systems are activated. 
LTD is defined by low-level currents of Calcium and as such the level of NMDAR activation is 
the key ‘decider’ in the outcome. It is generally accepted that low-level depolarisation and 
Figure 1.7.1 -Example schematic of the protein organisation and maintenance of dendritic spines 




short-term activity of CAMKII lead to LTD and high-level depolarisation and long-term activity 
of CAMKII lead to LTP. mGluR-dependent-LTD requires the activation of p38 and 
dephosphorylation of tyrosine kinases normally independent but sometimes dependent on 
NMDAR. 
Based on this excellent preceding work it is clear how the structure indicates the 
function of dendritic spines. Most of this work has been performed using time-lapse confocal 
imaging. The recent development of high-speed AFM combined with inverted fluorescent 
confocal imaging offers a more detailed insight into the structural changes that occur in short 
periods. However, no measurement criteria have been developed for atomic force microscopic 
assessment of spines. It would be advantageous to develop these criteria and use them to 
investigate pharmacological effects on the structure, which can be used in future as a measure 
of the activity of dendritic spines.  
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1.8 Xenopus laevis 
The African clawed frog (Xenopus laevis) is an ideal research animal. X. laevis has been at the 
forefront of developmental DNA and RNA investigations since 1958 when it was discovered 
that transplanting somatic nuclei into the egg can fully reprogram development (Gurdun, 
Elsdale and Fishberg, 1958; Gurdon and Uehlinger, 1966). Later X. laevis was key in finding 
evidence for mitochondrial DNA (Dawid, 1966) and was used to isolate the first eukaryotic 
genes (Birnsteil et al., 1968; Brown, Wensink and Jordan, 1971). They can withstand invasive 
surgical manipulations and their cells can be cultured reasonably easily compared with more 
complex organisms because their cells can survive in rudimentary salt solutions (Peng, Baker 
and Chen, 1991; Harland and Grainger, 2011). The oocytes can be injected with gene 
transcripts, which are readily taken up and expressed with many studies expressing human 
receptors on their surface (Gurdon and Uehlinger, 1966). The genomes of X. laevis are highly 
conserved and have a high degree of genomic synteny with other mammals (Harland and 
Grainger, 2011). However, one of the negatives of X. laevis is its allotetraploid genome thought 
to be the result of two species merging (Session et al., 2016). This means X. laevis has four sets 
of genes rather than two. Due to this, in the 1990s, researchers began looking at Xenopus 
tropicalis. X. tropicalis has a diploid genome and a shorter generation time, meaning it is better 
suited for studying genetic mutation over generations. The advantage of both X. laevis and X. 
tropicalis lies in the ease of access to oocytes to inject RNA transcripts and monitor changes in 
development (Gurdon and Uehlinger, 1966). Not limited to purely genetic studies, X. laevis 
oocytes were one of the first used to assess cloned acetylcholine receptors using 
electrophysiology (Kusano, Miledi and Stinnakre, 1977).  
In recent years X. laevis tadpoles have become a key model in neuroscience, as X. 
laevis hatchling tadpoles have very simple behaviour until developmental stage 45. The 
tadpole only exhibits 2 behaviours: swimming in response to touch/ shadow detection via 
pineal eye or struggling when held around the neck. If left untouched these tadpoles will not 
move, although some spontaneous twitching and swimming may be observed. Alongside this 
simple behaviour, the spinal neurology of their swimming is relatively simple. Being an 
ectotherm means the X. laevis tadpole requires external energy (heat) to enable maturation. 
This means that a reduction in temperature below 23oC can slow the development, 
maintaining the tadpole at certain stages for longer allowing more time for experimentation. 
Their spinal network’s CPG has been well characterised through electrophysiological 
examination (Li, Roberts and Soffe, 2010; Roberts, Li and Soffe, 2010; Li and Moult, 2012; 
Moult, Cottrell and Li, 2013).  
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Fictive swimming electrophysiological preparations of X. laevis involve the immobilisation of 
the tadpole with α-bungarotoxin, pinning it in place with a tungsten needle through the 
notochord and removing the skin and myotomes while the tadpole is in physiological saline 
solution. This allows access to the motoneurons and spinal cord using glass suction electrodes. 
Motor activity is then stimulated by a glass suction electrode placed on the skin delivering a 
1ms current pulse. Using this method the action potential patterns of the various neuron 
groups during swimming have been defined (Roberts, Li and Soffe, 2010; W.-C. Li, Roberts and 
Soffe, 2010; Li and Moult, 2012). This enables us to know the sequence of neuron firing and 




1.8.1 CPG of Xenopus laevis controls frequency of swim-cycles through reciprocal inhibition 
and NMDA pacemakers 
The X. laevis tadpole between stages 37-44 has a predictable and well-characterised reflex 
swimming response to touch or shadow detection via a pineal eye. This swimming response 
involves alternating contractions of swimming muscles spreading from head to tail along the 
tadpole’s trunk. The alternation of the muscle contraction is achieved with a CPG network. 
Using paired cell recordings from three neurons the Rohon-beard (RB) sensory neuron, the 
dorsolateral commissural interneuron (dlc) and the motoneuron (mn) it was identified that a 
touch on one side of the tadpole stimulated a motoneuron to fire on the opposite side, a 
process mainly controlled by AMPARs. The RB neuron will amplify the signal stimulating many 
dlc interneurons to produce a full flexion away from the point of touch (Figure 1.8.1). It also 
stimulates dorsolateral ascending (dla) interneurons, which project axons to the hindbrain. 







Figure 1.8.1- Example of initiation of swimming. Frame by frame example of stage 40-42 reaction to 
touch on the left side tail trunk. Touch at arrow. Recorded at 400fps. Sensory RB neurons stimulate dlc 
neurons to excite mn opposite side to touch which cause contraction away from touch.   
 
After the first full flexion, the signal has been amplified to the hindbrain where the descending 
interneurons (dINs) are located. These are excitatory interneurons, releasing glutamate and 
acetylcholine, which descend the spinal cord forming synapses with motoneurons, 
commissural interneurons (cIN) and ascending interneurons (aINs). Glutamate causes the 
motoneurons to become depolarised, firing action potentials and release acetylcholine onto 
the muscle causing contraction. The cINs release the inhibitory neurotransmitter glycine, that 
causes a hyperpolarising current (sometimes termed mid-cycle inhibitory release) in the dINs 
in the opposite half-centre. The aINs project back up the spinal cord releasing glycine to 
regulate timing of dIN firing and working with the cINs to create the smooth flow of muscle 
contraction down the tail of the tadpole. The dINs in the opposing half centre fire on rebound 
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after the hyperpolarising current has dissipated, stimulating the cINs, aINs and motoneurons 
repeating the process to control the frequency of tail contractions by reciprocal inhibition and 
rebound firing of dINs (Figure 1.8.2). Evidence has been provided that show the dINs in the 
hindbrain are connected via gap junctions. Gap junctions or electrically coupled synapses occur 
in excitatory neurons that wire together through these gap junctions. It has been shown that a 
hyperpolarising current to one dIN will stop the others nearby from firing an action potential in 
isolated X. laevis preparations (Li, Roberts and Soffe, 2009). This also provided evidence that in 
an isolated spinal cord with the half-centres of the spinal cord separated the dINs could 
generate a rhythm of action potentials similar to fictive swimming frequency regulated by the 
NMDAR pacemaker ability (Li, Roberts and Soffe, 2009). Although, it was demonstrated that 
stopping cIN release during fictive swimming stopped swimming and dIN action potentials 
(Moult, Cottrell and Li, 2013). Swimming will generally continue until the tadpole encounters a 
surface. The cement gland at the front of the tadpole produces a signal when it contacts a 
surface which releases GABA from axons that project from the trigeminal ganglia into the 
hindbrain and stop the NMDAR pacemaker activity (Li, Roberts and Soffe, 2010; Roberts, Li and 














Figure 1.8.2- Model of the neurons and connections in X. laevis tadpole spinal network central pattern generator. 
Red arrows indicate excitation, blue arrows indicate inhibition. Each box represents the two half-centres on the 
spinal cord. dINs stimulate all neurons in hemisphere (approx. 30-150 of each type) cINs produce inhibitory 
hyperpolarising currents in the dIN’s on the other hemisphere which fire on rebound, the aINs produce inhibitory 
current within each hemisphere ascending to inhibit previous dINs and motoneurons to allow co-ordinate wave of 
muscle contraction. The dla’s stimulate all fibres on side of touch whilst dlc produces initial reflex contraction.  




The dINs release glutamate and acetylcholine, which stimulate, the mns, cINs and aINs. The 
dINs are electrically coupled (figure 1.8.3) and contain NMDAR, AMPAR nicotinic acetylcholine 
receptors (nAchRs). They also contain Glycine receptors (GlyRs) which are responsible for 
hyperpolarisation generation via glycine released from the cINs and aINs (Li, Roberts and Soffe, 
2010; Roberts, Li and Soffe, 2010; Li and Moult, 2012; Moult, Cottrell and Li, 2013). The 
motoneurons also contain all these receptors on their postsynaptic densities and are proposed 
to contain group 1 mGluRs (Chapman and Sillar, 2007), although their exact location in the 
spinal cord of X. laevis is still to be confirmed. Similarly, the cINs and aINs are excited by 
glutamate and acetylcholine and inhibited by glycine. The location of group 1 mGluRs are not 
defined, but are expected to be present on most of the neurons in the spinal cord receptive to 
glutamate and previous experimental results would appear to confirm this. The location of CB1 
in the spinal cord of the X. laevis tadpole are unknown, however locations in the adult X. laevis 
are and are discussed in a later section (1.8.4).  
Figure 1.8.3-Schematic showing X. laevis neuron layout. Electrically coupled dIN’s in the hindbrain are 
stimulated to swim. They simultaneously excite (orange arrow) the motoneurons (red arrow), cINs (purple 
inhibitory line) and aINs (blue inhibitory line). The mns cause muscle contraction, the cINs release an inhibitory 
current hyperpolarising the opposing dINs and the aINs release modulatory ascending inhibitory current back 
up the spinal cord within one half-centre. Image modified from (Hull et al., 2016) using biorender.com 
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1.8.2 Group 1 mGluRs in locomotion and Xenopus laevis 
 The group 1 metabotropic glutamate receptors have previously been investigated in many 
locomotion models. In mice, it was shown that group 1 mGluRs increase the fire rate of 
motoneurons (Iwagaki and Miles, 2011). In fictive swimming of X. laevis, group 1 mGluRs 
increased locomotor network excitability through presynaptic inhibition of inhibitory 
interneuron release (Chapman, Issberner and Sillar, 2008). In fictive swimming of the isolated 
lamprey spinal cord, a similar result was achieved with group 1 mGluRs shown to be necessary 
to maintain the frequency of motoneuron output. However, both these experiments in X. 
laevis and lamprey highlighted a difference in the functions of the two group 1 mGluR sub-
types. When mGluR1 was inhibited a significant reduction in the frequency of motoneuron 
firing was observed, yet when mGluR5 was inhibited, a significant increase in motoneuron 
output was observed. It was shown that mGluR1 enhanced NMDAR depolarisation contributing 
a single calcium spike and reducing leak current, without which maintenance of normal 
excitatory depolarisation rate is reduced. This study also showed that DHPG would not induce 
depolarisation when neurons were held at resting potentials, but when held at slightly more 
depolarised potentials DHPG (group 1 mGluR agonist) increased depolarisation and rate of fire 
(Kettunen, Hess and Manira, 2003). This is evidence that group 1 mGluRs modulate rather than 
drive excitatory depolarisation. This study also provided evidence that mGluR5, although not 
necessary for maintenance of depolarisation rate, was responsible for persistent calcium 
spikes released from the endoplasmic reticulum indicating it may have more of a function 
long-term. From their work in the isolated lamprey spinal cord they also found evidence that 
increases in locomotor frequency induced by group 1 mGluR activation involved a decrease in 
the mid-cycle inhibitory release similar to what was shown in X. laevis (Chapman, Issberner 
and Sillar, 2008). With work showing that DAG is a precursor to the cannabinoid receptor 
ligand 2-AG it was hypothesised that retrograde cannabinoid action was part of the process 
which increased excitation in the network.  
The group 1 mGluRs have not been sequenced in X. laevis. However, the sequence has been 
predicted and it has been sequenced in X. tropicalis. The predicted sequence of mGluR1 in X. 
laevis has an identity of 95.49% to X. tropicalis, 79.62% to humans, 79.17% to mouse and 
79.32% to rat. The predicted sequence in X. laevis for mGluR5 has an identity of 95.9% to X. 
tropicalis, 82.85% to humans, 84.28% to mouse and 83.22% to rat. 
1.8.3 Cannabinoids in the CPG 
Previous studies in the isolated lamprey spinal cord provided evidence that retrograde action 
of cannabinoids at inhibitory interneuron terminals was partly responsible for the increase in 
 
30 
motoneuron burst frequency produced by group 1 mGluR activation (El Manira et al., 2002, 
2008; Kettunen, Hess and Manira, 2003a; Kettunen et al., 2005; Kyriakatos and El Manira, 
2007). In these series of experiments, it was demonstrated that 5µM of synthetic CB1 agonist 
WIN-55 increased locomotor frequency by inhibiting cIN release. This effect was found to 
occlude the increase seen from group 1 mGluR activation. Antagonising the CB1 receptor with 
inverse agonist/antagonist AM-251 was also found to stop the DHPG induced increases. This 
was evidence that through group 1 mGluR activation endocannabinoids ensure normal 
locomotor frequency by regulating the timing and concentration of cIN inhibitory glycine 
release. 
1.8.4 Cannabinoids in Xenopus laevis  
The cannabinoid receptors have been shown to be present in the CNS of the adult X. laevis 
(Cottone et al., 2003) and the functional receptor has been shown to be present in stage 41 of 
the developing tadpole (Beatrice et al., 2006) with mRNA present from stage 26. Cottone et al., 
(2003) showed that the nucleotide sequence identity between human and X. laevis was 73.9% 
with an amino acid sequence identity of 83.1%. To put this in context the two most studied 
organisms, rats and mice, have only marginally better sequence similarity. For rats, their 
nucleotide identity was 74.2% and amino acid identity was 83.5%, for mice it was 74.3% 
nucleotide identity and 83.1% amino acid identity. The distribution of CB1 in the spinal cord 
was at the highest intensity in the dorsal field and ventral field with high staining in large cell 
motor neurons alongside smaller adjacent cells, possibly interneurons. In particular staining in 
the dorsal field occurred in the Lissauer’s tract (Salio et al., 2002; Cottone et al., 2003). In the 
brain very high staining was found in most areas of the hypothalamus, olfactory bulb, 




1.9 Atomic Force Microscope (AFM) 
The Atomic Force microscope was developed in 1986 (Binnig, Quate and Gerber, 1986). It was 
an improvement on the scanning tunnelling microscope, for which Binnig and Rohrer won the 
Nobel Prize. The AFM transformed our ability to visualise and analyse the nanoscale, reaching 
the amazing goal of viewing the structure of molecules (Gross et al., 2009) confirming our 
theoretical calculations of natural carbon ring structures.  
There are two key components that enable the AFM to exist, the quartz crystal piezo and the 
laser/photodiode detector system. The advances in precision with these two systems are what 
make the AFM a desirable tool for investigation into the nanoscale structure of the natural 
world. The laser is targeted to the back of the cantilever and tracks it as it scans the sample 
(Figure 1.9.1). The laser reflects into a photodetector that is calibrated during set up. Once 
calibrated the laser will try to stay in the centre. Variation from the centre in the lateral or 
vertical direction is recorded as lateral or vertical deflection in separate channels. The piezo is 
responsible for oscillating and moving the cantilever, with the oscillation controlled via a 
quartz crystal. In contact mode AFM, the cantilever scans backwards and forwards across the 
sample with the laser tracking the nanometre changes in topography. Non-contact mode AFM 
(mainly used for atomic structure investigations) operates by scanning over the sample 
without coming into contact, oscillating the cantilever near-resonant frequency, measuring the 
interaction of forces between sample and tip as it moves through the air. This is often 
performed in a vacuum in order to measure atomic forces such as the analysis of biomolecules 
(Gross et al., 2009). In amplitude modulated (AC) mode (sometimes called tapping or 
intermittent contact mode) the piezo is tuned to the optimum oscillatory frequency for the 
cantilever type near-resonant frequency, it then oscillates the cantilever at this frequency as it 
scans the area selected. The laser measures the change in cantilever oscillation/amplitude. 
When the tip encounters a change in height or texture this will be shown in the height image 
or phase image respectively. This mode is advantageous to contact mode because it is less 
likely to damage the sample. For biological samples, which are large and very irregular in 
shape, this enables better resolution as the tip will not snag or catch on the membrane. AC, 
intermittent contact and tapping mode are used interchangeably as each hope to highlight a 
different aspect. AC mode refers to the amplitude of the tip, intermittent contact as the tip 
only ‘contacts’ the surface at the lowest point of oscillation and tapping mode is somewhat 
self-explanatory. It is now thought that AC mode or tapping mode is the most accurate 
descriptions as the tip is not really in contact with the sample, rather it is going through cycles 
of attraction and repulsion. If it does contact anything it is more likely a liquid bilayer on the 
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surface, which exerts attractive forces on the tip before it is repulsed and begins the oscillation 
again. 
Phase imaging measures the tip-sample interaction. When the tip interacts with the 
sample it can either be slowed by the surface if it is viscous/attractive, or it can be repulsed 
pushing the tip further forward and shifting the amplitude wave of the cantilever ahead, 
represented in degrees of phase shift. Common analysis of phase images suggests large phase 
lag equals brighter pixels and smaller phase lag equals darker pixels. One problem with phase 
imaging is brighter pixels only tell you the degrees of phase shift and there are several factors 
which interact to cause a phase shift. There are two components measured in a phase image, 
the first is the combination of the piezo-cantilever-tip: the tip sharpness, driving amplitude 
frequency (this affects the force of interaction) and the cantilever spring constant. The second 
component is the sample properties; viscoelasticity, hydrophobicity, friction, adhesion and 
surface materials (in the case of biological samples this would include the substrate cells are 
grown or contained on).  
The cantilever and tip are an important part of the AFM. The flexibility of the cantilever, 
termed the spring constant (k), is the force required to bend the cantilever. Different spring 
constants are required depending on type of sample and mode of scanning (contact, non-
contact or AC). There are also different tip shapes. The thinner the tip at its end the higher 
resolution can be achieved. However, a very thin tip on a hard sample risks breaking the tip. 
Similarly, a very thin sharp tip on a soft sample, such as a biological membrane, risks tearing or 
puncturing the membrane. Recent force/Young’s modulus measurements on neuronal 
membranes have used spheres on the tip to rectify this problem (Dimitriadis et al., 2002, 
(Nikkhah et al., 2011). Another factor is the material and reflective properties of that material 





Figure 1.9.1- Schematics demonstrating the principle mechanisms of Atomic force microscopes b) 
example of wave tip forms while scanning in AC and non-contact modes.  
As seen in Figure 1.9.1, the AFM works with the laser targeted to the back of the cantilever via 
mirrors into the photodetector. The mirrors can be adjusted via screws on the AFM head 
(termed laser screws). In contact mode AFM the tip will only be moved in the lateral direction. 
In non-contact and AC mode AFM the tip will oscillate in the vertical direction while scanning 
in the lateral direction, forming a wave. The amplitude of this wave is set during tuning via the 
set point if the black lines (figure 2.4.2b) demonstrate an amplitude of 1V (in AFM the 
amplitude is represented in volts V) then the red lines represent the reduction in amplitude via 
the set-point. The program then maintains it at this amplitude as it scans, changes are 
detected by the laser feedback and result in height image topography, and phase image, 
vertical deflection and lateral deflection all presented as separate channels graphically via 





1.9.1 Atomic Force Microscopy of Biological samples 
Since its inception, AFM has been a vital tool in physics and material science. It has also been 
used in biological and chemical sciences, to analyse everything from pentacene (Gross et al., 
2009) to DNA (Hansma et al., 1997) to red blood cells (Girasole et al., 2007). Recently it has 
been used more and more in neuroscience with increased scanning speed and resolution 
enabling live cell measurements that give detail of dendritic spine development never seen 
before (Shibata et al., 2015). For a detailed review of the possibilities of AFM in neuroscience 
see (Jembrek et al., 2015).  The attractive and repulsive forces of atomic interaction are 
measured in AC mode and non-contact mode AFM. In contact and non-contact mode, pN 
forces can be measured due to the tips extremely small size (5-50nm). This natural process can 
be enhanced in biological experiments by coating the tip in receptor ligands or antibodies and 
measuring the interaction forces while scanning the cell surface. Some experiments have taken 
this one step further attaching cells to the cantilever and measuring cell to cell adhesion 
(Benoit and Gaub, 2002). Topographic measurements can be used to assess cell health, for 
example,  the average roughness of red blood cells (RBC) was taken as a measurement of RBC 
health (Girasole et al., 2007). 
Force spectroscopy measurements (Young’s modulus) have been a widely used tool in 
biological science. This method pushes the tip into the sample with increasing force and 
measures the sample indentation vs force. This has been performed in live growth cones vs 
damaged growth cones (Martin et al., 2013). In biological samples, elasticity, the readiness 
with which the membrane returns to normal after indentation, is also taken as a measure of 
healthiness.  The viscoelastic properties of neurons and glial were compared (Lu et al., 2006). 
The stiffness of the developing spinal cord of mice was investigated (Koser et al., 2015) leading 
to a fascinating paper in which evidence was provided to show how mechanosensing receptor 
(piezo1) of developing growth cones effects branching and pathfinding, with variation in tissue 
stiffness causing aberrant axonal growth and pathfinding errors (Koser et al., 2016).  
However, force spectroscopy measurements of membranes have their drawbacks. Under 
physiological conditions the membrane is prone to ripping or tearing and finding and 
measuring small structures such as dendritic spine membrane viscoelasticity has never been 
done.  
1.9.2 Los tangent imaging 
In an ideal scenario, we could have the precision of contact mode, the lack of damage caused 
by AC mode and the force measurements of force spectroscopy. Using AC mode there have 
been developments in quantifying the tip-sample interaction by combining the amplitude data 
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with the lock-in phase data to produce the loss tangent (Proksch et al., 2016). The phase shift 
image has long been an image of frustration. It gives a great deal of detail, yet is specific to 
that image, making it difficult to use for anything other than individual qualitative image 
analysis. Loss tangent imaging takes the phase shift and quantifies it into a unitless ratio from 
0-1, zero being a hard substance and one being a very viscous substance. The drive amplitude 
in AC mode determines the force the tip will interact with the surface and the phase image 
give details of the tip-sample interaction (Proksch et al., 2016). 
 
1.10 Primary tissue culture  
Primary cell culture is a vital tool of analysis in all biological sciences. In neuroscience it allows 
us to strip away the complexity of inter-neuronal system communication and look directly at 
intrinsic signalling particularly in the synapse. The most common form of primary culture in 
neuroscience uses rats or mice. Being a mammal, the development of these neurons is much 
slower and more costly than X. laevis. In order to assess the structure of X. laevis neurons in 
culture we developed a primary neuron culture from stage 22-24 X. laevis embryos. This 
method has been developed over the years with the first publication in (Peng, Baker and Chen, 
1991; Peng et al., 2003) and a recent paper confirmed functional synapses within 24 hours 
tested by pre- and post-synaptic electrophysiological recordings (Yazejian et al., 2013). 
Although enabling clear structural analysis and protein localisation, cell culture is not a perfect 
method. The obvious reason is that cells are not in the same environment and do not receive 
the same cues and guidance that they would if developing in the organism. This may mean 
their structure and rate of development are different from whole organism studies and this 
should be considered when analysing the results. This also has implications for 
pharmacological assessment. In an organism applying treatments will modulate the signalling 
that already exists. It is unclear how much signalling across synapses occurs in cell culture, 
however, recent electrophysiological recordings demonstrate they are functional (Yazejian et 
al., 2013). Cell culture gives us the opportunity to scan the structure of dendritic spines which 
could not occur in the whole organism. It also offers the chance to visualise proteins tagged 
with fluorescent green fluorescent protein (GFP) or fixed and stained with fluorescent 
antibodies in immunohistochemistry techniques. 
1.11 Immunohistochemistry 
Immunohistochemistry stemmed from the discovery of serum antibodies in 1890. Quickly it 
was realised dyes could be attached to the antibodies to aid visualisation. The technique 
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developed until in 1941 Dr. Albert H. Coons produced the first fluorescent antibody labels. 
Fluorescent microscopes had been invented a few decades earlier in 1929 by Ellinger and Hirt 
with the epi-fluorescent microscope (the advancement being the ability to control which 
wavelengths of light reach the sample). Since the 1980s the development in this field has been 
rapid and the quality of fluorescent probes and the accuracy of microscopes, like confocal, 
enable us to visualise the inner workings and positioning of proteins of interest. This procedure 
is so endemic to biological sciences that it is almost impossible to think where we would be 
without it. The process of immunohistochemistry starts by first raising an antibody that will 
bind to a molecule of interest within the cell and the sequence must be unique in its 
expression. The cells must be permeabilised to allow antibodies into the cell. The antibody 
unique to the molecule of interest (termed primary antibody) is incubated with the 
permeabilised cells then unbound antibody is washed off and a secondary antibody specific to 
the primary antibody is added. The secondary antibody is attached to a fluorophore which can 
be excited by certain wavelengths of light. When the correct wavelength of light contacts the 
fluorophore, the interaction moves an electron in each atom up an energy level. The electron 
then moves back down an energy level releasing a photon that has less energy than one that 
first encountered the electron. This means the emission is always a larger (nm) wavelength of 
light than the excitation.   
This method allows us to identify proteins of interest and since the improvement of 
microscopes to the confocal microscope it in now possible to localise proteins within cells. 
Further to this the massive improvements of genetic modification now allow us to tag proteins 
in live cells by adding the gene for GFP to proteins of interest and tracking and measuring them 
in live cells. We will apply immunohistochemistry techniques to try and measure the 
expression of PSD-95 in cell culture and in whole tadpole spinal cord. PSD-95 can be used as a 
marker for excitatory postsynaptic densities and also increases in more active synapses. This 
measure will elucidate whether the effect seen in the whole tadpole or in treatment of cell 
cultures has effects on the number of excitatory synapses present.  
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1.12 Aims and objectives 
The overall aim of this study is to investigate the roles of group 1 mGluR and CB1 in the 
behaviour of X. laevis and how the structure of dendritic spines in primary culture may relate 
to this. We aim to focus our investigation on the dendritic spines first to demonstrate they are 
present in a primary spinal neuron culture, then to investigate their structural changes under 
pharmacological manipulation of CB1 and mGluR1/5. To achieve these aims, the objective is to 
create a method of measurement for the CPG controlled swim-cycle speed of the X. laevis 
tadpole between stages 37-42. Using this method our objective was to investigate the effect of 
group 1 mGluRs on the frequency of swim-cycles of the X. laevis tadpole between stages 37-
42. This has been investigated in fictive swimming electrophysiological preparations of X. laevis 
and other vertebrates. However, evidence of their effect in whole tadpole behaviour of X. 
laevis has not been observed. Following this, we wanted to examine if the CB1 receptor is 
involved in the control of this swim-cycle speed and if it is involved in group 1 mGluR induced 
changes. Evidence from fictive swimming electrophysiological recording in X. laevis and 
lamprey spinal cord suggest CB1 is responsible for regulating commissural interneuron 
inhibitory neurotransmitter release to dIN after group 1 mGluR activation. This measurement 
will be accompanied by an assessment of maximum flexion angle achieved during the swim-
cycle speed measurement. This will assess if group 1 mGluRs and/or CB1 affect 
motoneuron/muscle output during swimming and if muscle flexion and frequency of swim-
cycles are correlated (chapter 3). 
Our next objective will be achieved using primary neuron cultures of X. laevis spinal neurons at 
3 days in vitro (DIV). The neurons will be assessed for the presence of dendritic spines using 
atomic force microscopy and measurement criteria developed from previous literature. We 
will then test the treatments that caused changes in the behavioural assessment. The group 1 
mGluRs and CB1R agonists and antagonists will be investigated for their effects on dendritic 
spine dimensions and membrane stiffness (loss tangent) assessed using atomic force 
microscopy (chapter 4).   
Finally, 10µm thick microtome slices of whole tadpole spinal cord, treated in behavioural 
assessments, and the primary neuron cultures scanned in the AFM assessment, will be 
evaluated for changes in PSD-95 density using immunohistochemical staining measuring 
changes in fluorescence intensity, to assess if PSD-95 expression is correlated with behavioural 
and/or dendritic spine morphological changes. This will give an indication if the effects 
observed in behaviour or dendritic spine morphological analysis are short term ionic changes 




2.1 Behavioural assessment of Xenopus laevis tadpole swimming response to 
touch 
This section will outline the methods used to determine the length of time each swim-cycle 
takes during swimming, after it is initiated by touch to the tadpole trunk. By measuring the 
speed of the tadpoles swimming motion, we are assessing how pharmacological intervention 
of mGluR1/5 and CB1 affects the output of the CPG. The combination of both: excitatory drive 
and inhibitory modulation, produces the overall output of the CPG. This output is measured by 
timing the muscle contractions. This will be compared with maximum muscle flexion during 
the swim-cycle assessment, to try and elucidate the pharmacological effects on muscle 
contraction. 
2.1.1 Stages of X. laevis development 
During its oocyte and tadpole development (stage 1-45 (Nieuwkoop and Faber, 1995)), the X. 
laevis tadpole grows from food stores inside cells contained in yok sacs. The tadpoles are 
staged on morphology. The development is very predictable, once fertilised the egg changes 
colour and shows a little dot, this is stage one. Stage two is determined when the eggs visibly 
divide into two cells (under low magnification 50x). Stages 2-6 are termed the cleavage stages, 
where the cells continue to divide. Stages 7-9 are the blastula stages, by the end of which 
identifying separate cells becomes difficult. By stage 20 the neural fields are fused and distinct, 
which can be seen as a ridge along the top that will develop into the spinal cord. After stages 
21-25 they begin to elongate and break free of their jelly coat and vitelline membrane. Their 
first contractions of the tail begin to occur at stages 25-27. From stage 29 onwards they will 
swim briefly in response to touch and keep growing developing larger muscle columns 
(Nieuwkoop and Faber, 1995). As the tadpole develops past stage 45, the mouth opens, and 
the tadpole becomes self-feeding. At this stage they are classed as a sentient animal. Due to 
this all our tadpoles were anaesthetised by stage 44. They are an ectotherm, meaning the 
metabolism and development of the tadpoles (stage 1-45) can be staggered depending on 
temperature. At room temperature (23oC) X. laevis will reach stage 45 in 4 days (96 hours) 
(Nieuwkoop and Faber, 1995) and reach full size (stage 66) in 58 days. It has a generation time 
of 1 year. To produce X. laevis embryos, the breeding pair of adult frogs are injected with 
human chorionic gonadotrophin (HCG) to stimulate the pair to mate. This can produce 
hundreds, sometimes thousands, of fertilised eggs each time, making this is a very cost-




The concentrations of CB1 and group 1 mGluR, agonist and antagonist, used in the swimming 
assessment, were determined by literature review of previous experiments in X. laevis. Where 
none exist, such as CB1 receptor, experiments in similar models, like lamprey CPG, were used. 
For AM-251 application, a 5µM concentration was shown to have an effect in lamprey. We 
expanded the concentrations either side to 100nM, 2µM, 10µM and 50µM. Not only does this 
range exceed the EC50 for AEA and IC50 for AM-251 (Table 2.1.1), it also encompasses the 
concentration that DHPG will be used at (Table 2.1.2). AEA was selected for testing due to its 
endogenous activity at CB1 with lower affinity at CB2 (see Table 2.1.1), compared with 2-AG 
which is equally potent at both CB1 and CB2. This would make exogenous applications of 2-AG 
more likely to affect immune cells and tissue, compared to AEA. AEA also has a lower EC50 and 
higher affinity than 2-AG, which is thought to perform the majority of signalling in the CNS, as 
concentrations of 2-AG were 1000-fold higher than AEA. 
The treatment conditions assessed using this method were: CB1 antagonism via AM-251 
(50µM, 10µM, 2µM, 100nM), CB1 agonism via AEA (50µM, 10µM, 2µM, 100nM). All 
concentrations of AEA and AM-251 were assessed at two age group stages 37-39 and 40-42. 
Two age groups were chosen because previous reports suggested the presence of CB1 RNA at 
stage 26 but functional CB1 receptors from stage 41 (Beatrice et al., 2006). By splitting the age 
groups, we expect differing levels of CB1 activity, with a larger effect in the stage 40-42 age 
group, due to increased receptor expression. 
To investigate the functionality of both mGluR1 and mGluR5 in the control of swim-
cycle frequency, we applied DHPG (group 1 mGluR agonist) (50µM). This dose was chosen 
because it has previously been shown to have effect in X. laevis (Chapman, Issberner and Sillar, 
2008), and it is within the EC50 demonstrated in other studies (Table 2.1.1). To investigate the 
endogenous function and the constitutive activity of mGluR5, MPEP (mGluR5 non-competitive 
antagonist) (50µM) was applied. Similarly, to indicate the constitutive activity of mGluR1 in the 
regulation of swim-cycle frequency, we applied LY367385 (mGluR1 antagonist) (50µM). This 
aimed to differentiate the effect between the two subtypes that have previously shown to 
have different effects on swim cycle frequency (Chapman and Sillar, 2007; Chapman, Issberner 
and Sillar, 2008). Then, we antagonised both of group 1 mGluRs using MPEP (50µM) + 
LY367385 (50µM), to investigate the constitutive activity of both receptors. To test if this 
application had fully antagonised the group 1 mGluRs, we incubated the tadpole in MPEP 




To test the relationship between the CB1 receptor and the group 1 mGluRs, we antagonised 
CB1 with AM-251 (10µM, 20 minutes incubation), followed by incubation with group 1 mGluR 
agonist DHPG (50µM, 10 minutes incubation). We then assessed the effect of antagonism of all 
3 receptors with: MPEP (50µM) + LY367385 (50µM) + AM-251 (10µM) for 20-minutes 
incubation. Then, we assessed if there were differential roles for mGluR1 and mGluR5 in the 
interaction with CB1 by applying LY367385 50μM + AM-251 10μM and then MPEP 50μM + AM-
251 10μM, for 20-minutes incubation. All these conditions were performed on stage 40-42 
tadpoles. All treatments were compared with vehicle control. DHPG, MPEP, LY367385 and AM-
251 were compared with DMSO control. AEA was compared with Soya emulsion control.  
Pharmacological profiles of each of the chemicals applied are demonstrated below Tables 2.1.1 
and 2.1.2. 
Table 2.1.1- Cannabinoid receptor agonist and antagonist pharmacological profile 
Drug applied Mechanism of action EC50 and Ki Vehicle 
control 
AEA (in Tocrisolve) 
Purchased from 
Tocris uk 
CB1 agonist  
CB2 agonist 
TRVP1 agonist 
EC50= 31nM, Kd =89nM 
EC50 = 27nM, Kd=371nM 















Table 2.1.2- Agonist and antagonists of group 1 metabotropic glutamate receptors pharmacological 
profile 

















mGluR1 antagonist IC50 = 8.8µM DMSO 
 
2.1.3 Applying treatments to tadpoles 
The tadpole can absorb molecules through the skin, although the size of molecule and polarity 
can affect the uptake. To ensure substrate uptake a nick in the dorsal fin was made prior to 
treatment. To do this, the tadpoles were selected 1-2 stages before use (for stage 37-39 
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groups stage 36, and stage 40-42 stage 39 was used), the tadpole was anaesthetised in 0.1% 
MS222 by placing in for 20 seconds then removing to 10% saline (the tadpole was immobile for 
~5 minutes). Then, using sharp forceps/ sharp wire scalpel, the small incision is made in the 
dorsal fin. The tadpole is placed is sterile saline and left to reach stage of analysis and recover 
from MS-222 (1-2 hours). Once at the right stage, the tadpoles were placed in a petri dish 
containing the appropriate treatment concentration and left to incubate for 20 minutes. After 
which, the tadpole was moved to a fresh petri dish, containing 10% saline, to begin filming.  
The tadpole was stimulated with a stroke of the tail by a pipette tip. The swimming response 
was filmed at 400 frames per second (fps), then the tadpole was left for two minutes to allow 
for cessation of ultra-slow after-hyperpolarisation, synapse reorganisation and 
neurotransmitter replenishment (Sillar et al personal communication,(Zhang and Sillar, 2012; 
Zhang et al., 2015)). This was repeated 5 times for each tadpole, encompassing a 10-12-minute 
window, over which time the tadpole was filmed 5 times. After being removed from drug 
treatment, the tadpoles were fixed in 5% glutaraldehyde for 30 minutes, transferred to 10% 
saline and stored at 4oC for microtome and immunohistochemical analysis (methods chapters 





2.1.4 Analysis of frequency of swim-cycles 
Using windows media player classic, the length of one swim-cycle was determined by counting 
the frames it took for the tail to return to the same spot. The frequency in hertz (Hz) was 
calculated by dividing 400 (number of frames per second recorded) by the frames counted for 
the swim cycles. To eliminate subjectivity the speed of swimming was taken over three swim-






2.1.4.1 Statistical analysis 
The results were analysed in SPSS using a linear mixed model (LMM), with time point as a 
covariate and tadpole as a random factor, to assess if treatment (fixed factor) affected the 
frequency of swim-cycles. The assumptions for this model are normality of residuals, 
independence of residuals and linearity of the predicted vs residuals (presented in the 
appendix section 7.2). The test for normality used was Shapiro-Wilk, at a significance level of 
0.05. Almost all analyses carried out passed this test for normality of residuals, though it is 
recognised some did not, the LMM is sufficiently robust test to withstand some deviation from 
the assumption of normality. Shapiro Wilk tests have some degree of fallibility. In cases where 
significance was achieved in Shapiro-Wilk the normality was reviewed with skewness and 
histograms. If this was not satisfying, the result was tested using a generalised linear mixed 
model (GLMM) in SPSS that does not have the normality assumption. The generalised linear 
mixed model has different link functions, which transform the data into an unbounded 
continuous scale. The gamma regression link function was chosen because it transforms data 
that is always positive, but non-normally distributed. The results of the GLMM with gamma 
regression link function, gave the same or similar p-values as the linear mixed model. 
 
  
Figure 2.1.1-Example of 1 complete swim-cycle by a stage 40-42 tadpole from control group (DMSO). 
Filmed at 400 fps; time between each frame= 2.5ms Images taken from video and converted to binary in 
Image J for presentation. 
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2.1.5 Angle of Flexion (AOF) measurement 
As the frequency of swim-cycles was measured, three still images were taken of maximum 
flexions achieved during those swim-cycles. The flexion angle was measured in Image J using 
the angle function. This was repeated three times per image (Figure 2.1.2). This was necessary 
as there is some human subjectivity in this process as can be seen in Figure 2.1.2. From these 
three measurements an average was taken for each tadpole time point 2, 4, 6, 8 and 10 
minutes. The results were analysed in SPSS using a linear mixed model, with time point as a 
covariate and tadpole as a random factor to assess if treatment affected the maximum angle 
achieved during swimming. 
 
  
Figure 2.1.2- Angle of Flexion calculation example. Using the angle function (arrow) in Image J 
three points are selected; first the centre of the head at the pineal eye then straight back down the 
trunk to the edge then to the tail tip 3 measurements per image, 3 flexions per time point/video. 
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2.2 Microtome of Xenopus laevis tadpole 
Microtome is a process of dehydrating embedding and slicing tissue to a desired thickness 
before rehydrating to image. Prior to dehydration of the tadpole, the yolk sac was removed 
with thin wire scalpel. This was done to aid dehydration and the yok sac was extremely auto 
fluorescent. To begin dehydration of the tadpole, it was placed in 70% ethanol for one hour, 
changing tadpole to new ethanol every 20 minutes (two changes). After one hour, the tadpole 
was moved to 80% ethanol, with two changes. Then, the tadpole was moved into 90% ethanol 
for one hour with two changes. Then into 95% ethanol for one hour with two changes. Then, it 
was moved into 100% ethanol for one hour, with two changes. Finally, the tadpole was moved 
into Histoclear for one hour  with two changes. During this time, paraffin wax was heated to 
56-60oC. When removed from the histoclear, the tadpole was placed in the mould and the 
mould was filled with the melted paraffin wax. The tadpole was moved to the middle of the 
wax mould before the wax cooled. The moulds were left to cool and harden overnight. When 
the moulds were fully hardened, they were trimmed to the right size and mounted onto a 
wooden block by heating the wax and fixing it in place and allowing to cool. The block was 
placed into the sample holder of the microtome (Figure 2.1.1) and the blade was then inserted 
into the microtome, selecting 10µm thickness for the slices. The sample was moved by turning 
the handle and when working well would give ribbons of tissue slices. These tissue slices were 
moved to a water bath, set at 50oC for 5-10 minutes to get rid of the wrinkles. They were then 
picked up with a slide and placed on a heated drying rack, set at 45oC and left for 2-4 hours. 
This not only dries the slide, but aids in fixing the sample to the slide. The samples were 
rehydrated by working in the reverse order to the dehydration steps. The slides with the 
samples on them were put in Histoclear for 15 minutes changing solution at 7.5 minutes. This 
was repeated with 100% ethanol for 15 minutes with one change, then 95% ethanol 15 
minutes one change, 90% ethanol 15 minutes one change, 80% ethanol 15 minutes one 
change and finally 70% ethanol one change. After this the slide was gently washed with 10% 
saline. The integrity of the sample was assessed under the microscope (Figure 2.2.2).  If intact, 



























Figure 2.2.1- Microm Heidelberg HM330 Rotary Microtome. Sample is attached to wooden block. 
Thickness of slice is selected (µm). Blade is put in last then sample is sliced by turning rotary cutting 
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Figure 2.2.2- Example of a transverse section of the tadpole stage 40-42 (10µm thick) obtained 
using the microtome. Can see intact spinal cord and muscle columns. Slight tear in the skin at the 







2.3 Primary neuron culture of stage 22-24 Xenopus laevis embryos 
2.3.1 Method 
The most difficult aspect of this tissue culture method was eliminating bacterial infection.  To 
help with this, all stages of this method were carried out in a sterilised laminar flood hood 
using aseptic technique with the microscope and all areas around the hood wiped down with 
70% ethanol. Healthy embryos at stage 22-24 (Figure 2.3.1) were selected, with five embryos 
used per coverslip. The culture media was made up as L-15 50% + Normal Frog ringer (NFR) 
49% (per 1 litre: 116mM NaCl, 2mM KCl, 1.8mM CaCl2, 5mM Na+-HEPES, pH 7.35.) + Insulin 
transferrin serilium (ITS) (thermofisher) 1% + Brain derived neurotrophic factor (BDNF (AbCam 
ab9794)) (3.5µg/ml 30µl stock diluted to final concentration in culture media of 17.5ng/ml) + 
antibiotic solution (Penicillin 1000U/ml, Amphotericin B 25µg/ml and Streptomycin 10mg/ml 
stock diluted by 1/1000 in culture media) in sterile conditions, then the media was sterile 
filtered. The coverslips were sterilised in an autoclave and/or incubated in ethanol prior to use. 
Sterile NFR washes were set up (5 washes per coverslip) and sterile Ca2+/Mg2+ free solution 
(CMF) (per 1 litre 125mM NaCl, 2mM KCl, 1.2mM EDTA, 5mM Na+-HEPES, pH 7.35.) washes set 
up (5 per coverslip). To ensure sterility, the NFR and CMF was sterile filtered into sterile culture 
dishes for dissection and washes. In sterile NFR and under the microscope, the outer jelly coat 
and inner vitelline membrane were removed with sharp forceps. The embryos were washed 
through three sterile NFR washes transferred with sterile disposable pipettes. Then, in sterile 
CMF, the spinal column was removed by cutting each end of the concave spinal column (cut 
along white lines in Figure 2.3.1). The removed spinal columns were washed through sterile 
CMF, then left in CMF for 10 minutes. After 10 minutes the skin peels off easily. Once the skin 
was removed, the remaining spinal tissue was washed through two sterile CMF washes and 
left for 2 hours at room temperature in sterile CMF, for cells to dissociate and form a pile. 
Once cells are dissociated, they are ready to plate. While the cells were dissociating, dry sterile 
coverslips were coated in 100µg/ml laminin (purchased from sigma) (diluted in sterile NFR) for 
at least 1 hour at room temperature, then washed in sterile NFR. Laminin coated coverslips 
were then placed in sterile culture dishes and 3ml of culture media was added to the dish. The 
dissociated cells were then carefully pipetted onto the coverslip trying to ensure even 
distribution. Once the cells were placed onto the coverslip, the dish was not moved for at least 
12-24 hours, to ensure cells adhered to the coverslip. The culture media was replaced every 48 
hours. This was done by removing old media with a sterile pipette (always ensuring cells never 
encounter air-liquid interface) and replacing with new media.  
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This method combines information from 3 publications (Peng, Baker and Chen, 1991; Peng et 
al., 2003; Yazejian, et al., 2013) and through a process of trial and error (testing different 
coating proteins and their concentration, antibiotics, BDNF concentration, plating technique 
and food source (ITS or FBS))  arrived at this method. Consistent with Peng et al's., (2003) 
findings, keeping the neurons healthy past day 5 was difficult and is likely caused by the 
depletion of the yok sacs. We managed to keep cells healthy into week 2, however, this was 
irregular. With more development on the amount of additional nutrients and minerals needed 
to get the cultures past 7 days would enable these cultures to survive longer. However, for our 
purposes, we chose 3 DIV as our assessment. This time point was chosen because the neurons 
had developed multiple connections and the muscle cells were innervated and twitching, 
which is a sign of functioning synapses (Yazejian, et al., 2013). The health of the culture was 
determined by a number of factors: general confluence of cells (approx. 4000 per slide), 
twitching innervated muscle, lack of bacterial infection observed, clear branching and growth 
of neurons, few undifferentiated cells, structure of cells consistent across multiple trials, an 
example of such a culture is demonstrated in Figure 2.3.2. 
 
2.3.2 Drug treatment of Primary neuron culture for AFM and Immunohistochemical 
analysis 
The culture media containing the appropriate concentrations of drug treatments was made. 
These were: DHPG 50µM, MPEP 50µM, AM-251 50µM, Control (DMSO) 50µM (1/1000), AEA 
50µM and Control (soya emulsion) 50µM. The time point, 3 DIV was chosen for analysis, 
because dendrites had formed and muscle twitching was observed, indicating innervation 
(Yazejian, et al., 2013). Before the addition of drug treatments, the cultures were assessed for 
their viability. The key factors for selection were healthy growth of axons and dendrites with 
lots of possible connections. As there were some muscle cells in this culture, twitching muscle 
cells were taken as a sign of healthy functioning cultures. And finally, general confluence of 
approx. 4000 cells per coverslip (13mm in diameter), too many cells made it hard to analyse, 
too few cells made it less likely to find dendritic spines, and for the cells to be communicating. 
Once selected, the media was changed for the one containing drug treatment by removing 
90% of old media and replacing with media containing drug treatment, making sure not to 
expose the cells to air liquid interface, and left to incubate for 20 minutes.  After incubation 
the media was removed and replaced with fixing agent, 5% glutaraldehyde in NFR, for 10 
minutes. The glutaraldehyde was removed, and the cells were washed three times in NFR, and 
they were stored in NFR at 4oC for future assessment with AFM (methods chapter 2.4 and 
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Figure 2.3.1-Stage 24 embryo out of membrane shell. To remove spinal column, make 
incisions with thin wire at white arrows, then pick along curved white line until removed. 
























With yok sacs 








Figure 2.3.2- Example image of X. laevis primary culture of stage 22-24 embryos. Image taken 3 
DIV at 100x magnification with phase contrast microscope. The image demonstrates a good 
example of the neurons scanned with AFM. Axons are determined due to their thickness, 
straightness and lack of branching. Dendritic tree is identified by thinner projections with higher 
degree of branching. These areas were scanned for the possible detection of dendritic spines. 
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2.4 Atomic force microscopy method 
The AFM creates graphical heat maps representing the topography of a scanned area. As 
described in the introduction, a laser targeted to the back of a cantilever measures minute 
changes in surface topography as the tip scans across the surface. In AC mode the cantilever is 
oscillated at a set amplitude through the air, and the centre of the wave is maintained at a set-
point distance from the surface. The tip interacts with the sample being scanned through Van 
der Waals forces and nuclear forces. As the tip approaches the sample it travels through a 
period of attraction, which accelerates the tip, then repulsion when it nears the sample as two 
atoms cannot “touch”. Changes in the drive amplitude and set point change the speed with 
which the cantilever moves, and during set-up these factors are changed to ensure optimum 
oscillation for the cantilever. The resonance frequency of the cantilever is set by the tuning 
program, but the set-point can be changed dependent on the sample, to improve the image 
quality. The topographical scans give various channels. The two channels used in this study 
were the height channel, from which the 4 measurements of dimension were calculated, and 
the phase image which measures the tip-sample interaction and feeds into the loss tangent 
equation. Using the loss tangent equation, the phase image data can be normalised to a 
unitless ratio for comparison between samples.  
The AFM will be used to scan for the presence of dendritic spines in the primary 
neuron culture set up in section 2.3.1. When possible dendritic spines were found, a 
measurement criteria was established (sections 2.4.3 & 2.4.4,) and the cultures treated in 
section 2.3.2 were scanned to investigate the effect of group 1 mGluRs and CB1 on dendritic 
spine plasticity. AFM gives nanoscopic scale measurements of dendritic spines. Given the 
recent development of combining high speed AFM with inverted fluorescent confocal 
microscopy (Shibata et al., 2015), it is imperative an assessment criteria is developed so that 
this new technology can be utilised. This method does not use long-tip high speed AFM but the 
principles in measurement can be transferred. 
2.4.1 Atomic Force Microscope Set up  
The AFM head and cantilever were set up as explained in JPK user manual (JPK (2012) 
Nanowizard 3 user manual). Figure 2.4.1 shows the AFM head on the inverted microscope 
stage. The AFM head is movable and can be removed from the stage to fit cantilevers and put 
the sample on the stage. All the scans were performed in AC mode. Key set up points to get 
right are shown in Figure 2.4.2 and 2.4.3. The cantilever used was an aluminium reflex coated 
AC mode cantilever (Nanoworld technologies Non-contact / Tapping™ mode - Long Cantilever - 
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Reflex coating), with a resonance frequency of 190kHz, force constant 48N/m, length 225µm, 
mean width 38µm and thickness 7µm. The tip is shaped like a polygon-based pyramid with a 
typical height of 10 - 15 µm. Additionally, this probe has a typical tip radius of curvature of less 
than 8nm. 
While the AFM head is off the microscope, the slide is prepared by dipping the culture 
coated coverslip in distilled water then leaving to air dry on a glass slide for 20 minutes. Once 
completely dry the slide was placed on the microscope stage. Distilled water was used because 
the sample was stored in NFR, when left to air-dry large salt crystals formed on the slide. The 
sample also deteriorated faster probably again due to salt crystal damage. The AFM head was 
carefully placed onto the stage, checking the sample is centred and under the cantilever, then 
the cantilever is tuned. 
2.4.2 Cantilever tuning 
Firstly, the laser screws were adjusted (shown in Figure 2.4.1) on the AFM head so that the 
laser is in the centre, or as close to 0.00 vertical deflection by 0.00 lateral deflection as possible 
(Figure 2.4.3). Then, in the cantilever-tuning window, the infinity symbol is selected to keep 
the tuning running. The initial window looked like Figure 2.4.3. The peak in Figure 2.4.3 is 
enhanced and if it looked like Figure 2.4.3c the phase and amplitude are in tune. If not, and it 
looked like Figure 2.4.3d, then the phase shift is changed by a range of -180 to 180 degrees 
until the crossover of lock-in phase (blue line) and lock-in amplitude (red line) look as they do 
in figure 2.4.3c. This is a process of trial and error. Once the crossover was at the correct point 
the cantilever was tuned to near its resonant frequency (the red amplitude peak). As shown in 
Figure 2.4.3c, the point selected is just below the peak resonant frequency. The horizontal line 
represents the set-point (distance the cantilever will be maintained from sample i.e. range of 
amplitude) and the vertical line represents oscillating frequency (kHz). Phase shift (blue line) is 
the result of the difference between the drive and the response. In the tuning stage this is 
caused by the tip/cantilever, so it is tuned to a specific point. When scanning the sample, 
further phase shift is caused by the sample and this is measured in the phase channel as 









Figure 2.4.1- Atomic Force Microscope setup. AFM head sits on top of inverted microscope stage 
and connects to computer where it is controlled, and output is recorded 
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Figure 2.4.3- Tuning the cantilever. A) laser alignment window. Laser screws are adjusted on the AFM 
head which move the laser in the lateral or vertical direction. B) in automatic cantilever tuning selection, 
the program will find the peak resonance. The red peak is enhanced to achieve (c) C) perfect lock-in 
phase (blue line) crossing peak amplitude resonance (red line). The vertical line represents frequency 
cantilever will oscillate at (x-axis) and horizontal line (thin arrow) represents the set point (left y-axis). 
(Phase shift degree are show on right y-axis) D) example of bad tuning 
 
56 
2.4.3 Identification and scanning of dendrites 
Using the inverted microscope, the sample was assessed for suitable areas which contained 
projections identified as dendrites, with the possibility of dendritic spines (such as 
demonstrated in Figure 2.3.2). The areas identified were usually between groups of neurons, 
where axons and dendrites meet. Some cell bodies were scanned successfully with one image 
appearing to show a developing dendritic tree. However, the large size of cell bodies made 
results irregular, due to large noise infarctions in the images. This may be due to the tip either 
falling too far from a cell body or getting stuck on the way back up. As shown in Figure 2.4.5, 
once an area was identified an exploratory 50µm x 50µm scan was performed and assessed for 
possible dendritic spines based on size (under 15µM in diameter), location (was it part of the 
dendritic tree or an axon, axons were much thicker and straighter and don’t have dendritic 
spines, but occasionally have budding growth cones, these were larger and smoother than 
dendritic spines). Using the zoom and rescan function an area of the image containing 
dendritic spine-like structures were selected and rescanned (Figure 2.4.5a). In this example this 
produced a 9µm x 9µm scan (Figure 2.4.5b).  An area was selected for rescan and this gave a 
more detailed 3.5µm x 3.5µm image (Figure 2.4.5c). All scans were performed at 0.5Hz. The set 
point changed occasionally when retuned but was kept at a range of 0.55V-0.65V, with an 
average of 0.635V. The drive amplitude was set automatically during tuning giving quite a large 
range 0.159V-0.837V, with an average of 0.379V. Some of the ‘noisy’ lines in the image were 
due to AFM settings in the feedback loop which move the cantilever slightly too fast. This 
setting was adjusted, and the dendritic spine rescanned (image shown in Figure 2.4.4). It would 
be desirable to eliminate all ‘noise’ from the images; however, this was simply not possible for 
two reasons. Firstly, the uneven and unexpected nature of the cell culture is difficult for the 
AFM to cope with. As discussed in the introduction during AC mode AFM the feedback loop 
reacts to the strength of Van der Waals forces (amongst others) during its downward motion. 
At peak point where attraction turns to repulsion the tip rebounds. This means the tip should 
never truly contact the sample. The problem with large uneven surfaces, however, comes from 
the need to maintain the cantilevers movement at the optimum amplitude, speed and set 
point. Secondly, as mentioned Van der Waals forces play a big role in AC mode AFM so the 
deeper the water layer on the surface of the sample the greater the disturbance to the tip 
motion. Although the cells were dry the membrane likely accumulated more moisture than 
would normally be expected from air precipitation. The increased water also increases 
capillary action and can wet the tip, which renders it unusable. 
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2.4.4 AFM height image analysis 
All image analysis was performed using Gwyddion software. Using Gwyddion the line profile 
function was selected, and four cross sections of the dendritic spine were taken (Figure 
2.4.5d). The cross-section lines were set to 50 pixels wide to encompass as much of the 
dendritic membrane as possible. Figure 2.4.5c and 2.4.5e show the output generated from this 
analysis method. Figure 2.4.5c shows all four line profiles compared on a graph. Figure 2.4.5e 
is the statistics window opened from the graph in figure 2.4.5c. From the output in Figure 
2.4.5e, we recorded the: projected length, area under the curve, Ra and RMS (two 
measurements of roughness) and height was calculated by subtracting the minimum from 
maximum height of cross section. Once these figures were recorded for each line profile, the 





Figure 2.4.4-Identification and analysis of possible dendrites. A) 50µm x 50µm exploratory scan, b) 
9µm x9 µm rescan of possible dendrite, d) 3µm x 3µm scan of dendrite possibly a synapse with cross 
section analysis lines on dendrite. C) Cross section line graph output in Gwyddion. E) Line profile of 1 
cross sectional line and corresponding statistical output 
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2.4.5 Los tangent imaging 
In an ideal scenario we could have the precision of contact mode, the lack of damage caused 
by AC mode and the force measurements of force spectroscopy. Using AC mode there have 
been developments in quantifying the tip-sample interaction by combining the amplitude data 
with the lock-in phase data to produce the loss tangent (Proksch et al., 2016). The Phase shift 
image has long been an image of frustration. It gives a great deal of detail, yet, is specific to 
that image, making it difficult to use for anything other than individual qualitative image 
analysis. Loss tangent imaging takes the phase shift and quantifies it into a unitless ratio. The 
drive amplitude in AC mode determines the force the tip will interact with the surface and the 
phase image give details of the tip-sample interaction. These results are combined in the 
below equation, explained in (Proksch et al., 2016). 
In this expression, Fts is the tip-sample interaction force, z is the tip motion, ż is the tip 
velocity, ω is the angular frequency at which the cantilever is driven, Q is the quality factor of 
the resonance, V is the cantilever amplitude, the brackets ‹› represent a time average and tan 
δ represents the loss tangent. The parameter Vfree is the “free” resonant amplitude of the first 
mode, measured at a reference position. 
If we assume the cantilever operates at free resonant frequency (i.e. V/Vfree =1 and Ω=1) then 






Equation 2 can be viewed as an uncalibrated loss tangent calculation.  
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For our calculations of loss tangent, equation 2 was used with V/Vfree=1. This was because of 
large irregularities in the V/Vfree calculation leading to anomalous results.  
Unlike previous publications (Proksch et al., 2016), the software capable of producing loss 
tangent images was not available to us. This was also a factor in using the uncalibrated 
equation 2. We decided to take average measurements of the phase images, collecting data 
for the average phase-shift of the dendritic spine membrane and compare this with the 
average phase shift of the dendritic tree membrane (as shown in figure 2.4.6). 
 
Figure 2.4.5- Example of phase image analysis for loss tangent calculation. Yellow box indicates area of 
dendritic spine membrane sampled for analysis. White box indicates area of dendritic tree membrane 
sampled for analysis 
2.4.6 Study design and Statistical analysis 
The design of this experiment was to scan 5 dendritic spines per slide treated with DHPG 
50µM, MPEP 50µM, AM-251 50µM and AEA 50µM and compare these with vehicle control 
DMSO or soya emulsion. Due to time and financial constraints, two slides per treatment were 
scanned, meaning 6-11 different dendritic spines were scanned per treatment group, after the 
criteria for identifying dendritic spines was applied. 
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The statistical analysis method used was a linear mixed model carried out in SPSS. This was 
chosen because there is some variability between samples as the cantilever is lifted and 
retuned. The assumptions for this model are normality of residuals, independence of residuals 
and linearity of the predicted vs residuals (presented in the appendix section 7.3). The test for 
normality used was Shapiro-Wilk at significance level of 0.05. Almost all analyses carried out 
passed this test for normality of residuals, though it is recognised some did not, the LMM is 
sufficiently robust test to withstand some deviation from the assumption of normality. 
However, the assumption of linearity of residualsvs predicted value was questionable in some 
groups. This is most likely due to the small group size and large variation. More sampling 
would be required to see if this is a continued problem or just due to the small sample size. 





The sample (culture slide, microtome section or whole tadpole) was removed from the fridge 
and allowed to come to room temperature. 0.1% Triton X was applied to sample for 10 
minutes to permeabilise some of the cell membrane and allow diffusion of antibodies. After 
this, the sample was washed thoroughly with NFR. The excess sites were blocked with 5% BSA 
for 10 minutes, then the sample was washed in NFR. The primary antibody Anti PSD-95 
(purchased from Abcam: ab18258) (1:1000) was added to the sample and left to incubate for 1 
hour at room temperature. The sample was washed in NFR, then secondary antibody (Goat 
Anti-Rabbit IgG H&L (Alexa Fluor® 488 purchased from AbCam) (ab150077) (1:1000)) was 
added to the sample (carried out in reduced light to stop fluorophore damage). This was left to 
incubate for one hour at room temperature. The sample was washed with NFR, then imaged 
under a Lecia fluorescent microscope. The excitation wavelength for the fluorophore of 488 
emits at 522 (red light). Controls were carried out to determine background fluorescence and 
unspecific binding. The two control groups were primary antibody only added to sample and 
secondary antibody only added to sample for one hour at room temperature and washed 
three times in NFR then assessed under microscope.  
2.5.2 Fluorescence intensity calculation 
The fluorescence intensity was calculated using Image J. The measurements set were: 
integrated density, mean grey value and area. An area of interest was selected and measured, 
then an area of darkness/relatively low fluorescence nearby is selected and measured. To 
calculate fluorescence intensity this equation was used:  
corrected total cell fluorescence=Integrated density- (area selected x mean grey value of 
background readings). For whole tadpoles the spinal column was selected although this 
included many muscles (Figure 2.5.2). For microtome sections, only the spinal cord was 
selected (Figure 2.5.2). For cell culture areas that appeared to have high levels of neurite 
projections and neuron bodies were analysed. In many instances it was difficult to assess 
dendrites due to high background fluorescence with only cell bodies visible, so the neuron cell 
body was selected (figure 2.5.2).  




Figure 2.5.1- Lecia DMR fluorescent microscope. The Lecia DMR has 4 channels through 
which it excites a range of wavelengths. The excitation wavelength of the 4 channels are 1- 




Figure 2.5.2-Demonstration of the areas selected for fluorescence measurement top left- microtome 
slice 10µm thick cross section of tadpole tail, top right- primary neuron culture, bottom whole tadpole 











3 Investigating the effect of CB1 and group 1 mGluRs on the central 
pattern generator regulation of Xenopus laevis swim-cycle speed 
 
3.1 Introduction 
Central pattern generators (CPG) are a common neural network that regulates rhythmic motor 
patterns such as: walking, mastication and respiration. Understanding their function and the 
receptors which populate them will aid recovery from injury and may have implication for 
other neurological disease. It is imperative that simple animal models, such as the X. laevis 
hatchling tadpole, are fully characterised and modes of assessment are cheap and simple. 
The X. laevis tadpole, until stage 45, is non self-feeding and has two simple behaviours: 
swimming in response to either touch to the skin/shadow detection by pineal eye, and 
struggling when held (Roberts, Li and Soffe, 2010). If left unstimulated the tadpole will rarely 
move simply growing from internal food stores. The spinal network of the X. laevis has been 
well documented and extensively investigated in fictive swimming electrophysiological 
measurements (Li, Roberts and Soffe, 2009; Roberts, Li and Soffe, 2010; Li and Moult, 2012). In 
this investigation we aim to assess the whole tadpole swimming behaviour, measuring the 
locomotor output using high speed video.  
The swimming motion of the X. laevis tadpole is governed by a CPG. In the X. laevis 
hatchling tadpole, stage 28-44, the CPG regulates the left-right alternation of tail muscle 
contraction, as explained in the introduction. Briefly, rohon-beard sensory neurons are excited 
after skin stimulation. These neurons stimulate dorsolateral- commissural interneurons, which 
cause muscle contraction via motoneurons, while also stimulating excitatory electrically 
coupled descending interneurons (dINs). One half centre of the dIN population will excite 
motoneurons, ascending interneurons (aIN) and commissural interneurons (cINs) near 
simultaneously. The cINs inhibit the opposing sides dINs with a hyperpolarising current, the 
dINs on the opposing side then fire on rebound (Figure 1.8.2)  (Li, Roberts and Soffe, 2009, 
2010; Roberts, Li and Soffe, 2010; Li and Moult, 2012; Moult, Cottrell and Li, 2013). The 
frequency of alternation between the left and right is determined by the interplay between 
the size and speed of the hyperpolarising current received by the dINs (Li and Moult, 2012), 
and the underlying NMDAR pacemaker and gap junction excitation of dINs (Li, Roberts and 
Soffe, 2009, 2010). However, it is not possible for the tadpole to continue swimming without 
the hyperpolarising current of cINs  (Moult, Cottrell and Li, 2013). 
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The two main neuronal signalling systems regulating this behaviour are: excitatory glutamate 
signalling and inhibitory glycine signalling. The group 1 mGluRs are postsynaptic GPCRs of the 
Gq type, and their activation via glutamate enacts second messenger signalling systems. The 
second messengers activated are PLC, PKC, IP3/DAG lipase, and adenylyl cyclase. The effect of 
this is increased calcium release from the endoplasmic reticulum enhancing depolarisation, 
CAMKII action, transcription of survival genes via NFkappaB, and the outcomes are survival and 
growth. In the short term the increased calcium/CAMKII enhances the potential for dendritic 
spine potentiation. However, mGluR1/5 are also key players in the long-term depression of 
synapses, though this mainly happens in an NMDAR-independent manner. (Ito, Sakurai and 
Tongroach, 1982). Through PLC activation of DAG lipase, DAG is modified to the CB1 agonist 2-
AG, which through retrograde action can inhibit future neurotransmission from the 
presynaptic terminal (DSI/E) via CB1.  
The group 1 mGluRs have been investigated in the fictive swimming 
electrophysiological recordings of X. laevis, providing evidence for their intrinsic value in 
modulation of the CPG output (Chapman and Sillar, 2007; Chapman, Issberner and Sillar, 
2008). It was shown in these experiments that mGluR 1 and mGluR5 activation via DHPG 
increased locomotor frequency. Evidence was provided in these experiments that part of this 
increase was due to the reduction in the mid-cycle inhibition, regulated by glycinergic 
neurotransmission (the cINs) (Chapman, Issberner and Sillar, 2008). Work on fictive swimming 
of lamprey spinal CPG network provided similar evidence. First, it was shown that group 1 
mGluRs enhanced locomotor frequency and were necessary in normal maintenance of 
frequency (El Manira et al., 2002). Then evidence was provided that mGluR1 and mGluR5 
performed different roles in maintenance of frequency (Kettunen, Hess and Manira, 2003)  
with mGluR1 involved in mediating excitatory depolarisation. From these experiments, similar 
results and observations were drawn to the work in X. laevis, that the increase in frequency 
attributed to Group 1 mGluRs was in part, because of reduced inhibitory release during the 
mid-cycle (cIN hyperpolarisation of dIN). The same group performed a series of experiments 
defining the possible involvement of endocannabinoid signalling in the mGluR1/5 mediated 
increase in locomotor output. In these experiments it was observed that, during fictive 
swimming electrophysiological recording, activation  of mGluR1 on postsynaptic motor neurons 
caused production of endocannabinoids and subsequent activation of the presynaptic CB1, 
suppressing the release of inhibitory neurotransmitters (Kettunen et al., 2005; Kyriakatos and 
El Manira, 2007) (For review see El Manira and Kyriakatos, 2010). During normal swimming, 
glutamate activation of mGluR1/5 causes short and long-term depression of the mid-cycle 
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inhibitory interneurons and causes long-term potentiation of the on-cycle motor neurons 
driving locomotion. This was confirmed by addition of DHPG (mGluR1/5 agonist). It was found 
that inhibition with AM-251 (CB1 antagonist) had almost the opposite effect. It increased the 
effect of mid-cycle inhibitory neurons and decreased the on-cycle depolarisation. In normal 
swimming this would reduce the frequency of locomotor output. This provided strong 
evidence for the glutamate/endocannabinoid mediated long-term potentiation of excitatory 
synapses, and long-term depression of inhibitory interneurons, to enhance CPG mediated 
locomotion (El Manira et al., 2002, 2008; Kyriakatos and El Manira, 2007; El Manira and 
Kyriakatos, 2010).  
On review of this literature we set out to assess the frequency of left-right alternation 
in the swim-cycles of X. laevis in vivo, between stages 37-42, using high speed video analysis. 
Once we had established a reproducible assessment of swim-cycle frequency, we sought to 
confirm the effect of the group 1 mGluRs on the X. laevis tadpole’s swimming behaviour in 
response to touch. The role of CB1 in the maintenance of swimming frequency has not been 
confirmed in X. laevis tadpole stage 37-42, so we then sought to investigate if this receptor 
was involved in X. laevis swim-cycle frequency. If there was a measurable effect of these 
receptors, we wanted to investigate if, like lamprey, the CB1 receptor and the group 1 mGluRs 
interact in the modulation of frequency and have intrinsic value in maintenance of locomotion 
frequency in whole tadpole swimming behaviour. 
  Due to the nature of bath application and reports of cannabinoid receptors present in 
motoneurons (Newman et al., 2007; Sánchez-Pastor et al., 2007) and muscle mitochondrial 
CB1 receptors (Mendizabal-Zubiaga et al., 2016), the treatment groups were assessed for 
changes in the angle of flexion observed when measuring the frequency of swim-cycles. Still 
images were taken at 3 points of flexion during swimming, the angle was measured in Image J, 
and an average for each tadpole timepoint produced (as described in methods chapter 2.14). 
In isolated lamprey spinal cord it was reported that cannabinoid involvement in group 1 mGluR 
increases in frequency of swim-cycles, may have been cannabinoids produced from 
motoneuron dendritic spines, that inhibit cIN neurotransmitter release (Kettunen et al., 2005; 
Kyriakatos and El Manira, 2007). If this is the case group 1 mGluR and/or CB1 
agonism/antagonism may affect motoneuron output and thus the flexion of the muscle 
columns or simply effect the muscles themselves. However, it was also hypothesised that 
there is an optimum flexion: frequency ratio for efficient swimming. A fast swim-cycle with 
large flexion would by reason produce the fastest swim (i.e. shorter time to cover the same 
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distance). Similarly, however, there would be a point where a larger flexion might slow the 
CPG output or be due to reduced CPG swim-cycle frequency allowing larger tail flexions.  
This method will be an accessible tool for future investigation into CPGs, and 
understanding how these two receptor systems influence the excitation: inhibition balance 
that underlies the output of the CPG has ramifications for many neurological systems, such as 
the hippocampus. 
3.2 Method 
As described in chapter 2.1, the receptors involvement in the swimming behaviour was 
assessed by 20-minute bath application of the agonist/antagonist, then 5 measurements, 2 
minutes apart. The tadpole was stimulated to swim by touch to the tail and the swimming 
episode was recorded at 400 fps. The time taken for 1 swim-cycle was calculated by counting 
the frames for three consecutive sim-cycles, between the third and tenth cycle, and taking the 
mean (1 swim-cycle demonstrated in methods Figure 2.1.1). The flexion of the tail during 
swimming was measured to examine if there were effects on the motoneuron-muscle output 
by taking images of 3 flexions achieved during the measurement of frequency. The angles were 
measured in Image J and averages calculated for each tadpole timepoint. We hypothesised 
that changes in muscle contraction, without changes in flexion, or vice versa, would mean that 
the drug treatments are affecting either CPG or motoneuron/muscle contraction output 
independently. If both were affected, the effect at muscles may feedback to the CPG, indirectly 
affecting frequency of swim-cycles (Song et al., 2015), or changes in CPG output affect the 
flexion of the tail during swimming. Before the treatment groups were analysed, the frequency 
and AOF was assessed for correlation. All control tadpoles, stage 40-42, showed there was no 
correlation between frequency and angle of flexion, this was concurred in stage 37-39. To 
assess if treatments influenced the angle of flexion the results were analysed in a linear mixed 
model with time point as a covariate and tadpole as a random factor. Time point had no effect 
in any treatment groups as a covariate. Increases in angle size indicate reduced maximum 
flexion, decreases in angle size are evidence of larger maximum flexions. 
All treatments were compared with their respective vehicle control using a linear mixed 
model. Treatment was a fixed factor with timepoint as a covariate and tadpole was a random 
factor. Timepoint had no significant interactions with swim-cycle frequency in any of the 




3.3 Results -Group 1 mGluR activation increases the frequency of swim-cycles of 
stage 40-42 Xenopus laevis tadpoles  
The group 1 metabotropic glutamate receptor agonist DHPG (50µM 10 minutes), significantly 
increased the frequency of swim-cycles (8.45±1.37%; Figure 3.3.1, Table 7.1.1). DHPG activates 
both sub-types of the group 1 mGluRs, mGluR1 and mGluR5, so it was investigated if either of 
the subtypes had any more value than the other in the maintenance of normal frequency of 
swim-cycles. Inhibition of mGluR1 with LY367385 (50µM, 20 minutes) produced a significant 
decrease in frequency, with a change of -18.3±2.02% (Table 7.1.1, Figure 3.3.1), whereas 
inhibition of mGluR5 with MPEP (50µM, 20 minutes) showed no significant change (-
2.03±1.65% Table 7.1.1 Figure 3.3.1). When both subtypes were antagonised together (LY-
367385 50µM + MPEP 50µM, 20 minutes) a significant decrease was observed, although it was 
only marginally larger than the decrease observed with just mGluR1 inhibition, with a 
percentage change to EMM of -19.72± 1.959% (Figure 3.3.1, Table 7.1.1). It was investigated if 
both subtypes were fully antagonised by adding DHPG after the receptors were antagonised 
(LY365387 50µM + MPEP 50 µM (20 minutes) followed by DHPG 50 µM (10 minutes)). The 
decrease was still large and significant compared with DMSO control (-14.83±2.06% Figure 
3.3.1 Table 7.1.1). Although it was 4.89% higher than without DHPG addition the result still 
confirms a high percentage of antagonism. We then investigated whether the selective 
inhibition of mGluR1 and the addition of DHPG, effectively enhancing the activation of mGluR5, 
would affect the frequency of swim-cycles. LY367385 50µM, (20 minutes) + DHPG 50 µM (10 
minutes) caused no significant change (1.992±1.65% Figure 3.3.1). Next, the inhibition of 
mGluR5 and addition of DHPG (MPEP 50µM 20 minutes followed by DHPG 50µM 10 minutes) 
was tested giving a significant decrease in frequency of swimming (-13.03 ±3.035%, Figure 
3.3.1, Table 7.1.1).  
All treatments were compared pairwise in a linear mixed model with timepoint as a 
covariate. Timepoint had no significant effect on the frequency of swim-cycles. DHPG 50µM 
was significantly different to all other treatments. MPEP 50µM was significantly different from; 
MPEP 50µM +DHPG 50µM, LY367385 50µM, LY367385 50µM + MPEP 50µM and LY367385 
50µM + MPEP 50µM + DHPG 50µM. MPEP 50µM + DHPG 50µM was significantly different 
from all other treatments except LY367385 50µM + MPEP 50µM + DHPG 50µM.  
LY367385 50µM was significantly different from all treatments except LY367385 50µM + MPEP 
50µM and LY367385 50µM + MPEP 50µM + DHPG 50µM. LY367385 50µM + DHPG 50µM was 
significantly different from LY367385 50µM + MPEP 50µM, LY367385 50µM +MPEP 50µM 
+DHPG 50µM. LY367385 50µM + MPEP 50µM was not significantly different from LY367385 
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50µM + MPEP 50µM + DHPG 50µM (Table 7.1.1, Figure 3.3.1). Since a group size of 5 tadpoles 
with replicates at 5 timepoints is a small sample size, a power analysis was performed using 









Figure 3.3.1- The effect of group 1 metabotropic glutamate receptor activation (DHPG) or inhibition 
(LY367385 mGluR1 antagonist, MPEP mGluR5 antagonist) on the frequency of swim-cycle of the stage 40-
42 X. laevis tadpole swimming behaviour. All treatments compared treatment with vehicle control 
(DMSO). Significance indicated by asterisk. (*=p<0.05, **=p<0.005, ***=p<0.001). n=5 tadpoles with 5 
replicates over 10 minutes per tadpole  
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3.4 CB1 receptor inhibition effects group 1 mGluR induced increase in frequency 
We began by first inhibiting the CB1 receptor with AM-251 (10µM, 20 minutes). This produced 
a significant decrease in frequency of swimming (-9.47±1.56, Figure 3.4.1, Table 7.1.2). This 
was a slightly larger decrease than the increase seen in DHPG (8.45±1.37%), yet not so large a 
decrease as complete group 1 mGluR inhibition (-19.72±1.96%). Next, it was assessed if DHPG 
(50µM, 10 minutes) applied after CB1 antagonism (AM-251 10µM, 20 minutes) would still 
increase frequency. There was no significant change in frequency compared with control (-
2.05±2.54 Figure 3.4.1, Table 7.1.2). The antagonism of all 3 receptors, mGluR1, mGluR5 and 
CB1 (Am-251 10 µM + LY367385 50µM + MPEP 50µM, 20 minutes) significantly decreased 
swim-cycle frequency, compared with control DMSO (-6.24±3.22% Figure 3.4.1, Table 7.1.2). 
The inhibition of mGluR1 and CB1 (AM-251 10 µM + LY367385 50µM 20 minutes) was not a 
significant decrease (-3.58 ±3.09%, Figure 3.4.1., Table 7.1.2). When mGluR5 and CB1 were 
antagonised (AM-251 10µM + MPEP 50µM, 20 minutes) the decrease was significant (-
8.28±2.36%, Figure 3.4.1, Table 7.1.2). All treatments were compared pairwise in post-hoc 
analysis in the LMM. No other treatments were significantly different from each other (Table 
7.1.2, Figure 3.4.1). Since a group size of 5 tadpoles with replicates at 5 timepoints per 
treatment is a small sample size, a power analysis was performed using GLIMPSE program. The 












Figure 3.4.1- The effect of CB1 antagonism with mGluR1/5 antagonism or before mGluR1/5 activation on 
the frequency of swim-cycles in the stage 40-42 X. laevis tadpole. All treatments compared treatment 
with vehicle control (DMSO). Significance indicated by asterisk. (*=p<0.05, **=p<0.005, ***=p<0.001). 




3.5 The endocannabinoid system contributes to the maintenance of frequency of 
swimming  
As shown previously the CB1 receptor antagonist (AM-251 10µM, 20 minutes) significantly 
decreases frequency of swim-cycles in stage 40-42 X. laevis tadpoles. It is unclear from the 
results if this is related to group 1 mGluR activity or if it is affecting the regulation of neuron 
firing frequency separately. What is clear, it has a role in the maintenance of normal swimming 
frequency. Previous studies reported functional CB1 receptors at stage 41 and the presence of 
CB1 mRNA from stage 26 (Cottone et al., 2003; Beatrice et al., 2006) After our result with 
10µM AM-251 (20 minutes) the experiment was repeated with a range of concentrations 
(0.1μM, 2µM, 10µM, 50µM), with both the endogenous agonist AEA and synthetic antagonist 
AM-251. This was done at two different stages of development: 40-42 and stage 37-39, as it 
was noticed in preliminary studies that the frequency of swimming becomes faster during 
development between stages 37-39 and 40-42. Also based on Beatrice et al (2006) the 
expression of CB1 will be different between the two age groups. Age was assessed as a 
covariate and it has a significant effect on frequency of swim-cycles (F(1,396.139)=582.44, 
p=0.000). We then assessed if age interacted with Treatment (treatment*age). This was a 
significant interaction (F(15,192.860)=17.962, p<0.001). 
Table 3.5.1- Results of linear mixed model analysis of increasing concentration of AM-251 on the 
frequency of swim-cycles in X. laevis tadpole at stage 40-42 
 
Starting with stages 40-42, the low dose antagonist (AM-251 0.1μM, 20 minutes) caused no 
significant change (0.83±2.83%). AM-251 2µM (20 minutes) caused a significant increase in 
frequency of swim-cycles (12.14±2.9%). AM-251 10µM (20 minutes) caused a significant 
decrease (-20.15± 3.15 %,). The maximum concentration, AM-251 50µM (20 minutes) had a 













0.1μM F (1,8.055) =0.042; 
p=0.843 
W (46) =0.969; 
p=0.258 
Satisfied Satisfied 
2µM F (1,11.869) 
=10.742; p=0.007 
W (52) =0.962; 
p=0.098 
Questionable Satisfied 
10µM F (1,14.776) 
=39.172; p<0.001 
W (48) =0.947; 
p=0.029 
Satisfied Satisfied 
50µM F (1,15.396) 
=21.828; p<0.001 




+ AEA 50µM 
F (1,24.567) 
=51.792; p<0.001 





Table 3.5.2- Results of linear mixed model analysis of increasing concentration of AM-251 on the 
frequency of swimming in X. laevis tadpole at stage 37-39 
 
As mentioned, the CB1 receptor was reported at stage 41 with mRNA reported at stage 26 so 
we explored the same concentrations at a younger age group (stage 37-39) to examine if the 
effects are the same.  The overall trend was similar displaying a biphasic effect; however, the 
effect was not comparable between concentrations and age group. To begin with there was a 
significant decrease in frequency with 0.1μM AM-251 (20 minutes) (-11.04±1.63%, Table 3.5.2, 
Figure 3.5.1). AM-251 (2 µM, 20 minutes, and stage 37-39) had no significant change 
(2.47±2.66%) and in complete contrast to the stage 40-42 tadpoles AM-251 10µM increased 
frequency by 7.51±2.03% (Table 3.5.2). A significant decrease was observed with AM-251 
















0.1μM F (1,11.491) 
=23.207; p<0.001 
W (45) =0.974; 
p=0.387 
Satisfied Satisfied 
2µM F (1,16.468) =0.479; 
p=0.499 
W (47) =0.988; 
p=0.921 
Questionable Satisfied 
10µM F (1,8.153) =6.497; 
p=0.029 
W (48) =0.979; 
p=0.528 
Satisfied Satisfied 
50µM F (1,6.944) =32.263; 
p=0.001 






Figure 3.5.1- The effect of CB1 receptor antagonist AM-251 on frequency of swim-cycles of the X. 
laevis tadpole in vivo. Frequency normalised to respective vehicle control mean. All treatments 
compared with vehicle control (DMSO) respective to concentration of vehicle used in treatment. 
Control shown is vehicle control for 50μM. Significance indicated by asterisk. (*=p<0.05, **=p<0.005, 




Based on the work in isolated lamprey, that showed 5µM of synthetic CB1 agonist WIN-55 
increased frequency of swimming by reducing mid-cycle inhibition (Kettunen et al., 2005; 
Kyriakatos and El Manira, 2007), agonism of the CB1 receptor, with endogenous ligand AEA, 
was explored with increasing concentrations at both age groups (stage 40-42 and 37-39). In 
the stage 40-42 age group, the results illustrate that low dose AEA (0.1μM, 20 minutes) 
significantly decreased frequency of swim-cycles (-13.66±1.42%, Table 3.5.3, Figure 3.5.2). AEA 
2µM (20 minutes), was also a significant decrease (-11.75±1.76%). AEA (10µM, 20 minutes) 
was a significant decrease (-12.11±2.72%, Table 3.5.3, Figure 3.5.2). However, 50µM showed 
no significant change (0.122±2.849%).  
 
Table 3.5.3- Results of linear mixed model analysis of increasing concentration of AEA on the frequency 
of swimming in X. laevis tadpole tails at stage 40-42 
 
This trend was similar in the younger stage 37-39 age group. However, no concentration was 
significant compared with its respective vehicle control (Figure 3.5.2, Table 3.5.4).  
Since a group size of 5 tadpoles, with replicates at 5 timepoints is a small sample size, a power 
analysis was performed using the GLIMPSE program. Each treatment was compared to its 
respective vehicle control. The sample size was 5 (5 tadpoles in treatment and 5 tadpoles in 
vehicle control). One significant result (AM-251 stage 37-39 10µM) was significant in the mixed 
model result but was slightly underpowered. The power analysis suggested 2 more tadpoles 
















0.1μM F (1,11.092) 
=154.163; p<0.001 
W (45) =0.955; 
p=0.079 
Satisfied Satisfied 
2µM F (1,8.342) =19.466; 
p=0.002 
W (51) =0.975; 
p=0.361 
Questionable Satisfied 
10µM F (1,20.77) =10.751; 
p=0.004 
W (58) =0.985; 
p=0.683 
Questionable Satisfied 
50µM F (1,19.173) =0.905; 
p=0.353 







Table 3.5.4 - Results of linear mixed model analysis of increasing concentration of AEA on the frequency 
of swimming in X. laevis tadpole at stage 37-39 
 
  
Comparison of AEA 











0.1μM F (1,7.34) 
=0.277; p=0.138 
W (49) =0.96; 
p=0.099 
Satisfied Satisfied 
2µM F (1,9.731) 
=2.781; p=0.127 
W (46) =0.967; 
p=0.22 
Satisfied Satisfied 
10µM F (1,7.988) 
=0.579; p=0.469 
W (50) =0.948; 
p=0.029 
Satisfied Satisfied 
50µM F (1,9.019) 
=2.908; p=0.122 






Figure 3.5.2- The effect of CB1 receptor agonist AEA on frequency of swim-cycle of the X. laevis tadpole 
in vivo. Top) stage 40-42. Bottom) stage 37-39. Frequency normalised to respective vehicle control 
mean. All treatments compared with vehicle control (Soya) respective to concentration of vehicle. 
Control shown is vehicle control for 50μM. Significance indicated by asterisk. (*=p<0.05, **=p<0.005, 




3.6 Assessment of the angle of tail flexion during swimming: a role for group 1 
mGluRs and CB1 in maintenance of efficient muscle flexion during swimming 
3.6.1 Group 1 mGluR effects on angle of tail flexion  
As shown in Figure 3.6.1, MPEP 50µM (20 minutes) + DHPG 50µM (10 minutes) significantly 
increased angle size (12.35±2.11%, Figure 3.6.1, Table 7.2.1), as did MPEP 50µM + LY367385 
50µM (20 minutes) + DHPG 50µM (10 minutes) (12.35±2.4%, Figure 3.6.1, Table 7.2.1). 
Treatment with MPEP (50µM, 20 minutes) caused a significant increase in angle size, though 
not as large a change from control (8.84±2.22%, Figure 3.6.1, Table 7.2.1) as MPEP + DHPG.    
There were no other significant changes observed in flexion angle with mGluR1 inhibition or 
group 1 mGluR activation compared with control (Table 7.2.1, Figure 3.6.1). When the 
treatments were compared pairwise, DHPG was significantly different from LY367385 + MPEP 
+ DHPG. MPEP 50µM was significantly different to LY367385 50µM. MPEP 50µM + DHPG 
50µM was significantly different from DHPG 50µM and LY367385 50µM. LY367385 50µM was 
significantly different form LY367385 50µM + MPEP 50µM + DHPG 50µM (Table 7.2.1). 
Timepoint was not a significant effect on angle size. Since a group size of 5 tadpole with 
replicates at 5 timepoints is a small sample size a power analysis was performed using 





Figure 3.6.1- The effect of mGluR1/5 agonism and antagonism on the angle of flexion of the stage 40-42 X. laevis 
tadpole swimming behaviour in vivo. All groups compared to vehicle control (DMSO). Significance compared with 
vehicle control indicated by asterisk. (*=p<0.05, **=p<0.005, ***=p<0.001) n=5 
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3.6.2 Gp1 mGluRs interact with CB1 in the maintenance of normal tail flexion 
When antagonism of group 1 mGluRs was repeated with CB1 inhibition, a significant reduction 
in tail flexion was observed with mGluR5 + CB1 antagonism (MPEP 50µM + AM-251 10µM, 20 
minutes) (17.51±1.87%, Table7.2.2 Figure 3.6.2). AM-251 10µM (20 minutes), showed no 
significant change in flexion angle. MGluR1 and CB1 inhibition (LY367385 50µM + AM-251 
10µM, 20 minutes) significantly increased the size of flexion angle (12.17±1.66, Figure 3.6.2, 
Table 7.2.2), and complete inhibition of all three receptors (MPEP 50µM + LY367385 50 µM + 
AM-251 10µM, 20 minutes) significantly increased the size of flexion angle (8.21±1.66%, Table 
7.2.2, Figure 3.6.2). When the treatments were compared with each other in a pairwise 
comparison, AM-251 + MPEP was significant against all other treatment except AM-251 + 
LY367385. And AM-251 + LY367385 was significant against all other treatments except AM-251 


























Figure 3.6.2-The effect of CB1 inhibition before mGluR1/5 activation/inhibition on the angle of flexion of 
the stage 40-42 X. laevis tadpole swimming behaviour in vivo. All treatments compared to vehicle control 
(DMSO), Significance indicated by asterisk. (*=p<0.05, **=p<0.005, ***=p<0.001) n=5 tadpoles with 5 
replicates over 10 minutes 
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3.6.3 CB1 effects on tail flexion 
 Table 3.6.1- Results of LMM analysis of AM-251 concentration on angle of flexion of stage 40-42 
tadpoles 
 
The interesting interaction, of CB1 antagonism with group 1 mGluR antagonism on the angle of 
flexion, suggests some role for CB1 in this effect. As such, increasing concentrations of CB1 
agonist AEA and antagonist/inverse agonist AM-251, were assessed for changes in the angle of 
flexion. The effect of CB1 antagonism with AM-251, on angle of flexion, was not significant at 
any concentration in stage 40-42 tadpoles (Table 3.6.3, Figure 3.6.3). This was not the case for 
stage 37-39, where AM-251 2µM (20 minutes) significantly increased angle of flexion 
(13.31±2.21%, Table 3.6.4, Figure 3.6.3). This opposed the result for AM-251 50µM (20 
minutes, stage 37-39) which significantly decreased size of angle of flexion (-9.73±3.15%, Table 
3.6.4).  
Table 3.6.4- results of linear mixed model analysis of AM-251 concentration on angle of flexion in stage 
37-39 tadpoles 
  
The result with AM-251 50µM stage 37-39, is comparable with the endogenous CB1 agonist 
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significant decrease in angle of flexion (-9.66±1.74, Table 3.6.5, Figure 3.6.4). This is repeated 
in the treatment group AEA 10µM (stage 40-42), where the decrease in frequency is 
accompanied by a decrease in angle of flexion (-8.27±1.5%, Table 3.6.5, Figure 3.6.4). However, 
as with the two age groups treated with AM-251, this effect is not mirrored in the younger age 
group (stage 37-39) treated with increasing concentrations of AEA, where no concertation 
produced a change in angle of flexion (Table 3.6.5, Figure 3.6.4). Age was assessed as a 
covariate and has a significant effect on the angle of flexion of swim-cycles (F(1,601.9)=5.457, 
p=0.02). We then assessed if age interacted with Treatment (treatment*age). This was a 
significant interaction (F(15,172.1)=4.01, p<0.001).  
Table 3.6-5- Results of linear mixed model analysis of AEA concentration on angle of flexion in stage 40-
42 tadpoles 
 










































































Figure 3.6.3- The effect of CB1 receptor antagonist AM-251 on angle of flexion of the X. laevis tadpole in vivo. Angle 
normalised to respective vehicle control mean. All treatments compared with vehicle control (DMSO) respective to 
concentration of vehicle. Control shown is vehicle control for 50μM. Significance indicated by asterisk. (*=p<0.05, 




















Figure 3.6.4- CB1 receptor endogenous agonist AEA effects on angle of flexion of the X. laevis tadpole 
Frequency normalised to respective vehicle control mean. All treatments compared with vehicle control 
(Soya) respective to concentration of vehicle. Control shown is vehicle control for 50μM. Significance 
indicated by asterisk. (*=p<0.05, **=p<0.005, ***=p<0.001). n=5 tadpoles with 5 replicates over 10 




3.7.1 Group 1 metabotropic glutamate receptors effect frequency of swimming  
Our results give the first whole tadpole evidence, that Group 1 mGluRs contribute to the 
maintenance of locomotor frequency in the Xenopus laevis tadpole. This concurs with previous 
fictive swimming electrophysiological experimentation of the immobilised X. laevis tadpole 
(Chapman and Sillar, 2007; Chapman, Issberner and Sillar, 2008) and lamprey (El Manira et al., 
2002; Kettunen et al., 2005; Kyriakatos and El Manira, 2007; Nanou et al., 2009). The group 1 
mGluRs, activated by glutamate, can increase excitability of the network because of its g 
protein signalling. Once activated it increases intracellular calcium, inhibits inward rectifying K+ 
currents and through activation of phospholipase Cβ (PLCβ) can produce the endocannabinoid 
2-AG, which as described previously, acts as a retrograde messenger to inhibit future 
neurotransmitter release from inhibitory cINs in lamprey. With the evidence from previous 
literature demonstrating constitutive activity of cannabinoid receptors at inhibitory neurons 
(den Boon et al., 2014), transporter proteins (Panlilio et al., 2015) and intracellular regulatory 
proteins (Stauffer et al., 2011; Guggenhuber et al., 2016), the mGluR1/5-CB1 interaction is most 
likely a very tightly controlled retrograde signalling mechanism used to potentiate excitatory 
signalling (Kyriakatos and El Manira, 2007) or protect from excessive excitatory signalling 
(Marsicano et al., 2003; Stauffer et al., 2011). Based on this information, group 1 mGluRs may 
increase excitability in PSDs through a 2-fold mechanism: the potentiation of NMDA receptors 
(Nanou et al., 2009) and modulation of presynaptic inhibitory neurotransmitter release to 
enhance long and short-term potentiation of excitatory glutamate transmission (Kyriakatos 
and El Manira, 2007).  
The experimentation with both antagonists of mGluR1 (LY367385) + mGluR5 (MPEP) 
showed a significant decrease which was not reversed via application of the agonist DHPG. 
This corroborated previous evidence that group 1 mGluRs are involved in the maintenance of 
normal swimming frequency in X. laevis (Chapman, Issberner and Sillar, 2008). One result, that 
is not in accordance with previous studies, was the inhibition of mGluR5 via MPEP (50µM, 20 
minutes) then addition of DHPH (50µM, 10 minutes). Previous results showed inhibition of 
mGluR5 via MPEP increased frequency in isolated lamprey spinal cord (El Manira et al., 2002). 
However, we observed no change with just MPEP application and a decrease in frequency 
after the addition of DHPG. This may indicate over-excitation of mGluR1 reduces the locomotor 
output. The experimental setup used in the investigations in lamprey may lead to excessive 
activation of NMDAR and mGluR1, due to the baseline frequency set by NMDA application 
(Kettunen, Hess and Manira, 2003b; Kyriakatos and El Manira, 2007). To make matters more 
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interesting when we inhibited mGluR1 via LY367385 (50µM 20 minutes), there is a significant 
reduction in frequency, indicating its intrinsic value in the maintenance of swimming. When we 
inhibited mGLuR1 and DHPG is added there is no change in frequency. This implies either: 
mGluR5 can compensate for the absence of mGluR1, but as previous result shows are not itself 
intrinsic to the maintenance of frequency, or the competitive antagonism of mGluR1 by 
LY367385 is overcome by DHPG at this concentration, or there is some combination of the 
two. MPEP is a non-competitive antagonist. So the decrease in frequency when mGluR5 is 
inhibited and DHPG is added may suggest over activation of mGluR1 causes a decrease in 
frequency. The frequency of neuron firing in this swimming behaviour is one that, like all 
neuron systems, requires a homeostatic regulation of excitation via glutamate or acetylcholine 
and inhibition via glycine or GABA. This means that the modulatory effects of mGluR1/5 and 
CB1 are going to be biphasic, dependent on level of receptor activation. To explore this 
relationship further dose response curves of LY367385, MPEP and DHPG need to be performed 
ideally in electrophysiological preparations and filmed swimming behaviour to elucidate the 




3.7.2 Group 1 mGLuR and CB1 antagonism decrease frequency of swim-cycles 
The relationship between postsynaptic group 1 mGluRs and presynaptic CB1s has been 
investigated previously in fictive swimming electrophysiological preparations. Firstly, it was 
shown that the DHPG induced increases in fictive swimming frequency of swimming in the X. 
laevis tadpole was in part due to reduced glycine release (Chapman and Sillar, 2007; Chapman, 
Issberner and Sillar, 2008). In isolated lamprey spinal cord, this increased burst frequency and 
reduced glycine release, was attributed to cannabinoid production acting retrogradely on 
presynaptic CB1 receptors, inhibiting glycine release onto dINs (El Manira et al., 2002; 
Kyriakatos and El Manira, 2007). 
To assess the previous hypothesis that group 1 mGluRs increase frequency, partly 
through the production of endocannabinoids and activation of CB1, CB1 was inhibited in 
combination with group 1 mGluR activation and inhibition. Application of CB1 antagonist AM-
251 decreased frequency. When AM-251 was applied (10µM) followed by DHPG (50µM) 
application, there was no significant change. If DHPG induced increase was solely through 
subsequent CB1 activation, then the initial decrease observed in AM-251 group should be 
retained after DHPG application. This not being the case may mean that DHPG is increasing 
frequency, in this animal model, independent of CB1. It could be that CB1 was not fully 
inhibited, although our results assessing increasing concentrations imply 10µM AM-251 had 
the maximum decrease on frequency. Interestingly, mGluR5 inhibition (MPEP 50µM) + CB1 
inhibition (AM-251 10µM) decreased frequency. However, the recorded decrease matches 
that of AM-251 alone. In conjunction with MPEP not decreasing frequency,  indicates mGluR5 is 
not vital in setting baseline frequency. On review of the videos it was evident that the MPEP 
groups were difficult to initiate swimming. The first 2-3 swim-cycle would occur as normal 
after touch, but the swimming was not maintained after this point. The sequence of neurons 
that initiate swimming are primarily independent of the CPG, until hindbrain neurons (dINs) 
are stimulated to begin the rhythmic CPG pattern. This was the case in all MPEP groups but 
was most significant in the MPEP 50µM + LY367385 50 µM + AM-251 10µM group. It is 
interesting that this was the case with MPEP alone which did not affect frequency. It should be 
noted that in MPEP 50µM once swimming was maintained past the third swim-cycle, 
frequency of CPG measured was not changed compared with control. This could highlight a 
role for mGluR5 in the initial muscle contractions via the dlc, dla or rohon beard neurons. Given 
that frequency and flexion angle were not correlated in control groups it can be concluded that 
one does not predict the other. This would imply that although some treatments affected both 
the frequency of swim-cycles and the angle of flexion, their action might be occurring in two 
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places (CPG for frequency, muscle/motoneuron for flexion). However, it may also be 
hypothesised that muscle output is a measure of the CPG, as this is responsible for 
motoneuron depolarisation. If CPG signalling was impeded (by mGluR1/5 antagonism) all 
glutamate signalling could be affected, particularly this may affect dIN→motoneuron 
signalling. Similarly, the difficulty in maintaining swimming could be attributed to inhibited 
glutamate excitation of dINs by the rohon-beard neurons.  
When mGluR1 is inhibited and DHPG applied, there is no longer a decrease in 
frequency observed with mGluR1 inhibition alone. If we combine this information with the 
subsequent analysis of tail flexion it may be that mGluR5, present at motoneurons, can 
enhance frequency through eCB production, which inhibits cIN -glycine release. However, if 
this change was due to cannabinoid production why then does antagonism of mGluR1 
(LY367385 50µM) + CB1 antagonism (AM-251 10µM) not decrease frequency? Considering 
LY367385 alone decreased frequency and AM-251 alone decreased frequency it seems 
surprising that combined there was no significant change. If the mechanism by which mGluR5 
maintains frequency is via CB1, the inhibition of mGluR1 and CB1 should maintain this decease. 
We have shown that mGluR1 antagonism followed by DHPG addition causes no significant 
change, implying that increased mGluR5 activation is enough to mitigate decreased mGluR1 
availability. This is similar to the original in vitro studies in lamprey (El Manira et al., 2002), that 
showed mGluR1 inhibition decreased frequency and mGluR5 inhibition increased frequency. It 
is possible that AM-251 + LY367385 does not affect frequency compared with control because 
more glutamate released from presynaptic axon terminals, due to AM-251, activates more 
NMDARs and mGluR5 almost replicating the effect seen with LY367385 + DHPG which also did 
not change frequency of swim-cycles. 
To then explain why MPEP + DHPG would decrease frequency, we must consider that 
inhibition of one subtype receptor with addition of DHPG may excessively activate the other 
subtype and cause opposing or negative effects. As discussed previously, DHPG at 100µM can 
cause LTD in hippocampal slices (Palmer et al., 1997), yet 10-50µM has resulted in potentiation 
of certain neural connections, such as the dIN of lamprey (Kyriakatos and El Manira, 2007). As 
such, the receptor systems themselves do not determine the fate of the synapse but the 
location specific conditions modulate the signalling of the group 1 mGluR -eCB system which 
could be better thought of as a tuning and homeostasis regulator of excitatory synapses. 
3.7.3 Cannabinoids affect the frequency of swim-cycles 
We have presented the first evidence that exogenously applied cannabinoids affect the 
frequency of swim-cycles of the X. laevis hatchling tadpole, stages 37-42. Our data suggests 
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that AM-251, the CB1 antagonist, biphasically affects frequency in a concentration dependent 
manner in both age groups. Rather interestingly, we have also shown that the endogenous CB1 
agonist AEA, decreases frequency at low concentrations, the decrease becoming less 
pronounced as the concentration increases, until no change was observed at 50µM. As 
mentioned in the methods, it was also observed that stage 40-42 tadpoles had a faster swim-
cycle frequency than stage 37-39 tadpoles. When assessed as a covariate in the LMM it 
confirmed that the differences were significant between the two age groups. The fact that age 
had a significant interaction with treatment, also highlights that CB1 is most likely expressed 
differently in the two age groups.  
AEA is a complex molecule in terms of the array of affects attributed to it. As 
mentioned previously, it is  an endogenous CB1 ligand with a higher affinity than 2-AG (ki=89 
and 472nM respectively), and a greater potency than 2-AG (EC50 =31 and 519nM 
respectively). However, it is 2-AG that is found in the brain at concentrations up to 1000-fold 
higher than AEA (Buczynski and Parsons, 2010). Given AEA’s more complex synthetic pathways 
and more complex degradation pathway (covered in introduction section 1.5), it is thought 
that 2-AG performs the majority of the signalling. If synthetic agonist WIN-55 increased 
frequency of locomotor output in fictive swimming in lamprey, why has there been no 
increases observed with AEA in X. laevis? The answer to this conundrum may lie in the 
constitutive activity of the endocannabinoid system. If the normal function of the 
endocannabinoid system is to enhance excitatory signalling and reduce IPSPs in such a manner 
as to enhance frequency of swim cycles, it stands to reason that many of the cIN-CB1 receptors 
would be active during swimming. So exogenous application of AEA would not find an active 
site at the cIN-CB1 or not change the already active state of it. However, there are also CB1 
receptors presents at glutamatergic terminals (Glu-CB1) in other organisms so it may be the 
case in X. laevis. It is possible that the low concentration of exogenous cannabinoid has only 
found its target on open Glu-CB1s, with 2-AG occupying its normal position on Glycinergic-CB1 
receptors (Gly-CB1). Evidence has been presented previously which provides some substance 
to this argument. Mice were generated lacking CB1 at either GABAergic axon terminals (GABA-
CB1-KO) or glutamatergic axon terminal (Glu-CB1-KO). From this the constitutive activity was 
calculated to be 30-40% for GABA-CB1, but only 5-7% at Glu-CB1 (Steindel et al., 2013). If the 
function of CB1 is to enhance excitatory signalling in the CPG, it could be expected that the 
activity profile would be very similar, if not larger in difference. However, if we follow this train 
of thought, would 50µM AEA not just produce a massive reduction as it reaches maximum 
saturation and activates CB1 receptors on both excitatory axon terminals and inhibitory axon 
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terminals. The answer may lie in the distribution of CB1 and in the distribution of neuron 
populations. The expression of CB1 is thought to be higher at inhibitory terminals according to 
previous studies. This might mean that the low concentrations produce a decrease because 
they initially take the easy path, activating free Glu-CB1s and reducing excitation, but as the 
concentration increases they outcompete 2-AG for Gly-CB1s, causing a larger decrease in 
glycine release compared to glutamate release and begin to readdress the balance in 
excitation: inhibition ratio (den Boon et al., 2014).   
The biphasic interplay of inhibitory and excitatory signalling, in relation to exogenous 
cannabinoid application, has been evidenced in: voluntary movement (Sulcova, 1998; Sañudo-
Peña et al., 2000; Bruijnzeel et al., 2016), reward seeking and locomotion (Katsidoni, 
Kastellakis and Panagis, 2013; Polissidis et al., 2013), anxiety (Viveros, Marco and File, 2005; 
Rubino et al., 2008; Rey et al., 2012), hippocampal acetylcholine release (Tzavara, Wade and 
Nomikos, 2003; Steindel et al., 2013) and feeding behaviour (Wiley et al., 2005; Bellocchio et 
al., 2010). The consensus is cannabinoids effect different neuron populations in time and dose 
dependent manner. As the concentration increases, more CB1s in different neuron groups are 
activated/inhibited and the effects become opposing. This effect means that application of an 
antagonist, with much higher affinity than the endogenous ligands, such as AM-251, would 
increase GABA/glycine release more so than glutamate release. However, this effect would be 
time and dose dependent. Therefore, a low dose antagonist would have an easier time finding 
a free Glu-CB1 than a GABA-CB1, initially increasing glutamate release. As this concentration 
increases, the balance is redressed eventually becoming biphasic.  
As discussed in the introduction, Li and Moult, 2012; Moult, Cottrell and Li, 2013 
demonstrated the role of the cINs in maintaining and regulating frequency of left-right tail 
contractions. Through hyperpolarising current injection and optogenetic hyperpolarisation, 
testing the parameter of hyperpolarisation rebound firing, indicated weak hyperpolarisation 
(below -43.3mV) produced slower rebound firing and above -43.3mV there was no change. 
One explanation of the results could be that AEA reduced cIN release so as to delay threshold 
hyperpolarisation potential attainment and reduce frequency. However, as discussed above, 
also decreased background depolarisation which can also effect frequency (Li and Moult, 
2012). I propose that although a large decrease in cIN-glycine release can slow frequency by 
not initiating hyperpolarisation rebound firing, increasing glycine release via AM-251 inhibition 
of CB1R, reduces frequency because the hyperpolarisation is large and sustained, delaying 
rebound firing. It can be thought of as having an optimum hyperpolarisation range if the 
release of glycine is too little of too slow rebound firing is delayed, if the glycine release is 
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sustained and too large rebound firing is delayed. This could be one explanation for the 
biphasic results presented in this work. Particularly, it may affect the cannabinoid regulated 
potentiation of glutamate signalling previously proposed (Kyriakatos and El Manira, 2007). 
Some evidence has been presented that might substantiate the theory that high dose AM-251 
generates such a large IPSP at the dIN that rebound firing is delayed. Li and Moult (2012), 
showed large chlorine injections slowed frequency.  
Cannabinoids, in the context of the CPG, have been investigated in the fictive 
swimming of lamprey (Kettunen et al., 2005; Kyriakatos and El Manira, 2007; El Manira et al., 
2008; Song, Kyriakatos and El Manira, 2012). The short conclusion from these studies was that 
cIN-CB1 inhibition increased the IPSP at dINs and decreased the frequency of MN bursts. 
Further experiments showed cannabinoid ligands, particularly 2-AG or synthetic cannabinoid 
WIN 55, potentiated the excitatory transmission by decreasing glycine release from adjacent 
synapses, particularly cINs. When considering these conclusions, in the context of our AEA 
application results, it seems surprising that more increases in frequency were not observed. It 
is highly likely that the cIN-CB1s are tightly regulated, activated by 2-AG and the effect of 
exogenous AEA is more likely to affect background depolarisation. So only at specific 
concentrations, it will modulate the network in such a manner as to increase frequency. 
Although slightly different results were obtained in lamprey, the conclusions the group drew 
are consistent with the literature even producing a biphasic sine plot to explain how 
cannabinoids shift the relationship between excitation and inhibition (for review of lamprey 
cannabinoids and group 1 mGuRs studies see El Manira & Kyriakatos 2010). Recent work has 
produced measurements of different brain regions with cannabinoid application and the 
results show a shift in inhibition: excitation ratio from 90:10 to 70:30 (den Boon et al., 2014). 
When discussing AEA we must also consider its limitations as an exogenous cannabinoid. There 
are conflicting reports on the affinity and efficacy of AEA compared with 2-AG. The previously 
mentioned Kd and EC50 for AEA and 2-AG were from the supplier (Tocris). However, AEA has 
been described as a partial agonist compared with 2-AG which is a full agonist (Console-Bram, 
Marcu and Abood, 2012). Often affinity and efficacy experiments are tissue and cell type 
dependent, and CB1 effects have not been characterised in the neural system of X. laevis. It is 
possible that the lower EC50 value for AEA is because it has a lower maximum response than 
2-AG, making it a partial agonist. With a higher affinity this would mean AEA is acting almost 
like an antagonist at low concentrations, occupying the receptor and causing less of a 
response. In this context it is possible that low concentrations outcompete 2-AG for the active 
site at cIN-CB1, but do not reduce glycine release to the same extent. As the concentration 
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increases, the effect caused is similar to 2-AG’s endogenous effect and frequency of swim-
cycles are not changed. This would fit with our data in the stage 40-42 group, where low doses 
decreased frequency and as the AEA concentration increased this effect became lessened, 
until at 50μM no change was observed. AEA can also activate TRVP1 cation channels, which 
can allow calcium into the PSD (Starowicz, Nigam and Di Marzo, 2007; Tóth, Blumberg and 
Boczán, 2009). If TRVP1 was present on cINs, this would increase their rate of depolarisation, 
possibly increasing glycine release rate. If TRVP1 was present on dINs it may increase the rate 
of dIN depolarisation and increase frequency. AEA application has also been reported to inhibit 
the production of 2-AG and lessen the effect of DHPG (Maccarrone et al., 2008). 
  Noting our slightly different results to previous in vitro lamprey experimentation, we 
must comment on the difference in methodology. Our drugs were bath applied, possibly 
increasing off target effects, and were only applied for 20 minutes prior to recording, as 
opposed to experiments in lamprey which had 1-2 hours perfusion of the spinal cord. Although 
the CPG of X. laevis operates with little to no input from higher brain regions, the trigeminal 
ganglia that stop swimming, are activated in response cement gland touch, and release GABA 
onto hindbrain to stop dIN pacemaker firing. It was noted in our preliminary experiments that 
AEA treated tadpoles swam for longer periods, but there were too many variables such as 
frequency of cement gland touch and our camera only recorded for short timeframes leading 
to incomplete datasets. This is something that could be looked at in more detail in the future. 
Cannabinoids also affect metabolism and there is a body of work beginning to provide 
evidence for mitochondrial cannabinoid receptors (Bénard et al., 2012; Hebert-Chatelain et al., 
2014; Ma et al., 2015), which may mean a reduced energy availability. In the lamprey the 
baseline frequency was set by NMDA bath application (Kyriakatos and El Manira, 2007), as 
opposed to our work were control frequency is set purely based on CPG function and initiated 
by touch to the trunk. There is also the in vitro vs in vivo debate to be had, especially 
considering the neuroprotective properties displayed by endocannabinoids (Marsicano et al., 
2003). Surgical preparations can evoke cannabinoid signalling (Arevalo-Martin et al., 2012), 
which may affect the level of constitutive activity of CB1 before treatment application.  
From this work in neuroprotection an interesting family of proteins, the cannabinoid 
receptor interacting protein (CRIP) 1a, was identified to modulate the activity of the CB1R 
(Stauffer et al., 2011; Ahmed et al., 2014; Blume et al., 2014; More and Choi, 2015; 
Guggenhuber et al., 2016). Current consensus is this protein interacts with the intracellular 
domain but does not contribute to desensitisation. It would appear that CRIP1a interacts in 
such a manner as to change/enhance preference for certain G-protein signalling, in some cases 
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sequestering stimulatory alpha g- protein as opposed to inhibitory alpha g-protein that CB1 
normally activates (Blume et al., 2014). In one study it even reversed the effect of an 
antagonist to an agonist (Stauffer et al., 2011). This could mean the biphasic effect of 
cannabinoids is due simply to this protein becoming active in order to stop erroneous 
cannabinoid signalling, severely changing the range of neurotransmission past a certain point 
and may be why fatalities are not seen with cannabinoid abuse. If this protein is present in X. 
laevis, its activation may change the neurotransmitter release probability and explain the 
biphasic response. Particularly in AM-251 as the neural systems try to balance the 
dysregulation in excitatory signalling CRIP1a could become active to effectively change the g-
protein signalling and thus the effect on ion channels where necessary to maintain signalling 
within a range and allow swimming to continue. This is essentially an evolutionary fail safe that 
would mean, if for example an animal ate a cannabinoid plant, it could still maintain neuronal 
signalling without completely reducing neurotransmitter release to the point of shutting down 
key functions such as movement and homeostatic regulation. 
Finally, I would like to highlight a study into spike timing dependent plasticity involving 
the endocannabinoid system and group 1 mGluRs (Cui et al., 2015). This study explored 
standard LTD and LTP spike timing dependent protocols in corticostriatal neurons. The 
fascinating outcome was a bidirectional role of endocannabinoids in the induction of either 
LTD or LTP. The evidence shows that cannabinoids are involved in both LTP and LTD the 
defining factor was the induction protocol. A small number of paired stimulations (5-10 pre 
and postsynaptic spikes) induced LTP and this was dependent on both TRVP1 and CB1 
activation. In the same neuron groups, paired stimulation was increased (50x pre and 
postsynaptic spike) and the LTP was reversed to a LTD. Then increasing this to 100 pre and 
post stimulations induced LTP again. This is further evidence in a short term setting that 
cannabinoids are not solely responsible for increases or decreases themselves, they modulate 
synaptic activity based on complex activity dependent signalling systems that are neuron 
population dependent.  
3.7.4 Angle of tail flexion affected by mGluR1/5 and CB1  
If angle of flexion is affected and not frequency, it is assumed the treatments have affected 
motorneuron depolarisation rate/ muscle cell contraction. If frequency is affected it has likely 
affected the balance of cIN-dIN hyperpolarisation and dIN pacemaker activity.The results of 
the tail flexion measurement demonstrate that the two measurements are independent as the 
groups that reduced or increased frequency were not the same as ones which altered tail 
flexion. However, some groups did affect both frequency and flexion, such as MPEP + DHPG 
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and LY367385 + MPEP + DHPG. This is an interesting result, and hard to explain why the 
addition of DHPG to these groups would affect tail flexion, when LY367385 + MPEP did not 
significantly affect flexion. When CB1 antagonism was combined with these groups tail flexion 
was once again affected significantly. By far the largest increase in angle size (reduction in tail 
flexion) was seen in the MPEP + AM-251 group. However, LY367385 + MPEP + AM-251 also 
significantly reduced tail flexion. Although it is unclear how the DHPG/ increased glutamate 
(via AM-251 application) would reduce the tail flexion, unless excessive activation of a 
particular receptor causes negative effects on muscle contraction. 
  Although the control groups displayed no correlation between frequency of swim-
cycles and angle of flexion, many groups which display significant decreases in frequency also 
had reduced tail flexions, but not all of them. For example, LY367385 application significantly 
reduced swim-cycle frequency but tail flexion was not altered significantly. This sequence of 
results may indicate that mGluR5 is present on motorneurons whereas mGluR1 is present on 
dINs. If we compare this with the result of measured change in frequency of swim-cycles, we 
can see that the increased tail flexion of 50µM AM-251 was accompanied by a very large 
decrease in frequency of swim-cycles. If CB1 receptors are present at cIN axon terminals it is 
possible that motoneuron depolarisation produces cannabinoids which inhibit adjacent cIN 
neurotransmitter release. In the antagonism of CB1, this process is decreased effectively 
increasing inhibitory neurotransmission and slowing frequency. It might also be the case that 
larger muscle contractions slow the frequency of swim-cycles, if larger depolarisations/ 
increased group 1 mGluR activation produced more cannabinoids. If the CPG frequency slowed 
but the motoneuron output is the same this might enable larger flexions as there is longer 
between alternating contractions, simply allowing the tail to travel slightly further before the 
other side pulls it back.  
AM-251 (2µM, 20 minutes) did not affect frequency of swim-cycles in stage 37-39 
tadpoles, but it did affect the angle of flexion. This is different to the trend seen in mGluR1/5 + 
CB1 inhibition, where the frequency of swim-cycles decreased, and the tail flexion decreased.  
As the two variables are not correlated it can be deemed that two separate effects are being 
measured, unless, mGluR1/5 and CB1, present at motoneuron PSD/dIN axon terminal 
respectively, modulate motor output (angle of flexion) in such a manner as to affect and 
feedback to modulate CPG output (frequency of swim-cycles) through cannabinoid modulation 




3.7.5 Assessment of method as a viable measure of swimming output in Xenopus laevis 
tadpoles 
The methods used to assess the motor output of the X. laevis tadpole are novel and as such 
are imperfect. The power analysis highlights that where results are significant in all but one 
case the study was sufficiently powered. Where there are not significant differences in the 
data, the studies are generally underpowered (results in appendix Tables: 7.1.1-7.1.4). 
However, there are a couple of groups where they only appear marginally underpowered 
suggesting in some cases 4-14 more tadpoles in the sample would ensure a sufficiently 
powered study. The small sample size and imperfect method of data collection has led to some 
variability in the standard deviation and large variations in this were usually a predictor for an 
underpowered study. The possible issues identified that may have led to increased variability 
are: tadpole staging, drug penetration/application, subjectivity in swim-cycle selection, 
subjectivity in angle of flexion selection. 
3.7.5.1 Staging 
Firstly, the staging of the tadpoles was performed according to Nieuwkoop and Faber (1995). 
Although there is a clear progression of stages at room temperature, we staggered the 
development by placing the tadpoles in coolers at 12oC. This meant that the timeframe no 
longer applied. The reduction in temperature slows the metabolism and thus development of 
the tadpole. Experiments were performed to assess the differences in stage 37-39 compared 
with stage 40-42 defined by stage, with significant differences in swim-cycle frequency 
between the two age groups. Tadpoles which had their development staggered by cooling 
showed no significant changes to their developmental stages when they were compared. 
However, it is possible that over the course of the experiments when treatment was applied 
that slight misjudgements in the stages could have caused variability in the controls. A good 
example of this would be the controls for AEA in the stage 37-39 group, which varied more 
than the means of the treatment did with each other. When a post-hoc test was performed 
comparing all groups including controls with each other, the control groups had statistical 
significance from one another and treatment groups did not. It was difficult to differentiate 
between a stage 37 tadpole and stage 39 so they were classed as one group. If a situation 
arose where one control was predominantly stage 39 and the other stage 37 it would be likely 
those two means would be significantly different from one another. This would need to be 
explored further to identify this as the source of variability as we do not know if stage 39 
swims significantly faster than stage 37. This again could be a problem in the stage 40-42 
groups. However, there is a much clearer developmental change that happens at stage 40 and 
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again at stage 42 so this group is easier to differentiate and can be more confidently asserted 
that all tadpoles tested were in fact stage 40 or stage 41. By stage 42 there is a clear change in 
the yolk sac mass and the shape of the proctodueum becoming conical. There is also a colour 
change in the skin as pigment becomes more pronounced. Although not entirely related, the 
staging problems also relate to how the drug was applied. The tadpole was anaesthetised in 
MS-222 and a small nick was made in the dorsal fin. The tadpole was allowed to recover for 
longer than 1 hour. This recovery time was not always exact as the nick was done in batches 
and thus some tadpoles may have healed more than others by the end of a treatment group. 
This would then have inter-treatment differences dependent on the size and polarity of the 
molecule. The unknown factor of this may have led to some increase in random variation 
between tadpoles and treatments. 
3.7.5.2 Selection of swim-cycles 
The subjectivity in the selection of the data may have caused variation. Although this method 
was carried out methodically and without bias the swim-cycles that were measured had to be 
ones where the tadpole swam at the best angle to be filmed. Sometimes the tadpole would 
swim on its side for some of the video meaning those swim-cycles could not be measured. The 
method used always measured swim-cycles between the 3rd and 10th cycle. However, what is 
not known is if there is variation in these cycles. Also, it is unlikely that two people analysing 
the same video would get exactly the same results. To improve this, two things should happen 
in the future: the sample sizes could be increased, this would increase the power where it is 
underpowered, but would also allow for ruthless elimination of swimming bouts that did not 
produce measurable swim-cycles between the 3rd and 6th cycle. To improve this further all 
swim-cycles would be measured and recorded with no average taken.  There are video analysis 
programs, such as worm tracker for Image J, which could measure the frequency of all the tail 
movements so the analysis would be much more in depth giving a clear picture of the 
variability in swim-cycle speed across the entire swimming bout. The use of worm tracker was 
investigated during the project, however, the video format we used was not compatible with 
this program. In future studies this would need to be considered. The frame rate could be 
increased to improve accuracy. One frame represents 2.5 milliseconds in our current set up. 
The average swim-cycle for the control groups for all stage 40-42 tadpoles in the cannabinoid 
receptor assessment was 33.137 milliseconds (30.177Hz with SD=2.7Hz). This allowed for 
significant interaction to be determined when they are very large but possibly not when they 
are small, as indicated by the power analysis. 
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One way to eliminate many of these problems would be to use spinalised tadpoles. The 
tadpole can be decapitated above the brainstem and survive in an appropriate saline solution. 
This would remove drug accessibility issues, remove possible off target effects in the brain and 
allow electrophysiological recording from the 3 main neuron groups (dIN, cIN and 
motoneurons) that produce and regulate swim-cycle frequency. Corroborating these results in 
this way would ensure that the effect seen in whole tadpole swimming under these drug 
treatments is caused by neuron specific interaction in the CPG of the spinal cord.  
3.7.5.3 Statistical analysis and power analysis 
The sample size was low and as such the power analysis indicates that some groups were 
underpowered. On assessment of the assumptions it is clear this is not an ideal dataset and 
the linear mixed model used was not the best fit to get the most accurate assessment of the 
data. In many of the residual vs predicted value plots (appendix 7.2) clear patterning and 
unequal distribution/ non-linearity can be seen, particularly in the cannabinoid groups which 
due to being compared with individual concentrations of vehicle control (i.e. 0.1uM AEA to 
equivalent volume of soya emulsion AEA was dissolved in) had very low numbers per model 
(10 values). However, there is also some patterning in the mGluR  and CB1 + mGluR data, 
which had larger model numbers. To address this a generalised linear mixed model was 
attempted with the different link functions offered by SPSS. Link functions transform the data 
so that it can be modelled linearly. This is particularly relevant to our frequency data. Since 
timepoint did not significantly change frequency across treatment groups it meant we had lots 
of values around the same frequency for each tadpole. It may be this factor combined with the 
averaging of the 3 swim-cycles, compounded the error and made the data badly grouped and 
not continuous. However, when link functions such as loglinear and binomial were attempted 
the model excluded lots of data points sometime up to 90% of them. This would need to be 
examined further to understand what can be done to improve the analysis of this method.  
3.8 Summary of proposed effects at each key synapse 
Figure 3.8.1 is a simple schematic showing the effect the different drug treatment would 
theoretically have on each key synapses in the CPG. The location of the receptors in this 
system has not been confirmed to these exact locations so we have assumed they are present 
at all synapses in the most commonly located positions (i.e. CB1 located on axon terminals and 
group 1 mGluRs located on PSDs). If we assume a 1:1 ratio of each neuron type, then AM-251 
would increase glutamate released by dIN to the cIN and the motoneuron. This would increase 
the rate of summation for action potential generation at the motoneuron and cIN. However, it 
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would also increase the amount of glycine released by the cIN to dIN possibly increasing the 
length of time of hyperpolarisation of the opposing side dINs. This would have a concentration 
dependent result on the frequency of dIN rebound firing as shown in (Li and Moult, 2012). In 
that study weak IPSP from the cINs, smaller than -43.2mV, slowed the rate of dIN rebound 
firing. Above this threshold the speed of dIN rebound firing was not changed. However, large 
chlorine injections slowed frequency of dIN rebound firing. This would indicate that large 
hyperpolarisation is needed to maintain normal frequency of swimming, whereas reduction in 
the glycine induced hyperpolarisation of the dIN (below -43.2mV) from the cIN would reduce 
frequency. This would suggest there is an optimum level of hyperpolarisation, and either side 
of that level it will decrease frequency. This might mean that 2μM AM-251 stage 40-42 is in 
that optimum range, where it has increased glutamate and glycine release just the right 
amount to increase frequency. Concentrations above this (10µM and 50μM) significantly 
decrease frequency by releasing so much glycine that it causes a longer hyperpolarisation 
decreasing frequency. Similarly, if we look at AEA it would theoretically decrease glutamate 
released by the dIN to the cINs and motoneurons, decreasing the rate of action potential 
generation, while simultaneously decreasing the glycine released by the cIN to dIN. The effect 
of this would expect a decrease in frequency of swim-cycles. Particularly a decrease in the size 
of hyperpolarisation, below that previously discussed threshold would slow the rate of 
rebound firing. However, again we only see a significant decrease in the stage 40-42 group 
with AEA applied at 100nM, 2µM and 10μM and no significant change at 50µM. A possible 
explanation for the unexpected results with AEA and AM-251 lie in the work of previous 
experiments documenting the distribution and constitutive activity of CB1 in various brain 
regions. As discussed previously CB1 was shown to be constitutively active at GABAergic 
terminal 30-40% of the time while only constitutively active at glutamatergic terminal 5-7% of 
the time. This would mean the active site is occupied more often on inhibitory 
neurotransmitter releasing terminals, such as glycine releasing cINs, and make exogenous 
application more likely to affect glutamatergic-CB1 first. Functional selectivity experiments 
would also indicate that these receptors at inhibitory terminals may be more receptive to 
particular ligands than others, and different ligands cause different effects possibly through 
the action of CRIP1a, further confusing the elucidation of results for whole organism 
application.   
Using the same theory for group 1 mGluRs, activation of either receptor subtype via 
DHPG is likely to increase the rate of dIN, motoneuron and cIN depolarisation and action 
potential generation. This is corroborated by what our results show, a significant increase in 
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frequency by 8.45± 1.37%. It would then be expected that inhibition of either group 1 mGluR 
subtype would significantly decrease frequency. However, this is only the case with mGluR1 
antagonism via LY367385 and not mGluR5 antagonism via MPEP. This result may highlight the 
different locations of mGluR5 compared with mGluR1. Previous studies in X. laevis and lamprey 
also highlight a different effect of the two receptors on frequency. From our studies it would 
appear that mGluR1 is located on the dIN, as increased rate of depolarisation and rebound 
firing helped by increased internal calcium release is the most probable explanation of 
increases in frequency. If mGluR5 is not present on the dIN PSD or dIN –dIN gap junctions, then 
it makes sense that it is not vital in the maintenance of normal swimming frequency. The 
interesting and unexplained results for mGluR5, come when DHPG is added after inhibition via 
MPEP reducing frequency of swim-cycles. This may indicate that over activation of mGluR1 is 
detrimental and may be akin to the DHPG induced LTD protocol. Similarly, antagonism of 
mGluR1 and application of DHPG had no effect on frequency. When just mGluR1 was inhibited 
frequency was significantly reduced. This indicates either mGluR5 can substitute for the loss of 
mGluR1 or the competitive inhibition of mGluR1 by LY367385 is washed out/ out competed by 
the subsequent application of DHPG. 
The picture becomes more complicated when we try to assess the combination of CB1 
and group 1 mGluRs. Evidence from the literature suggests group 1 mGluRs potentiate 
glutamate signalling by producing endocannabinoids which retrogradely inhibit 
neurotransmitter release from adjacent inhibitory neurotransmitter releasing terminals. If we 
go back to Figure 3.8.1 and imagine the dINs are in larger groups than 1 neuron which 
electrically couple through gap junctions, the rate at which they fire is the interplay between 
the hyperpolarising current and rate of rebound firing and the underlying excitation generated 
by glutamate at NMDARs. To enhance this excitation group 1 mGluRs may produce 
endocannabinoids which reduce cIN glycine release to enhance depolarisation and rate of 
action potentials. This would be a tightly controlled mechanism which if unregulated would 
lead to large variations in frequency of dIN action potentials. This might explain the results of 
AM-251 application and the result that AM-251 then DHPG application cause no significant 
change as part of the increase seen with DHPG application comes from the reduction in 
rate/amount of glycine released from the cIN. The theory would suggest that DHPG application 
after AM-251 would lead to increased post-synaptic rate of depolarisation via group 1 mGluR 
and increased neurotransmitter releases from all axon terminals. This would increase the 
amount of glycine released to the dIN, possibly counteracting the increased depolarisation of 
the dIN via DHPG. If as previous studies suggested all hyperpolarisation above -43.2mV had no 
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effect on rate of rebound firing then this AM-251 + DHPG treatment would increase frequency. 
However, this is not the case in our results here. It must be that very large releases of glycine, 
unregulated because of CB1 antagonism, delays the rate of dIN firing action potentials and 




Figure 3.8.1-Schematic of the effect of drug treatment at each of the important synapses in the CPG. Top left- simple 
schematic of the CPG (yellow-RB, purple-DLC, orange-dIN, Blue- cIN, green-motoneuron. Top right- a schematic of dIN-
cIN synapse, bottom left dIN motoneurons synapse, bottom right- cIN-dIN synapse (Blue -AM-2521, Green -AEA, orange -
DHPG and Red- LY367385 or MPEP). Theoretically describes in simple terms whether drug treat will increase/decrease 




This series of experiments has presented further evidence for the involvement of the group 1 
mGluRs, and new evidence for the CB1R, in the CPG mediated regulation of left-right muscle 
contraction frequency during swimming of the X. laevis tadpole, from stage 37-42. Group 1 
mGluRs, when activated via DHPG, increase the frequency of swim-cycles. MGluR1 is revealed 
to be intrinsic in this maintenance of normal swimming frequency, whereas mGluR5 is not. 
Although the data suggests mGluR5 may compensate for mGluR1 when it is antagonised. We 
provide the first evidence that CB1 contributes to swim-cycle frequency in X. laevis. Although, 
the extent of its intrinsic effect is unclear, due to a biphasic dose-dependent response to 
antagonism via AM-251. In future it would be advised to use a neutral antagonist which simply 
occupies the active site and induces no inverse agonism and of target effects that AM-251 is 
marred with. Similarly, the picture with endogenous agonist AEA is unclear. However, its 
application does affect frequency of swim-cycles. Again, in future synthetic agonists need to be 
applied and electrophysiological recordings made to confirm the extent of CB1’s action and the 
location that it affects. This method offers a cheap and accessible way of measuring the effect 
of pharmacological intervention on the output of the CPG of X. laevis, which can be used in 




4 Assessment of dendritic spines in primary Xenopus laevis neuron 
culture with AFM 
4.1 Introduction   
In the previous results chapter, we presented evidence of pharmacologically induced changes 
in the swimming output of the CPG, which reduced or enhanced the frequency of swim-cycles 
in the swimming behaviour of the X. laevis tadpole stages 37-42. To exert these changes in the 
frequency of swim-cycles the treatments are most likely activating their corresponding GPCR 
and causing an effect through changes in ion channel conductance and neuron excitability. 
When the GPCR (mGluR1/5 or CB1) is activated, the g-proteins affect second messenger systems 
that lead to changes in the transcription of RNA. The products of transcription can change the 
shape, enhance or reduce the size of the PSD and change the receptor expression density. 
Over a continued period of time these changes result in long-term potentiation (LTP) or long-
term depression (LTD) of synapse transmission.  
One of the key constituents of excitatory synapses are dendritic spines. Dendritic 
spines are tiny protrusions that receive the excitatory signal released from the axon terminal. 
They are generally split into four categories: mushroom, filipodia, thin and thick (Sala and 
Segal, 2014). Dendritic spines have been examined in primary culture of X. laevis granule cells 
(Zhang, Huang and Hu, 2016), but not yet in the culture of spinal neurons. The development 
and maintenance of dendritic spines is fluid. Recent high-speed AFM imaging, on living 
cultured hippocampal neurons, provided evidence of dendritic spines developing in 20 minutes 
(Shibata et al., 2015). The evidence on dendritic spines in vivo indicates they increase in 
number and size during the day and decrease during sleep. Current theory suggests the 
strength of the synapse and stability of the dendritic spine at point of sleep determines if the 
synapse will be consolidated or pruned (Tononi and Cirelli, 2014, 2016). Currently the 
measurements of dendritic spines in vitro rely on confocal imaging, documenting the stability 
of spines over time or sectioning organisms and monitoring spines position and size (Bosch, 
Martínez, Masachs, C. M. Teixeira, et al., 2015). Recent developments have been made 
combining confocal spine imaging with algorithms of machine learning (Shi, Huang and Hong, 
2014). Improvements on this method have recently been presented (Basu et al., 2018). From 
these studies the key measurements of dendritic spines were volume, shape/morphology and 
length. 
Alongside size and number, there are key components of dendritic spines that are 
used as determinants of strength. The primary measure is AMPAR expression (Matsuzaki et al., 
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2001, 2004). The most abundant excitatory glutamate receptor, increased AMPAR expression 
increases the conductance of the spine and is accompanied by phosphorylation events that 
enhance potentiation (Barria et al., 1997; Ehlers, 2000; Lee et al., 2000; Huganir and Nicoll, 
2013). The current theory on AMPAR potentiation suggests the receptors are trafficked in 
laterally where they are tagged to the PSD if the dendritic spine is potentiated. If it is not, the 
receptor continues to the extra-synaptic location where it is degraded or cycled back into the 
synapse (Barria et al., 1997; Redondo and Morris, 2011; Huganir and Nicoll, 2013). Other key 
measures of the potentiation state of dendritic spines are the phosphorylation states of 
CAMKII and GSK3β (Lee et al., 2009). CAMKII is activated when Ca2+ increases in the spine. 
When the threshold is reached the Ca2+/calmodulin auto-phosphorylates CAMKII. Once 
activated it sets off a series of phosphorylation events that strengthen the actin cytoskeleton, 
binding newly created F-actin to the PSD-95 and Homer domains, enabling large AMPA 
receptor rafts to be in optimal position for enhanced synaptic signalling. It is also involved in 
LTD where it phosphorylates AMPAR at S567, a site known to reduce synaptic GluA1 
localization (Lee et al., 2009; Okamoto, Bosch and Hayashi, 2009; Bosch et al., 2014). The 
difference appears to be the rate of CAMKII phosphorylation, which fits with the knowledge 
that high frequency stimulation results in LTP and low frequency stimulation results in LTD. 
Using the AFM, we sought to identify dendritic spines in the primary neuron culture of 
developing X. laevis spinal neurons. Once possible dendritic spines were identified, a 
measurement criteria was determined, analysing the volume, radius, cross-sectional area and 
the roughness of the membrane. The roughness (RMS) of a surface is the root means square 
(RMS) of the surface’s peaks and valleys. AFM assessment of red blood cell membrane 
roughness was used as a measure of health (Girasole et al., 2007). Recently the roughness of a 
neuronal cell calculated using non-interferometric wide-field optical profilometry (NIWOP) 
(Lee et al., 2016) and proposed as a measure of health. It could be hypothesised that a 
rough/folded membrane would be a sign of poor transmission and connectivity, as it is 
accepted that mushroom shape spine, with the PSD located in prime position for signalling, is 
preferential. Volume and radius changes are the standard measurements of dendritic spines, 
and changes in these parameters might indicate spines that are undergoing plasticity. We also 
developed a method of quantifying the visco-elasticity of the membrane by using the loss 
tangent equation (Proksch et al., 2016). It was hypothesised that spines undergoing plasticity, 
whether to decrease surface area and become depressed or increase surface area and become 
potentiated, would change the tension in their membrane. 
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We then set out to test if the drug treatments used in the previous chapter significantly 
affected these measurements. It may be expected that group 1 mGluR agonist (DHPG) or 
antagonist (MPEP) are more likely to induce plasticity changes in dendritic spines compared 
with CB1 agonist and antagonist, as they are located on the PSD. The CB1 receptor is a 
presynaptic receptor so any changes in dimensions of dendritic spines would have to be 
caused by either: affecting neurotransmitter release from axon terminals, which in turn 
modulates the dendritic spine; activating off-target sites such as TRVP1 or possibly effecting 
mitochondrial CB1 receptors if they are present in X. laevis. It has been shown that neurons 
have functional synapses from 24 hours (Yazejian, Rita M Yazejian, et al., 2013) and the 
twitching muscle observed in cultures indicates spontaneous signalling. The cannabinoid 
agonist AEA and antagonist/inverse agonist AM-251 both caused measurable changes in the 
output of the CPG of the swimming tadpole (results chapter 3). 
4.1.1 Method 
Primary X. laevis neuron cultures were generated, then treated for 20 minutes with DHPG 
50µM, MPEP 50µM, AM-251 50 µM or AEA 50 µM and fixed in 5% glutaraldehyde (as 
described in the methods 2.3.2). Cultures were scanned with the atomic force microscope in 
air using AC mode (described in detail in section 2.4). 
 
4.2  Identification of dendritic spines 
 The criteria for identifying dendritic spines was formulated upon review of confocal 
assessment of spines in culture (Bosch et al., 2014; Basu et al., 2018). Previous work, in 
multiple animal model cultures, shows spines vary in length and volume depending on cell 
type and organism (Bosch et al., 2014; Huang et al., 2015; Zhang, Huang and Hu, 2016). X. 
laevis spinal neurons are relatively large and we expected them to have far fewer dendritic 
spines than a neuron culture from the brain, such as the granule cells assessed previously 
(Zhang, Huang and Hu, 2016). As a result of this, we investigated protrusions from areas 
identified as dendritic trees due to morphology. Dendritic trees are thinner with more 
branching than axons. These projections were identified with an inverted microscope and 
scanned with the AFM. Protrusions from the dendritic trees were determined as dendritic 
spines if they were less than 7µm in length. We further assessed the likelihood they were 
dendritic spines by morphological analysis. We deemed it unlikely for a spine to be completely 
spheroid with no clear branching from the dendrite, and should resemble previous images and 
models of dendritic spines (Harris, Jensen and Tsao, 1992; Hering and Sheng, 2001; Mancuso et 
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al., 2013). Figure 4.2.1 presents 3 examples of dendritic spines that were scanned and used 
(Figure 4.2.1a, c, e), compared with 3 protrusions that were scanned and excluded (Figure 
4.2.1b, d, f).  Figures 4.2.1b and f were excluded for similar reasons; both were too large, they 
were quite near the soma and were part of what appears to be the axon, based on its 
thickness, smoothness and straightness coming from the soma. Figure 4.2.1d was excluded 
due to lack of membrane integrity. Although fragments can be seen in Figure 4.2.1c, the 
membrane was deemed of good enough quality for analysis. These images (Figure 4.2.1 a, c 









Figure 4.2.1- Identification of dendritic spines. Left- dendritic spines accepted for analysis. Right- rejected as 
dendritic spines based on size and morphology and integrity. As described in methods, exploratory 50µm 
x50µm scans were performed on areas recognised to be dendrites. Then areas were selected for possible 
dendritic spines and rescanned to produce images like these. 
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4.3 Changes in dendritic spine dimensions  
More than just identifying dendritic spines in a spinal neuron culture of X. laevis, we wanted to 
produce reliable measurements of structural plasticity. Could we detect changes in dendritic 
spine radius, volume, cross sectional area, membrane roughness and membrane viscoelasticity 
(loss tangent), when treated with DHPG 50µM (20 minutes) (group 1mGluR agonist), MPEP 
50µM (20 minutes) (mGlUR5 antagonist), AM-251 50µM (20 minutes) (CB1 antagonist/inverse 
agonist) or AEA 50µM (20 minutes) (endogenous CB1 agonist). All these treatments produced 
measurable changes in behavioural output (chapter 3). There were two neuron culture slides 
(containing cells from five X. laevis embryos (stage 20-22) per slide) per drug treatment, with 
five different dendritic spines sampled per slide. The total number of dendritic spines 
identified and included in the analysis was 53.  
The scans with the AFM produce different channels depending on what is being 
measured. The height channel produces the topographic images, represented graphically in a 
heat map. These images were evaluated using Gwyddion software line profile analysis. Using 
4-line profiles of each dendritic spine, the mean value of four parameters were investigated: 
mean dendritic spine radius, mean dendritic spine volume, mean dendritic spine area of cross 
section and mean roughness (RMS) of dendritic spine membrane. A linear mixed model (LMM) 
was performed to compare each drug treatment with its respective control. In the LMM, slide 
was a random factor and dendritic spines were the participant nested within the slide. We also 
ran an independent t-test to test if there were differences within groups between the two 
slides, the results of which indicated there were no significant differences between slides 
within treatments (results presented in appendix 7.5).  
4.3.1 Results- Group 1 mGluRs influence dendritic spine dimensions 
The results of the LMM demonstrate significant changes in mean dendritic spine radius when 
treated with either DHPG (50µM, 20 minutes, n=10) (Figure 4.3.1, Table 4.3.1) or MPEP (50uM, 
20 minutes, n=10) (Figure 4.3.1, Table 4.3.1). Both had an increased radius compared with 
control (DMSO, 50μM, 20 minutes, n=6) (control estimated marginal mean (EMM) 0.736µm vs 
DHPG 1.208µm and MPEP 1.353µm).  
Table 4.3.1- The results of linear mixed model comparing the effect of group 1 mGluRs on EMM radius of 
dendritic spine 


























 Both DHPG 50µM and MPEP 50µM (Figure 4.3.1) increased the mean volume of the dendritic 
spine compared with control, although neither were significantly different. Compared with 
control it was the MPEP treatment which had the greatest increase (control DMSO EMM 
6.461µm3 vs MPEP 25.01µm3 (Figure 4.3.1, Table 4.3.2)). 
Table 4.3.2- Results of linear mixed model comparing the effect drug treatment has on volume of 
dendritic spines 
























The effect of DHPG and MPEP on the mean cross-sectional area of the dendritic spine obtained 
from line profile analysis was analysed with an LMM. This, similar to the volume analysis, 
highlighted the result of treatment with MPEP increasing the size of the dendritic spine. In this 
measurement parameter MPEP 50µM (Figure 4.3.2) was significant compared with control 
(Table 4.3.3). DHPG 50 µM (Figure 4.3.2) was not significant and as with the volume 
measurement it was slightly behind the increase seen in MPEP treatment (EMM MPEP 
15.937µM2, DHPG 12.822µM2 compared with DMSO control 8.169µM2 (Figure 4.3.2). 
 
Table 4.3.3- The results of linear mixed model comparing the effect of drug treatment has on cross-
sectional area of dendritic spines 
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The last parameter of the height image analysis to be evaluated was roughness (RMS). There 
were no significant changes in average roughness when treatment groups were compared to 







Table 4.3.4- Results of linear mixed model comparing the effect of drug treatment on EMM Roughness 
(RMS) of dendritic spine 
























4.3.2 CB1 did not affect dendrite dimensions 
 
Table 4.3.5- The results of linear mixed model comparing the effect of drug treatment on EMM radius of 
dendritic spine 
 
 In all measures of dendritic spines scanned with AC mode AFM, AEA 50µM (n=10) or AM-251 
50µM (n=11, 20 minutes) caused no significant changes in radius (Table 4.3.5 and Figure 4.3.1), 
dendrite volume (Table 4.3.6 and Figure 4.3.1), dendrite cross sectional area (Table 4.3.7 and 
Figure 4.3.2) and dendrite membrane roughness (RMS) (Table 4.3.8 and Figure 4.3.2).  
The number of dendritic spines sampled were small and only two slides containing 
cells from five embryos per slide were scanned. To assess this a power analysis was performed 
using GLIMPSE sample size software. The low sample number was expected to be an issue for 
the non-normal distribution of residuals. However, when the data was put into glimpse the 
power of the study was 0.951. This would imply that, despite large standard deviation for 
some measurements (particularly volume), the study was sufficiently powered. 
 
  

























Table 4.3.6- Results of linear mixed model comparing the effect of drug treatment on EMM volume of 
dendritic spine 
























Table 4.3.7- Results of linear mixed model comparing the effect of drug treatment on EMM area of cross 
section of dendritic spine 

























Table 4.3.8- Results of linear mixed model comparing the effect of drug treatment on EMM Roughness 
(RMS) of dendritic spine 


























Figure 4.3.1- Boxplots of the radius (Top) and volume (bottom) of dendritic spines in each treatment group. 
Significance compared to vehicle control indicated by asterisk (*=p<0.05, **=p<0.005, ***=p<0.001). n=6-11 





Figure 4.3.2-Boxplots of the mean cross-sectional area (top) and mean roughness (bottom) of dendritic 
spines in each treatment group. Significance compared to vehicle control indicated by asterisk (*=p<0.05, 







Figure 4.3.3- A figure of representative dendritic spines (blue box) in each group. a) Control (DMSO), b) DHPG 50μM, c) 
MPEP 50μM, d) AM-251 50μM, e) AEA 50μM, f) Control (Soya) 
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4.4 Loss tangent analysis of dendritic spine membranes  
Treatment with DHPG 50µM (20 minutes), significantly altered the loss tangent (Figure 4.4.1 
and Table 4.4.1). MPEP 50µM (20minutes) also significantly affected the loss tangent (Figure 
4.4.1 and Table 4.4.1). When looking at the original measurements, both DHPG (mean loss 
tangent of dendritic spine 0.44) and MPEP (mean loss tangent of dendritic spine 0.42) had 
considerably lower loss tangents than the control DMSO (0.84), suggesting the membranes 




Table 4.4.1- Results of linear mixed model comparing the effect of drug treatment on the loss tangent 
measurement of dendritic spines 
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Figure 4.4.1-Boxplot of the loss tangent measurement of dendritic spine membrane compared with vehicle 










Figure 4.4.2- Demonstration of the phase images of one dendritic spine from each group the same spine demonstrated in 




4.5.1 Dendritic spines identified with AFM in primary culture of spinal neurons  
This is the first evidence that dendritic spines exist in the spinal neurons of X. laevis tadpoles. 
Using the AFM and an inverted microscope it was possible to scan dendritic spines with a high 
resolution and minimal technical noise, in a primary spinal cord culture at 3 DIV. Dendritic 
spines have been scanned with AFM before. However, a measurement criterion has not been 
adopted. Using previous literature of confocal z-stack images of dendritic spines in culture, the 
measurement criteria of length and volume was applied to AFM scanned spines in our study.  
Dendritic spines were identified and quantified based on previous observation, analysis and 
modelling (Matsuzaki et al., 2004; Bosch et al., 2014; Bosch, Martínez, Masachs, C. M. Teixeira, 
et al., 2015; On et al., 2017; Basu et al., 2018). Examples of the dendritic spines measured in 
each group are presented in Figure 4.3.3.   
4.5.2 Group 1 mGluRs increased dendritic spine dimensions 
As shown in chapter 3, DHPG increases the frequency of swim-cycles and based on the action 
of the group 1 mGluRs in previous studies in X. laevis (Chapman and Sillar, 2007; Chapman, 
Issberner and Sillar, 2008) and in other animal organisms (Kettunen et al., 2002, 2005; 
Kettunen, Hess and Manira, 2003;), may be expected to increase the excitability of the 
excitatory interneurons and grow dendritic spines through the increase in Ca2+, activation of 
kinases such as CAMKII, the regulation of transcription factors and the subsequent increase in 
protein transcription. However, it is well recognised that 100µM DHPG application for 10 
minutes in the hippocampus will induce LTD  (Palmer et al., 1997). It is worth noting that 
CAMKII activation is not a prerequisite for potentiation and it is involved in LTD and LTP, the 
defining factor is rate of activation. Constitutively activated CAMKII will continue to grow 
dendritic spines but CAMKII activated for less than 1 minute at a time can lead to 
phosphorylation events that promote depression (Lee et al., 2009). Further investigation in the 
hippocampus revealed that 100µM application of DHPG (10-30minutes) resulted in dendrite 
elongation (Vanderklish and Edelman, 2002). In that study it was shown that Ca2+ increase was 
key to this elongation. The fact we observed an increase in radius with DHPG at 50µM, might 
suggest that it is the excessive activation of group 1 mGluRs with 50µM- 100µM that elongates 
the dendritic spine, and this may be a sign of LTD-like changes in spine morphology. It was 
noted that elongation in the hippocampus was not accompanied by increase in volume, so it 
may be that DHPG-induced LTD in the hippocampus results in elongated dendritic spines 
whereas potentiated dendritic spines increase in volume in the X. laevis spinal cord, or that 
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DHPG enhance the spinal cord CPG by depressing adjacent synapses so on average dendritic 
spines are elongated and depressed allowing excitatory gap junctions to enhance dIN 
depolarisation rate. It would be interesting to examine the effects at particular neuron groups 
in vivo to assess dendritic spine changes at dIN compared with other neuron groups, such as 
cINs and aINs.  
The rather surprising result is the bigger average increase seen when cultures were 
treated with MPEP 50µM. It was expected that antagonism of the mGluR5 for such a short time 
(20 minutes) would not affect dendritic spines. MGluR1 and mGluR5 can have several splice 
variants and their locations can differ, meaning there is a great deal of variability in their 
action. However, it is generally accepted that activation of mGluR1 and mGluR5 leads to 
phospholipase C γ (PLCγ) activation and IP3 induced release of Ca2+ from stores in the 
endoplasmic reticulum that can enhance activation of CAMKII.  Also, the activation of PI3K and 
PDK1 can stimulate mtor and NFkappaB transcription of survival and growth genes, and AKT 
phosphorylation can inhibit apoptosis (Willard and Koochekpour, 2013). MPEP inhibits mGluR5 
but it may also antagonise NMDA receptors (O’Leary et al., 2000) and be an positive allosteric 
modulator of mGluR4 (Mathiesen et al., 2003). The antagonism of NMDA receptors could be 
helping promote LTD for which elongation may be a measure (results presented in Table 4.3.1 
and Figure 4.3.1).  
Evidence for the increase in volume of dendritic spines with constitutively active 
CAMKII demonstrates the role CAMKII plays in the potentiation and growth of the dendritic 
spine. This process is blocked by NMDAR antagonism (Lee et al., 2009). Activation of the group 
1 mGluRs has long been a model for LTD in the hippocampus, and elongation of dendritic 
spines was observed under LTD inducing conditions (100µM DHPG + LFS, 10 minutes) 
(Vanderklish and Edelman, 2002; Cruz-Martín, Crespo and Portera-Cailliau, 2012). We provide 
further evidence for the elongation of dendritic spines with the treatment of DHPG. Since we 
did not observe a significant increase in volume this might indicate reduced signalling in the 
dendritic spines measured. However, this then asks the question what is happening in the 
MPEP treated dendritic spines? In all categories of size; radius, volume and cross-sectional 
area MPEP had a greater effect than DHPG. It seems impossible that this is a result of 
potentiation. MPEP is an interesting molecule and has been shown to be a positive allosteric 
modulator of mGluR4 (a presynaptic metabotropic glutamate receptor responsible adenylyl 
cyclase inhibition) and a mild antagonist of NMDAR (O’Leary et al., 2000). In a whole organism 
the inhibition during a behaviour decreases the excitability of the neuron, inhibiting existing 
signalling that would have taken place. In the primary culture the level of signalling will not be 
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as strong and is likely to be very different from in vivo. As demonstrated in previous studies, 
from 24 hours onwards the neurons in primary X. laevis cultures have functional synapses 
(Yazejian, et al., 2013), and as discussed earlier twitching muscle cells were observed 
throughout the cultures, indicating spontaneous signalling. It is possible that the interference 
with normal signalling, caused by mGluR5 antagonism and mild NMDAR antagonism, combine 
to change the dendritic spine structurally especially given the developing nature of the culture. 
Another avenue that should be explored is the inactivation of the RNA binding protein FMRP. 
Activation of mGluR5 initiates a number of signalling cascades that can lead to growth of 
dendritic spines. However, it also activates FMRP, which binds RNA and can stop local protein 
synthesis. The abnormality in this gene is thought to be responsible for fragile X syndrome. 
Evidence has shown that during development, in vivo and in vitro, glutamate elongates 
dendritic spines through mGluR5. This elongation was not observed in FMRP knockout or with 
MPEP application (Cruz-Martín, Crespo and Portera-Cailliau, 2012). This was performed in 
cortical pyramidal neurons of immature mice, so there is likely to be differences compared 
with our study. This data would confirm the effects of DHPG. To explain why MPEP may have 
increased dendritic spine size, we must consider the conditions of the culture. BDNF was 
added to the culture media to stimulate growth through TrkB receptor activation. BDNF is a 
neurotrophic factor thought to be essential in the developing CNS. Combined with the 
possibility that neurons are releasing glutamate and the observed rapid growth and 
development over the first 48 hours, the cultures are in a high state of growth. BDNF through 
the TrkB receptor initiates many of the same excitatory signalling cascades as glutamate, such 
as PI3K, IP3, PLC, NFkB and Erk1/2 (Gupta et al., 2013). There is evidence showing that BDNF 
interacts with FMRP (Louhivuori et al., 2011). In FMRP knockout mice BDNF’s effects lead to 
abnormal dendritic spine development. It was noted in this study that there were large 
differences between cortical neurons and hippocampal neurons, as such it would be difficult to 
draw conclusion across species and neuron groups, but based on the signalling cascade they 
are involved in, there is a high probability of an interaction between them. This interaction in 
our study might be that mGluR5 antagonism via MPEP has attenuated the negative regulation 
of FMRP on BDNF development of dendritic spines. This combination of BDNF and MPEP leads 
to a fragile X autism like developmental culture. 
Next, a rather interesting study showed that FMRP has effects beyond transcription, 
through interaction with Bk channels (voltage activated potassium channels) it has a role in 
regulating neurotransmitter release, by modulating action potential duration. FMRP knockout 
leads to excessive action potential broadening, enhanced presynaptic Ca+ influx and elevated 
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neurotransmitter release (Deng et al., 2013). This combination of BDNF and FMRP inactivity 
(due to MPEP antagonism of mGluR5) may have contributed to an increase in dendritic spine 
size. It would be interesting to test this culture without BDNF in the culture media, to assess if 
this is the interaction causing these results or it is simply that antagonism of mGluR5 has 
blocked FMRP activation in this developing culture. If this is the case, we would need to assess 
how regularly and how much glutamate is released during spontaneous signalling in this 
culture setting. If very little glutamate is released spontaneously it would be questionable that 
mGluR5 antagonism should change the morphology of dendritic spines. If lots of glutamate is 
released during development, then it is reasonable that MPEP has these effects. 
Given that DHPG did not significantly affect volume, we would suggest that on average 
the dendritic spines in this group followed previously reported results demonstrating a role for 
group 1 mGluRs in dendritic spine elongation in developing cultures (Cruz-Martín, Crespo and 
Portera-Cailliau, 2012). The two treatments which activate/inhibit post-synaptic receptors 
(mGluR1/5) present in dendritic spines, both caused measurable changes in dendritic spine size 
and membrane loss tangent. The results are supported by the fact that the CB1 
agonism/antagonism did not cause any measurable changes in dendritic spine size or 
membrane loss tangent. This could be expected given its presynaptic location.  
4.5.3 CB1 receptor did not affect dendritic spine dimension 
The agonism (AEA 50µM) or antagonism (AM-251 50µM) of the presynaptic CB1 receptor 
produced no measurable changes in the dimensions of dendritic spines. The CB1 receptor has 
been linked to synapse depression and one of its key functions in the short term is to inhibit 
neurotransmitter release. Beyond this it inhibits adenylyl cyclase, which is often thought to 
decrease growth through decreased CREB transcription of growth factor activation, although 
CREB transcription is a broad and often cell-type dependent transcriptions factor. For the 
activation or inhibition of CB1 receptor to affect dendritic spines it would have to be through 
secondary effects. If for example the CB1 had inhibited neurotransmitter release to such an 
extent as to stop glutamate exciting and growing dendritic spines, then some change in 
dendritic spine dimensions may have occurred. As it did not, we can assume the effect of 
reduced neurotransmitter release had minimal if any structural effects on the dendritic spines. 
In the future it would be pertinent to examine the dendritic spines during and after high 
frequency stimulation induced-LTP (HFS-LTP) with cannabinoid application which has been 
shown to have a bidirectional role in LTP or LTD of a synapse (Cui et al., 2015). This, alongside 
treatment with mGluR1/5 agonist/antagonist application, could help elucidate this relationship. 
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MGluR1/5 has been studied extensively in LTP and LTD protocols, but its relationship with CB1 is 
still undetermined, particularly in the hippocampus.  
4.5.4 Group 1 mGluR treated dendritic spines have harder membranes measured through 
loss tangent 
During structural changes in the dendritic spine, the tension or viscosity of the membrane is 
likely to change as the actin cytoskeleton is remodelled. Young’s modulus assessment 
(described in the introduction) of cell membranes has been used extensively. However, there 
are limitations to this method. One of the limitations lies within the size of dendritic spines. 
Locating them and performing force measurements is challenging in live neurons. Also, there 
are other disadvantages, such as tearing or puncturing the cell membrane. AC mode AFM 
protects the sample, the tip having very limited contact. AC mode also produces phase images. 
These are graphical heat maps depicting the degrees of phase shift the cantilever/tip has 
undergone due to the sample, compared with the expected path of the tip based on the set-
point, drive amplitude and frequency. As such, the phase measurement is said to represent the 
tip-sample interaction. General assessment of these images suggests that low-negative phase 
degrees measurements represent an attractive interaction, with high degrees shift 
representing repulsion/hard materials. The problem with phase imaging in the past is the 
result is not comparable between images due to changes in drive amplitude, set-point, 
frequency and scan rate altering the force of tip-sample interaction. Recent developments in 
the algebra of this problem have lead researchers to the loss tangent (Proksch et al., 2016). 
This calibrates the phase shift by tying it to changes in the amplitude through trigonometry 
(equations provided in methods section 2.4.4). The outcome of this equation is to produce a 
unit less ratio where 0 represents a hard surface and 1 would be a very viscous surface.  
Both group 1 mGluR activation and mGluR5 inhibition caused significant changes in the 
stiffness of the membrane measured by loss tangent (Proksch et al., 2016). As discussed in the 
introduction, changes in dendritic spine signalling are accompanied by structural changes 
which enhance/reduce the size of the PSD and result in enhanced/reduced receptor 
expression and positioning. In our cultures they were treated with the drug then fixed in 
glutaraldehyde. The glutaraldehyde fixation works by crosslinking the cytoskeleton. If there 
was an increase of F-actin within the 20 minutes, then fixation, it is possible that this would 
make the membrane stiffer, due to a higher degree of cross-linking internally. Also, receptors 
would register as harder than the membrane so increased receptor expression would be 
expected to give a lower loss tangent value. The combination of the two events may suggest 
that we should have observed harder membranes for potentiated spines and softer 
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membranes for depressed spines. The lack in volume increase with elongation may suggest the 
opposite. It is possible that under these conditions, dendritic spine remodelling; whether it be 
to enhance the dendritic spine or depress the dendritic spine; will give harder membrane 
measurements when fixed regardless of which direction the synapse is heading as there is 
increased protein activity and actin remodelling required for any change in spine morphology. 
This may mean that in a fixed culture loss tangent will only tell us if the spine or cell was 
undergoing some transition. If this was used in living cells with new high-speed AFM scanning 
and the software to produce the loss tangent channel, we could obtain almost real time 
information on the changes in loss tangent at cell membranes. This would be much more 
relevant as it may allow us to detect immediate changes in viscosity during LTP and LTD 
conditions which could then be used as a template for further investigations in pharmacology 
and neuroscience. 
4.5.5 Assessment of method 
While the results are extremely interesting, and the method used to collect them was robust, 
this was a process of development and could be improved upon. The most important 
improvement would be increased sampling per slide. At set out it was expected that at least 
five different dendritic spines would be scanned on each of the slides treated per group with at 
least three slides scanned. However, due to unforeseen circumstances and significant time 
delays this was not achieved, meaning our total sample size was 53 dendritic spines, 6-11 per 
treatment group and only 2 slides scanned. In hindsight, with the variability in spine size and 
morphology evident in Figure 4.3.3, five per slide seems too little. The power analysis 
performed on GLIMPSE indicated the study was sufficiently powered. However, I would still 
question whether 10 dendritic spines per group is a large enough sample size, given the 
variability in measurements of the control groups. If we look at Figure 4.3.3 the variation in 
spine morphology is clear to see. One factor that might have been worth assessing, but was 
not in this method, was whether the dendritic spines were forming or close to forming a 
synapse. This figure demonstrates that there was variation in this respect. On a review of the 
images the majority of the spines identified were not forming a synapse. This was generally a 
practical reason as it was easier to scan the small protrusions on their own. As one can see in 
Figure 4.3.3a and e, there is more technical noise than the other images and these were the 
good scans of synapses. There were many synapses identified that simply could not be 
scanned. It is also evident in Shibata et al’s (2015) paper that some noise and disruption at the 
synapse has not been resolved, but given the speed of their scan and the number of images 
generated in a short space of time, this noise can be overcome. Our scans took up to 40 
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minutes depending on size of the scan area and sometimes the image produced was not good 
enough quality for analysis. As can be seen in Figure 4.4.2 there is a great deal of variation is 
the degrees measurement between images. This initially meant phase images were only 
assessed qualitatively. The development of the loss tangent equation by Proksch et al has 
changed this dramatically. By considering the variation in the scans it normalises the data into 
a unitless ratio enabling comparison between scans and between treatments. 
Repeatability is an issue in this study. For two observers to get the same result they 
would have to scan the entire slide to find the same dendritic spines I found in the cultures. 
Once dendritic spines are identified the method of measurement criteria can be followed to 
achieve the same results. The loss tangent measurement I used was subjective as I selected an 
area of the membrane then took an average of phase to put into the loss tangent equation. 
Programs have been developed which give the loss tangent as an output channel, meaning the 
entire phase image is converted into loss tangent and each pixel can be measured for its 
hardness. This would offer a much more detailed examination of the changes in membrane 
tension than the method I carried out. 
It would be desirable to induce LTP using stimulatory protocols (High frequency 
stimulation) and chemical protocols (NMDA 100µM, Mg2+ free solution) and LTD protocols (low 
frequency stimulation + DHPG 100µM or chemical LTD DHPG 100µM + high Mg2+ solution). 
This way any ambiguity in the direction of change could be tested against known parameters.   
The next issue was all samples were fixed and air-dried. This would significantly affect the 
integrity, stiffness and viscoelasticity of the membrane. This also made problems for AFM 
scans as varying degrees of moisture affect the tip-sample interaction (phase shift). If the 
experiment was repeated in a fluid cell the cells could be live and the measurement of changes 
in membrane viscosity would be much more relevant. Although these conditions are not 
desirable it was the same for all treatments and the controls they were compared with. 
Compared with confocal z-stack, this method offers more detail ,although interpreting that 
detail is tricky. Also scanning dendritic spines with AFM only measures one half of the spine. As 
can be seen from the images they are far from uniform in shape and size so losing the 
underside of the spine means measurements are only ever an estimation.   
There were dendritic spines in the culture, but they were sparse meaning lots of tips 
were lost scanning objects that turned out not to be dendritic spines. If we were to continue 
trying to develop methods measuring structural plasticity of dendritic spines with AFM, it 
would be recommended to use a model such as the granule cells previously mentioned (Zhang, 
Huang and Hu, 2016) or the classical neurons studied for dendritic spines, pyramidal neurons 
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of the hippocampus. This way large group sizes would be made more achievable. It would also 
be interesting to compare the differential effects treatment have on dendritic spines of 
immature cultures vs mature cultures as this may help tease apart the effect of group 1 
mGluRs. One of the main issues with this study comes from idrentifying what type of neuron is 
being scanned and the affect the drug treatment has had on a particular dendritic spine. It 
would be much more valuable to scan a spine, apply the drug then scan the same spine again. 
If this was combined with electrophysiological recording, identifying the electrochemical and 
neurotransmitter properties of the synapse, we could understand how drug treatments are 
truly interacting in spine remodelling.   
 
4.5.6 Future directions 
We have shown that the use of AFM to study dendritic spines is a viable tool. The recent 
showcasing of long-tip high-speed AFM combined with inverted fluorescent confocal 
microscopy opens possibilities for dendritic spine structural investigations in near real time. If 
high-speed long tip AFM is combined with loss tangent calculations, this could give details of 
immediate changes in membrane viscoelasticity. The value of combining fluorescent confocal 
with high speed AFM could help eliminate the pitfalls of the two methods and by doing it in 
real-time, the pharmacologically induced changes could be viewed and measured in close to 
real-time ((Shibata et al., 2015) scanned a 5µmx5μm sample in 5 seconds). This would enable 
us to view the movement and estimate concentration of proteins, while measuring the 
structural changes of the membrane occurring. As we look to the current very exciting work, 
which demonstrates the relationship between mechanical forces and chemical signals in the 
development and guidance of neuron growth (Koser et al., 2016), understanding and defining 
the structural and mechanical properties of neurons in health and disease could provide the 
key to neuron regrowth and repair. It is in these experiments, using live cells to assess 
receptors such as piezo 1, that the loss tangent could be an excellent tool in understanding the 
mechanical properties of the membrane as conditions change, and how this interacts to guide 
the neurons growth. Live cells also come with drawbacks, such as puncturing. However, the 
recent developments in high-speed AFM appear to have progressed this to a more viable 




4.5.7 Conclusions  
Dendritic spines exist in the primary culture of stage 22-24 X. laevis spinal neurons at 3 DIV and 
they can be observed by scanning with AFM. The structural dimensions appear to be 
significantly changed when group 1 mGluRs are activated or mGluR5 is inhibited and in both 




5 Fluorescent immunohistochemistry of PSD-95 in X. laevis 
5.1 Introduction 
In the previous result chapters, evidence was provided that manipulation of group 1 mGluRs 
and CB1 receptors induce changes in the output of the CPG and muscle flexion. Then, possible 
events of plasticity at dendritic spines were investigated in vitro, using a primary neuron 
culture, scanned with AFM and assessed for changes in structure. Changes in the activity of 
mGluR1/5 affected the dimensions of the dendritic spines, and resulted in a harder membrane 
measurement via loss tangent. The literature, mostly produced in mature hippocampal slices 
and cultures, suggests that dendritic spines grow and stabilize before increases in PSD proteins 
(such as Homer and SHANK) occur. The timescale of dendritic spines undergoing potentiation 
was suggested to be: 1-7 minutes- increases in actin accumulation and polymerisation to F-
actin; 7-60 minutes- stabilisation of newly polymerised actin cytoskeleton via G2 proteins (such 
as CAMKIIβ, α-actinin and drebrin); 60+ minutes- increases in structural MAGUKS (Homer and 
SHANK)(Bosch et al., 2014). These results were obtained using quantitative fluorescence and 
confocal assessment of dendritic spines undergoing LTP protocols and suggest that increases in 
proteins, such as PSD-95, can take up to an hour. There is other evidence that PSD-95 can be 
inserted into dendritic spines via microtubules initiated by BDNF (Hu et al., 2011) and that this 
occurred over the course of 20 minutes. In Hu et al's  study, it was shown that BDNF increases 
the length of time microtubules invade dendritic spines and not how many spines are invaded, 
and it is this increased window that enhanced PSD-95 density. Another study into the 
dynamics of PSD-95, demonstrated that the density of PSD-95 is fluid, changing rapidly in 
20min-1hour. Evidence was provided which indicates PSD-95 is exchanged with neighbouring 
spines by diffusion and that larger spines accumulated more PSD-95 and retained it for longer. 
When the mice underwent sensory deprivation, PSD-95 retention and density decreased 
dramatically (Gray et al., 2006). The conclusions from that work suggests dendritic spines 
compete for PSD-95 based on their activity, and there is something that ‘tags’ PSD-95 to larger 
PSDs where it is needed.  
PSD-95 is a key structural protein of dendritic spines. It is responsible for tethering 
AMPA receptor rafts and can be used as a measure of functional dendritic spines. It has roles 
in stabilisation of dendritic spines, and increases in PSD-95 density at dendritic spines have 
been associated with increased signalling efficiency (Ehrlich et al., 2007; Cane et al., 2014; 
Henley and Wilkinson, 2016). The slot hypothesis would suggest that increases in PSD-95 
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correlate with increased AMPAR expression or at least increases the probability of increased 
AMPAR expression on dendritic spine surface. 
Since this evidence suggests that PSD-95 is in effect a determining factor if an excitatory 
synapse is functional, the aim was to investigate if PSD-95 expression changed as a result of 
the activation/inhibition of group 1 mGluRs and/or the CB1receptors in vivo and in vitro. 
Increases in PSD-95 expression may indicate increased level of excitatory synapses, an increase 
in active synapses or an increase in the ability of the synapses present to tether more AMPARs 
making it more efficient and increasing the probability of potentiation.  
5.2 Methods 
As described in section 2.5, the whole tadpoles were fixed in 5% glutaraldehyde for 10 
minutes, then they were permeabilised in 0.1% triton X for 15 minutes, and were either 
incubated with: primary antibody goat-anti-PSD-95 (1:1000, 1 hour, room temp.); secondary 
antibody (anti-goat fluoro488, 1:1000, 1-hour room temp.); primary antibody (1 hour room 
temperature) + secondary antibody (1 hour room temperature), or control (no antibodies). The 
spinal cords/muscle columns were assessed in Image J, selecting and area away from the yok 
sac and ensuring the area selected was the same section for each group. This was repeated in 
microtome sections of the tadpole as described in methods section 2.2 and 2.5. The same 
experiment was also repeated in the cell cultures, first to see if the cells without any 
antibodies would be fluorescent individually, then to see if areas with high neurite 
concentration would increase in fluorescence with the correct addition of primary antibody 




5.3.1 Developing Xenopus laevis tadpoles when fixed with glutaraldehyde are auto 
fluorescent 
The results (Figure 5.2.1a) analysed in SPSSS using a one-way ANOVA with Bonferroni post-hoc 
analysis showed there was no significant difference between any of the groups (n=3; p=1 for 
all groups). This was repeated in microtome sections where the spinal cord can be more 
accurately assessed without fluorescence from other tissues (shown in methods 2.5). The 
result for this was the same as whole tadpole, with no significant changes in fluorescence 
intensity between any of the groups (Figure 5.2.2). The results of cell culture assessment 
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(Figure 5.2.3) demonstrate that no statistically significant changes were seen in the cultures 









           
   
Figure 5.3.1-Comparing the change in fluorescence of with no antibodies (control), primary 
antibody only, secondary antibody only and primary then secondary treated tadpoles. Excitation 
wavelength 470-520nm; n=9. Top- example images of whole tadpole tail fluorescence a) 
secondary antibody only, b) primary antibody only, c) primary and secondary antibody, d) control 




Figure 5.3.2- microtome slices of stage 40-42 tadpoles. Top- a) example of slice treated with no 
antibodies b) example slices treated with both primary and secondary. Bottom Boxplot representing 







Figure 5.3.3-Boxplot comparing the fluorescence of neuron cell bodies in culture without antibody 
application compared with neuron cell bodies with immunohistochemical antibody staining(n=9). 
Above- example images of the neurons measured left) control with no antibodies added, right) culture 





5.3.2 Cures for glutaraldehyde induced autofluorescence 
There are a few methodological publications which suggest cures for glutaraldehyde, or just 
aldehyde fluorescence. The most common proposed are: sodium borohydride (Beisker, 
Dolbeare and Gray, 1987; Wessendorf, 2004) glycine quenching and H2O2 bleaching (personal 
communication). Glycine and hydrogen peroxide 0.3% were methods consistently mentioned 
on research forums as solutions to autofluorescence, they are also readily available in most 
labs, so these were tried first. Glycine is hypothesised to work by binding to glutaraldehyde’s 
free amine groups thought to be primarily responsible for high degrees of fluorescence. 
5.3.2.1 Result of autofluorescence quenching techniques 
 After fixation and permeabilization tadpoles were incubated in 50mM glycine for three hours. 
There was a slight, but not significant decrease compared with the fixed tadpole control. When 
Primary + secondary antibody was added to the same glycine quenched tadpoles there was 
still no significant change (Figure 5.2.5). This was the same conclusion for hydrogen peroxide 
bleaching, which besides probably damaging the tissue, was ineffective at reducing 
fluorescence compared with control, and once antibodies were added no significant change 
was observed (Figure 5.2.5).  
  
Figure 5.3.4- Boxplot comparing fluorescence of whole tadpole after methods to decrease 




No clear result was obtained that signified the antibody staining was successful. These results 
suggest that either: the antibody used is not specific to PSD-95 in X. laevis tadpoles, the 
secondary or primary antibody are binding to unspecific sites in X. laevis tadpoles or that the 
background fluorescence is ‘drowning out’ the fluorescent signal of the fluorophore.  
The pictures of whole tadpoles where only the secondary antibody was added appear 
remarkably similar to images of both primary and secondary antibody application, with clear 
areas of increased fluorescence, and although neither group were significantly different to 
control, both groups showed increased fluorescence intensity. This may indicate unspecific 
binding of secondary antibodies. However, the microtome section showed very few puncta in 
any group assessed and all groups were even more similar to control groups with no 
antibodies added. It was also noticed that the general level of fluorescence in microtome slices 
was reduced per µm2 compared with whole tadpole (although this doesn’t consider that the 
tadpole is deeper than the 10µm slice). Similarly, the results obtained in cell culture produced 
no discernible differences between no antibody and antibody treated groups. 
 
5.4.1 Assessment of method 
Although controls were applied that demonstrated either unspecific binding or tissue 
autofluorescence drowning out the signal, other positive and negative control should possibly 
have been carried out to ensure the validity of the results. Areas of pure central nervous 
system should have been separated and compared with negative control, such as an area of 
tissue with known non-existence of PSD-95 such as adipose or connective tissue. This extra 
level of certainty in the positive and negative controls would have ensured the validity of the 
results. However, despite a full complement of antibody assessment we can still ascertain that 
our experimental procedure using 5% glutaraldehyde, lead to increased autofluorescence. In 
future it would be recommended that X. laevis are fixed in paraformaldehyde, as other groups 
have done and achieved positive staining using immunohistochemical means for PSD-95 (Liu, 
Tari and Haas, 2009). Another method which would ensure specificity of PSD-95 in X. laevis to 
these antibodies would be to perform a western blot. This would definitively confirm the 
presence of PSD-95, if a positive control of a known PSD-95 sample was used alongside. It 
would also be of interest if in subsequent analysis of bound proteins from X. laevis sample that 
protein other than PSD-95 were binding to the primary or secondary antibody to help 
eliminate the possibility of unspecific binding. Another method would be to genetically 
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manipulate the tadpole to express PSD-95 with a GFP tag. We did experiment with acquiring 
some tadpoles with a MAP-2 GFP tag which were excellent to image live. However, when fixed 
the tadpole became autofluorescent. If the cells were not necessary to be fixed and the AFM 
could be performed in a fluid cell allowing the analysis to be performed in live cells in real 
time, such as in (Shibata et al., 2015), GFP tagged proteins could feasibly be used without 
detrimental autofluorescence.  
The possibility of unspecific binding meant that an alignment analysis of the protein 
sequence was performed. Firstly, it is worth mentioning that the sequence for PSD-95 in X. 
laevis has not been sequenced, but predicted by computational model. The genome of X. 
tropicalis has been fully sequenced and data exists for the protein sequence in X. tropicalis. 
Although very similar organisms, there is quite a difference in genetic organisation mainly that 
X. laevis has four sets of chromosomes compared with X. tropicalis which has two, like most 
other vertebrates. To begin our alignment using NCBI gene and protein database a BLAST 
(basic local alignment search tool) query was run on the predicted sequence of X. laevis PSD-95 
encoded by the gene dlgh4 (disks large homolog 4 isoform X1), which identifies proteins with 
similar sequences in other organisms or different isoforms in the same organism. The results of 
this search show that PSD-95 is highly conserved across species. However, there were 
differences. To investigate further a CLUSTAL omega alignment was performed using the 
FASTA sequences for X. laevis, X. tropicalis, zebrafish, human, mouse and rat. The sequence 
identity of X. laevis was: 86.96% to X. tropicalis, 87.01% to human, 78.93% to zebrafish, 85.15% 
to mouse and 86.29% to rat. This is fairly high level of conservation between species, although 
it is clearly not 100% across species. If we compare human PSD-95  to rat the sequence identity 
is 98.85%. Although there are clearly some differences in sequence of the protein, the 
antibody has been reported to work in zebrafish, human, mouse and rat. It then seems unlikely 
that the one area of difference in X. laevis has caused the antibodies not to bind, especially if 
we compared zebrafish to human which has a sequence identity of 83.36%. There are also 
publications which have successfully identified a signal from PSD-95 in X. laevis. To investigate 
this further it would be beneficial to have the sequence of the active site of the antibody. 
Maybe then a more in-depth analysis would clarify if the differences in sequence lie in areas of 
antibody binding or not.  
5.4.2 Autofluorescence 
The fluorescence of biological molecules has been well categorised, and in fact fluorescent 
microscopes were invented before fluorescent antibodies. Fluorescence occurs by aiming a 
known wavelength of light at a sample, this light (photon) is absorbed into the electron cloud 
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of the molecule and briefly increases the energy level of the outer electrons. When the 
electrons move back to their original energy level, they emit a photon now at an increased 
wavelength. For example, a molecule may absorb/be excited by light of a wavelength at 
450nm and emit the photon at 520nm. This occurs in almost all molecules to some extent, but 
certain biological molecules have a higher probability of excitation and emission. Review of the 
literature shows that the most fluorescent biomolecules categorised are: flavins, NADPH, 
lipofuscins, collagen and elastins (Billinton and Knight, 2001). Tadpole spinal cords and the 
majority of their tail structure at this age are extremely high in collagen which is fluorescent at 
the wavelength used for assessment. Flavins are also a ubiquitous biomolecule that we can 
assume are in high quantities in X. laevis, given their high energy demand for metamorphosis 
and are very fluorescent excited by 488nm, the same excitation wavelength as the secondary 
antibody used in our experiments. Flavins have been studied in X. laevis (Weber et al., 2002), 
and riboflavin is classed as an essential biomolecule for the existence of life. Lipofuscins are 
molecules which are documented to fluoresce a red-orange colour when excited at 460-
490nm, although there are reports of excitation from 345nm (Yin, Yuan and Brunk, 1995). The 
literature states that lipofuscins are accumulated in aging, through continual oxidative stress 
the lipofuscin complexes form. This makes it an unlikely candidate for 3-day old X. laevis 
tadpoles. However, the orange-red fluorescence is similar to what was regularly observed 
particularly from the yok sac. Lipofuscins are essentially lipids, proteins and carbohydrates, 
which through failure of the cells recycling system, form large heterogenous cross-linking 
fluorescent complexes. Although they may not exist in X. laevis cells there are a great deal of 
vesicles within their cells at this age which are full of carbohydrates, lipids and proteins. The 
process of glutaraldehyde fixation cross links carbon molecules inside the cell, probably cross 
linking the vesicles forming similar complexes to lipofuscins. 
Glutaraldehyde on its own has been reported to have a very weak blue fluorescence, 
and this was attributed to possible impurities (Lee et al., 2013). The same study showed that 
glutaraldehyde linked most biomolecules and once linked produced fluorescence of varying 
wavelengths dependent on the biomolecule attached. The fluorescence of glutaraldehyde was 
attributed to a free ethylenediamine and a secondary amine (Lee et al., 2013). Given the 
developing nature of the primary cultures and the tadpoles themselves the combination of 
lipids, proteins, flavins, amino acids all cross-linked with glutaraldehyde may result in high 
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autofluorescence as shown in Figure 5.4.1, comparing a live tadpole imaged in methylcellulose 
and the same tadpole after 30-minute fixation in 5% glutaraldehyde. 
5.4.3 Exploration of our hypotheses 
Our hypothesis for this experiment was that drug treatment which increased the swim-cycle 
frequency and altered dendritic spine dimensions, such as DHPG, would increase the 
expression of PSD-95, a key protein in the enhancement of excitatory signalling. Similarly, drug 
treatments which depress synaptic excitatory signalling, such as cannabinoid agonists, CB1 
antagonists at specific concentrations in vivo (through enhanced glycine signalling depressing 
future glutamate releasing neurons) and group 1 mGluR antagonists MPEP and LY367385, may 
all decrease PSD-95 expression. The likely hood of mGluR1/5 antagonists to decrease PSD-95 
expression is questionable and may be concentration dependent, as we would also expect 
DHPG to be concentration dependent. Group 1 mGluR induced LTD requires very high 
concentrations of DHPG (Fitzjohn et al., 1999), this may have been sufficient in our culture 
model where 50µM DHPG was applied without significant stimulation protocols which may 
have led to an LTD-like dendritic spine morphology possibly observed in the AFM assessment. 
The result in culture may have discriminated between DHPG and MPEP, both of which showed 
similar results in the AFM analysis of dendritic spine dimensions and loss tangent. Or if the 
result was the same expression levels of PSD-95 it may have indicated that in this culture 
system MPEP and DHPG have inadvertently had the same effect on dendritic spines overall. As 
I have mentioned DHPG can cause LTD like phenotypes. In the live tadpole swimming motion 
DHPG may have potentiated excitatory synapses and depressed adjacent inhibitory synapses. 
This would have happened because the excitatory synapses were undergoing high frequency 
signalling during the swimming bouts. This would mean large amounts of glutamate release 
and consequently AMPAR and NMDAR excitation. DHPG on top of this already highly active 
Figure 5.4.1-Example of fluorescence in live tadpole imaged in methylcellulose (left) and the same 
tadpole after 30-minute fixation in 5% glutaraldehyde (right). 
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system may increase output of the dIN and reduce rebound firing through inhibition of glycine 
release. However, in the culture system, the frequency and strength of signalling is likely to be 
reduced. In these circumstances, large amounts of DHPG lead to depressed synapses and an 
LTD-like phenotype of dendritic spines. For this chapter it might have meant we saw an 
increase in PSD-95 in the fixed tadpoles treated with DHPG and a decrease in PSD-95 in the 
cultures. Similarly, the CB1 antagonist AM-251 may well have decreased PSD-95 expression in 
whole tadpoles. Large concentrations of AM-251 significantly decreased frequency and this is 
likely because high amounts of glycine were released onto the dINs. This may have depressed 
signalling and effected the growth of adjacent dendritic spines, possibly decreasing the 
expression of PSD-95.However, in culture AM-251 and AEA are unlikely to have effected PSD-
95 expression as their effect on signalling and growth of dendritic spines may have been 
negligible. In future, it would be interesting to investigate if the axon structure was affected by 
CB1 in culture and see if this correlated with reduced axon protein expression such as SNAP-25 
(synaptic associated protein-25, a vesicle release protein) or tau/ MAP-2 (structural neurite 
proteins). These may be affected due to the inhibitory g-protein signalling effected by CB1 
activation. 
The most interesting results in this section would have come from the microtome 
sections of hindbrain/rostral spinal cord of mGluR1/5 manipulated tadpoles, as this would have 
determined if increases in swim-cycle frequency seen from treatment of DHPG were transient 







There is evidence in previous studies that PSD-95 is present in X. laevis at this stage and that it 
can be detected and visualised using immunohistochemical methods (Liu, Tari and Haas, 2009). 
In our study we observed high levels of autofluorescence when the tadpoles and cultures were 
fixed in 5% glutaraldehyde. Although no positive and negative control were carried out which 
are recommended in the previous section, there would appear to be sufficient evidence that 
autofluorescence meant the signal, if there was any, could not be detected. Previous studies 
which have successfully used immunohistochemistry to identify, visualise and quantify PSD-95 
and other synaptic proteins, have done so via paraformaldehyde fixation (Liu, Tari and Haas, 
2009). It would be recommended that this be used in future IHC experiments using X. laevis, 
although it would be interesting to test if this affected structural integrity for AFM assessment. 
It would also be recommended that these antibodies be tested using western blot for the 
specificity to PSD-95 in X. laevis, compared with known samples of PSD-95 from other 
organisms and using tissue from the brain known to contain PSD-95. This could ensure the 
specificity and accuracy for future experimentation. 
With the success of genetic manipulation in recent years and the possibility of live cell 
AFM analysis in the future GFP tagged PSD-95 could be used so that AFM assessment of 
dendritic spine morphology and evolution under drug treatment conditions could be explored. 
However, genetic addition of GFP to key proteins in the synapse may come with its own set of 
problems that affect development and correct expression. This may not solve the issue of 
localising PSD-95 in microtome sections as we observed “bleeding” of the fluorescence into 





6 General Discussion 
6.1 Behavioural results 
In this thesis we set out to determine if an in vivo measurement of X. laevis tadpoles 
swimming, at stage 37-42, with high-speed video, could determine changes in the swim-cycle 
frequency, regulated by a well characterised CPG network, when group 1 mGluR and CB1 
receptors are manipulated. The results of this experiment, outlined in chapter 3, demonstrate 
that in agreement with previous studies (Chapman and Sillar, 2007; Chapman, Issberner and 
Sillar, 2008), activation of group 1 mGluRs increases swim-cycle frequency in vivo. Also, in 
corroboration with those previous electrophysiological investigations in X. laevis, were the 
findings that antagonism of mGluR1, and not mGluR5, reduced the frequency of swim-cycles, 
indicating an intrinsic role for mGluR1 in the maintenance of normal swim-cycle frequency. In 
vitro studies suggest (Chapman, Issberner and Sillar, 2008) an intrinsic role of mGluR1 in the 
maintenance of swim-cycle frequency and the increases seen with DHPG may be due to 
decreased inhibitory glycine release from cIN to dIN. Previous studies in lamprey CPG had 
observed similar results and went further attributing this decrease in glycine release to the 
presence of CB1 receptors (Kettunen, Hess and Manira, 2003a; Kyriakatos and El Manira, 
2007). CB1’s endogenous function when activated is to reduce neurotransmitter release from 
axon terminals. We hypothesised that this mechanism was similar in X. laevis and the CB1 
receptor may be present and interact in the swim-cycle frequency. To test this, we first used 
our in vivo high-speed video method of swim-cycle assessment to see if CB1 agonism or 
antagonism affected frequency of swim-cycles. The results from this experiment were difficult 
to attribute directly to cIN-CB1 presence, and produced some interesting biphasic results. First, 
to address agonism of CB1 we applied endogenous cannabinoid ligand AEA and we observed 
an interesting result where low doses (0.1µM) significantly decreased frequency. As this dose 
increased the decrease in swim-cycle frequency compared with vehicle control became less 
pronounced, until at highest concentration (50µM) no significant changes were observed. We 
have attributed this effect to two possible explanations. First, it may simply be that the 
endogenous ligand constitutively active at this receptor is the cannabinoid 2-AG, a ligand 
produced in response to mGluR1/5 activation. AEA has a lower EC50 value and Kd, but lower 
maximal response than 2-AG in some experiments (Reggio, 2010), meaning it is possibly a 
partial agonist with a higher affinity. This may mean that at low concentrations AEA almost 
behaves like an antagonist, occupying the receptor while causing a lower response. This would 
mean less axon terminals are inhibited from releasing neurotransmitter, this would increase 
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the level of inhibition in the CPG if CB1 is located on more glycine axon terminals. As the 
concentration increases it begins to have similar effects to 2-AG eventually reaching normal 
cannabinoid effect and normal swim-cycle frequency. Another explanation may lie in the 
distribution and constitutive activity of CB1. Experiments in mice and rat brains demonstrate 
that CB1 is more constitutively active on inhibitory GABAergic terminals (the main inhibitory 
neurotransmitter releasing neurons in the brain) and although CB1 is present on glutamatergic 
axon terminals, glutamatergic-CB1 is only active 5-7% of the time (Steindel et al., 2013; den 
Boon et al., 2014). If this pattern of expression and activity was consistent in the X. laevis 
tadpole spinal cord, it may be that low doses of AEA would initially reduce neurotransmitter 
release from glutamatergic axons first, such as the dINs. If this was the case it would be 
reasonable that low concentration would first decrease excitatory release, then as the 
concentration of AEA increases more glycinergic CB1s are activated reducing inhibition and 
readdressing the excitation-inhibition balance (den Boon et al., 2014). It is noted that neither 
of these explanations take into account that other experiments have shown that reducing cIN 
glycine release only effects frequency of swim-cycles to a certain point (reducing 
hyperpolarising current below -43.2mV decreased frequency of motoneuron firing but any 
hyperpolarisation greater than -43.2mV had no significant effects) (Li and Moult, 2012). This 
would mean that significant reduction in glycine release by CB1 activation would slow 
frequency and not increase it as other studies previously stated in X. laevis and lamprey 
(Kettunen et al., 2005; Chapman, Issberner and Sillar, 2008). As the effect of cannabinoids in 
the X. laevis CPG have not previously been determined, it would be recommended that these 
experiments are repeated using electrophysiological recordings to clarify if the effect on swim-
cycle frequency is due to cIN-dIN CB1 or dIN-motoneuron/dIN-cIN CB1. If time to summation in 
the cIN was decreased this may reduce the frequency of swim-cycles as hyperpolarisation is 
needed at the opposing side for rebound firing. 
Our results with CB1 antagonism via AM-251 gave a complicated biphasic result at 
stages 40-42. Low concentration of AM-251 (0.1µM) decreased frequency, 2μM increased 
frequency significantly and 10μM and 50μM significantly decreased frequency. This biphasic 
concentration dependent pattern has been observed in mice during voluntary locomotion 
studies and may be due to the previously discussed shift in excitation: inhibition balance (den 
boon et al 2014). Our explanation of this result pattern relies on the variation in antagonism of 
cIN-CB1 or dIN-CB1. The concentration dependent shift in the excitation: inhibition balance 
which is at the heart of what determines swim-cycle frequency in the CPG, means that either 
glycine release is increased by such a large amount that it delays dIN rebound firing reducing 
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frequency or increased glutamate release and increased glycine release, but not so much as to 
delay rebound, can increase frequency as seen at 2µM. Previous results using AM-251 in 
lamprey suggested that increased glycine release is responsible for decreases in frequency. 
However, a significant range of concentrations was not used (Kettunen et al., 2005). Those 
studies had also set the baseline frequency with bath application of NMDA.  
From the literature research a protein of interest identified was CRIP1a. This protein, 
activated through coincidence detection of internal neuron environment, can sequester 
opposing g-proteins, meaning an agonist which would normally activate inhibitory alpha g-
protein can activate stimulatory alpha g-proteins (Stauffer et al., 2011). In this vein it is noted 
that AM-251 is often considered an inverse agonist rather than a neutral antagonist which 
means at certain concentrations it may activate stimulatory alpha g-protein, but this effect 
may be concentration dependent. This complicated picture would need clarification via 
electrophysiological recording, but also confirmation of CB1 receptor location using 
fluorescent confocal imaging. Also, it would be beneficial to determine if the CRIP1 protein is 
present and active in X. laevis at this stage.  
This complicated picture makes determining the explanation results obtained when 
CB1 was antagonised (via AM-251) and group 1 mGluRs were activated (via DHPG) or 
antagonised (via MPEP or LY367385), more difficult. Although AM-251 10µM application 
occluded the increase of DHPG 50µM, it is difficult to say this is directly related to blocking 2-
AG action at CB1 on cINs after mGluR1/5 activation from DHPG. It was previously suggested that 
this reduction in glycine release, via CB1 present at cIN terminals, was responsible for some of 
the increases in swim-cycle frequency seen with DHPG application, which is also thought to 
increase dIN depolarisation rate. Again, this should be confirmed with electrophysiological 
recording. Also as previously mentioned confirming the location of CB1 at this stage would 
make understanding the results easier.  
We also hypothesised that if cannabinoid and mGluR1/5 receptors were present in dIN-
motoneuron synapses, reduction in the excitation of motoneurons may result in reduced 
maximum tail flexion achieved during swimming. The results from this analysis aroused some 
interesting possibilities. In the case of mGluR5 inhibition with MPEP significantly increased 
angle size (decreased tail flexion). Then, when MPEP inhibited mGluR5 followed by DHPG 
application or both subtypes were inhibited (MPEP + LY367385) and DHPG added, there was a 
larger significant decrease in the amount of tail flexion. This may indicate that mGluR5 and not 
mGluR1 is present on motoneurons. However, it does not explain what DHPG is activating to 
increase this effect given MPEP is a non-competitive antagonist. Since there is no clear 
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explanation for the results it is worth considering that the variability in the method led to false 
significance. As these measurements are taken from high-speed video frames there is 2.5 
milliseconds between each frame that the camera does not pick up. Also, to compound this 
error the tadpole did not swim perfectly upright in every video and even the measurement 
criteria using Image J was imperfect, meaning three measurements of the same image produce 
three slightly different angles. It might also be that, as discussed in chapter 3 hypothesis for 
this experiment, there is an interplay between speed and angle of tail-flexion. This might mean 
that tail flexion is not itself a good measure of swimming functionality and should be combined 
with a speed over distance measurement to see if the tadpoles swim faster or slower with 
larger or smaller tail flexions. For these reasons it is difficult to prescribe any significance to the 
effect of treatment on tail flexion angle.  
6.2 AFM scanning of dendritic spines 
The results obtained using AFM to scan for and assess dendritic spines, presented in chapter 4, 
indicate that changes in dendritic spine morphology take place within the 20-minute 
incubation period. Particularly, activation of mGluR1/5 with DHPG or antagonism of mGluR5 
with MPEP significantly affect the radius and membrane stiffness of dendritic spines identified. 
The significant increase in radius, seen with both DHPG and MPEP, indicate a possible 
elongation of dendritic spines, which is consistent with previous literature (Vanderklish and 
Edelman, 2002; Cruz-Martín, Crespo and Portera-Cailliau, 2012). We hypothesise that 
application of DHPG in this culture set up may produce a LTD-like response, as previous 
literature has shown that group 1 mGluR activation without high frequency stimulation or 
NMDAR activation can elongate and depress synapse signalling (Vanderklish and Edelman, 
2002). We hoped in chapter 4 to a) see if identification of dendritic spines in this culture was 
possible and an assessment criterion could be generated and b) test if treatments that 
changed frequency of swim-cycles or tail flexion effected dendritic spine dimension in culture. 
As this culture is not behaving in the same way as the whole tadpole it may be unlikely that 
DHPG is elongating dendritic spines in the whole tadpole as, if mGluR1/5 is effective on dINs 
and motoneurons there is likely to be high frequency stimulation during swimming bouts. For 
this experiment to be developed it would be beneficial to assess dendritic spines under LTP 
and LTD protocols as the results could be clearly compared to existing literature.  
6.3 Immunohistochemistry 
This is not dissimilar to what we had hoped to achieve by measuring the fluorescence intensity 
of PSD-95 in culture and in whole tadpole in chapter 5. Had it worked we may have teased 
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apart some of the relationship between dendritic spine morphology, tadpole swim-cycle 
frequency and PSD-95 expression. However, this final experiment to quantify PSD-95 
fluorescence intensity failed to obtain any signal which we could be certain was of antibodies 
attached to PSD-95. Particularly of disappointment, it may have offered some clarity on the 
difference between DHPG and MPEP application as both increased radius and had harder 
membrane measurements. If PSD-95 had been increased with DHPG application, for example, 
it may have indicated these dendritic spines were enlarging for more efficient synaptic 
transmission. Unfortunately, the only result we can offer from this chapter is that 5% 
glutaraldehyde fixation significantly increases the auto fluorescence of the tadpole compared 
with a live tadpole. 
6.4 Future implications 
Many neurological diseases such as fragile X, autism, neurodegeneration and stroke, have 
problems which are compounded by erroneous glutamate signalling and abnormal neuron 
morphology. One of the main issues with targeting glutamate signalling is it’s vital and 
ubiquitous nature in the CNS. For example, inhibiting or reducing NMDAR function (NMDAR 
hypofunction) can lead to psychosis as seen in ‘angel dust’ (Phencyclidine (PCP)) consumption, 
but also to lesser extent in cannabis abuse, particularly in youth. Understanding how 
modulatory GPCRs such as mGluR1/5 and CB1 can alter glutamate signalling in particular neuron 
systems may hold the key to treating or at least managing certain diseases without extreme 
negative effects. An obvious application of cannabinoids, for example, would be to severely 
reduce glutamate release after stroke or injury to stop or slow the runaway effects of 
excitotoxity. It is imperative that we fully characterise and utilise accessible, yet relevant 
model systems such as X. laevis. Our work developing behavioural methods can be used in 
future alongside electrophysiology to test the pharmacological implications of receptor 
systems in a CPG, which is representative of how inhibitory and excitatory signalling regulate 
each other to produce output, a commonality in neural systems.  
The AFM methods can be improved and used in understanding the dynamics of 
membranes in the development of dendritic spines and their changes in mature samples. 
During the development of this method, experiments were published which combined 
confocal imaging with high-speed AFM scanning, meaning near real-time assessment of 
dendritic spines in culture could be performed (Shibata et al., 2015). The future of this field 
could apply this set-up under aforementioned LTP/D protocols and not only measure radius, 
volume and membrane stiffness changes in real time, it could also, via fluorescent confocal 
imaging, track and measure internal protein changes. The measurement of loss tangent could 
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vastly improve our understanding of membrane dynamics in developing neurons as recent 
studies show the importance of physical cues in the growth of neurons (Koser et al., 2016). 
This measurement may also enable us to visualise and understand how membrane tension 
during these events changes and be enhanced to enable neuron recovery from injury. The 
ability of the loss tangent to measure stiffness while obtaining other information about the 
dimensions means that, in the setup of high speed AFM scanning with inverted fluorescent 
confocal in the future, we can measure the movement and quantity of proteins of interest, 
measure the dimensions of dendritic spines by combining z-stack from confocal and AFM 




7.1 Frequency of swim cycles results tables 
Table 7.1.1-Results of linear mixed model comparing the effect agonism/antagonism of the group 1 
metabotropic glutamate receptor has on the swim-cycle frequency of X. laevis tadpole, stage 40-42, all 













Control (DMSO) vs 
DHPG 50µM 
p=0.009 p=0.252 Satisfied Satisfied  
Control (DMSO) vs 
MPEP 50µM 
p=1.000 p=0.197 Satisfied Satisfied 
Control (DMSO) vs 
MPEP 50µM + DHPG 
50µM 
 p=0.000 p=0.039 Satisfied Satisfied 
Control (DMSO) vs LY  
50µM 
p=0.000 p=0.197 Satisfied Satisfied 
Control (DMSO) vs LY 
50µM +DHPG 50µM 
p=1.000 p=0.475 Satisfied Satisfied 
Control (DMSO) vs LY 
50µM +      MPEP 
50µM 
p=0.000 p=0.376 Satisfied Satisfied 
Control (DMSO) vs LY 
+ MPEP 50µM+ DHPG 
50µM 
 p=0.000 p=0.937 Satisfied Satisfied 
DHPG 50µM vs MPEP 
50µM 
p=0.000 
DHPG vs MPEP+DHPG p=0.000 
DHPG vs LY p=0.000 
DHPG vs LY+DHPG p=0.035 




MPEP vs MPEP+DHPG p=0.000 
MPEP vs LY p=0.000 
MPEP vs LY+DHPG p=1.000 
MPEP vs LY+MPEP p=0.000 
MPEP vs LY+ MPEP+ 
DHPG 
p=0.000 










LY vs LY+DHPG p=0.000 
LY vs LY+MPEP p=1.000 
LY vs LY+MPEP+DHPG p=0.652 









Table 7.1.2-Results of linear mixed model comparing the effect selective antagonism of CB1 effects 
mGluR1/5 induced increase in frequency of swimming of X. laevis tadpole tail at stage 40-42 
Treatment Mixed Model Result Normality of residuals Independence of 
Residuals 
Linearity of residuals 
v observed 
Control (DMSO) vs 
AM-251 10µM 
p=0.013 W (47) =0.978; 
p=0.522 
Satisfied Satisfied 
Control (DMSO) vs 
AM-251 10µM 
+DHPG 50µM 
p=1.000 W (47) =0.94; p=0.018 Satisfied Satisfied 
Control (DMSO) vs 
AM-251 10µM + LY 
50µM 
p=1.000 W (47) =0.956; 
p=0.078 
Satisfied Satisfied 
Control (DMSO) vs 
AM-251 10µM + 
MPEP 50µM 
p=0.019 W (46) =0.976; 
p=0.436 
Satisfied Satisfied 
Control (DMSO) vs 
AM-251 10µM+ LY 
50µM + MPEP 50µM 
p=0.007 W (47) =0.988; 
p=0.905 
Satisfied Satisfied 




AM-251 10µM vs 
AM-251 10µM + LY 
50µM 
p=.111 
AM-251 10µM vs 
AM-251 10µM + 
MPEP 50µM 
p=1.000 
AM-251 10µM vs 
AM-251 10µM +LY 
50µM + MPEP 50µM 
p=1.000 
AM-251 10µM 
+DHPG 50µM vs AM-
251 10µM + LY 50µM 
p=1.000 
AM-251 10µM 
+DHPG 50µM vs AM-




+DHPG 50µM vs AM-
251 10µM +LY 50µM 
+ MPEP 50µM 
p=0.064 
AM-251 10µM + LY 
50µM vs AM-251 
10µM + MPEP 50µM 
p=0.165 
AM-251 10µM + LY 
50µM vs AM-251 
10µM +LY 50µM + 
MPEP 50µM 
p=0.068 
AM-251 10µM + 
MPEP 50µM vs AM-
251 10µM +LY 50µM 








7.2 Angle of Flexion results tables 































Linearity of observed v 
Predicted value 
Control (DMSO) vs 
DHPG 50µM 
p=1.000 p=0.153 Satisfied  Satisfied 
Control (DMSO) vs 
MPEP 50µM 
p=0.037 p=0.809 Satisfied Satisfied 
Control (DMSO) vs 
MPEP 50µM 
+DHPG 50µM 
p=0.005 p=0.406 Satisfied Satisfied 
Control (DMSO) vs 
LY  50µM 
p=1.000 p=0.752 Satisfied Satisfied 
Control (DMSO) vs 
LY 50µM + DHPG 
50µM 
p=1.000 p=0.023 Satisfied Satisfied 
Control (DMSO) vs 
LY 50µM +      
MPEP 50µM 
p=1.000 p=0.751 Satisfied Satisfied 
Control (DMSO) vs 
LY + MPEP 50µM+ 
DHPG 50µM 
p=0.003 p=0.239 Satisfied Satisfied 






DHPG vs LY p=0.827 
DHPG vs LY+DHPG p=1.000 







MPEP vs LY p=0.001 
MPEP vs LY+DHPG p=1.000 
MPEP vs LY+MPEP p=1.000 
MPEP vs LY+ 
MPEP+ DHPG 
p=1.000 










LY vs LY+DHPG p=0.115 















Table 7.2.2- Results of LMM analysis of AOF when CB1 antagonism combined with mGluR1/5 
agonism/antagonism 





















Control (DMSO) vs 





Control (DMSO) vs 





Control (DMSO) vs 
AM-251 10µM+ LY 




DHPG 50µM vs AM-
251 10µM 
p=1.000 
DHPG 50µM vs AM-
251 10µM +DHPG 
50µM 
p=1.000 
DHPG 50µM vs AM-
251 10µM + LY 
50µM 
p=0.004 
DHPG 50µM vs AM-
251 10µM + MPEP 
50µM 
p=0.000 
DHPG 50µM vs AM-
251 10µM+ LY 50µM 
+ MPEP 50µM 
p=0.338 




AM-251 10µM vs 
AM-251 10µM + LY 
50µM 
p=0.011 
AM-251 10µM vs 
AM-251 10µM + 
MPEP 50µM 
p=0.000 
AM-251 10µM vs 
AM-251 10µM +LY 
50µM + MPEP 50µM 
p=0.667 
AM-251 10µM 
+DHPG 50µM vs 




+DHPG 50µM vs 




+DHPG 50µM vs 
AM-251 10µM +LY 
50µM + MPEP 50µM 
p=0.001 
AM-251 10µM + LY 
50µM vs AM-251 




  AM-251 10µM + LY 
50µM vs AM-251 
10µM +LY 50µM + 
MPEP 50µM 
p=1.000 
AM-251 10µM + 
MPEP 50µM vs AM-
251 10µM +LY 50µM 




7.3 Power analysis of Cannabinoid data 
A power analysis was performed on frequency of swim-cycle measurements to determine if 
sufficient sample sizes were achieved. In the table below sufficient power is designated at 
>0.95, results below this are deemed to be underpowered and required total sample size is 
calculated. All power analysis were performed on GLIMPSE software and were done for each 
treatment compared with its respective vehicle control. Where initial analysis of data with 
LMM showed no significant interaction and null hypothesis is accepted a power analysis is not 
applicable. 
Table 7.3.1- Power analysis for AM-251 stage 40-42 
concentration power Sample size needed for power of 0.95 
0.1µM n/a n/a 
2µM 0.98 n/a 
10µM 0.99 n/a 
50µM 1.00 n/a 
 
Table 7.3.2- Power analysis for AM-251 stage 37-39 
concentration power Sample size needed for power of 0.95 
0.1µM 1.00 n/a 
2µM n/a n/a 
10µM 0.833 14 (n=7) 
50µM 1.00 n/a 
 
Table 7.3.3- Power analysis for AEA stage 40-42 
concentration power Sample size needed for power of 0.95 
0.1µM 0.959 n/a 
2µM 1.00 n/a 
10µM 1.00 n/a 
50µM n/a n/a 
 
Table 7.3.4- Power analysis for AEA stage 37-39 
concentration power Sample size needed for power of 0.95 
0.1µM n/a n/a 
2µM n/a n/a 
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10µM n/a n/a 






7.4 Frequency appendix 
All residual vs predicted plots for the assumption of linearity and independence of residuals 
obtained for frequency of swim-cycles. Plots indicate the model may not be a good fit if there 
is clear patterning and grouping rather than an equal distribution of errors.  
Stage 40-42 
 




























































Figure 7.4.10- Residuals from LMM for AM-251 10μM compared with control (DMSO)  vs predicted 











Figure 7.4.12- Residuals from LMM for AM-251 0.1μM compared with control (DMSO) vs predicted 
































Figure 7.4.17- Residuals from LMM for mGluR1/5 manipulations compared with control (DMSO)  vs 
predicted values. Stage 40-42 
 
 
Figure 7.4.18- Residuals from LMM for Cb1 antagonism +mGluR1/5 manipulation compared with control 








Figure 7.4.19- residual vs predicted plot for angle of flexion measurement mGluR1/5 vs control DMSO 
dataset 
 









7.5 AFM appendix  
 
Table 7.5.1- table of p-values investigating if slide had effects within groups. Slide 1 was tested against 
slide 2 for each treatment in an independent t-test in SPSSS 
Treatment radius Volume Cross-section Roughness Loss tangent 
Control 
(DMSO) 
0.486 0.563 0.614 0.255 0.109 
DHPG 0.515 0.436 0.218 0.055 0.061 
MPEP 0.163 0.183 0.108 0.373 0.082 
AM-251 0.783 0.253 0.140 0.083 0.894 
AEA 0.279 0.219 0.170 0.419 0.708 
Control 
(Soya) 
0.253 0.210 0.116 0.327 0.085 
 
Although no slides within groups were significantly different to one another there are some 




Loss tangent linear mixed model assumption predicted vs residuals 
 
Figure 7.5.1- loss tangent residuals v predicted  











Figure 7.5.3- cross-section residuals v predicted values 
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